<ead xmlns="urn:isbn:1-931666-22-9" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:isbn:1-931666-22-9 http://www.loc.gov/ead/ead.xsd">
  <eadheader countryencoding="iso3166-1" dateencoding="iso8601" langencoding="iso639-2b" repositoryencoding="iso15511">
    <eadid>FA1103A.xml</eadid>
    <filedesc>
      <titlestmt>
        <titleproper type="filing">Rockefeller University collection of the Medical Letter publication, 1996-2004</titleproper>
        <titleproper>A Guide to the Rockefeller University collection of the Medical Letter publication, 1996-2004 <num>FA1103A</num></titleproper>
      </titlestmt>
      <publicationstmt>
        <publisher>Rockefeller Archive Center</publisher>
        <address>
          <addressline>15 Dayton Avenue</addressline>
          <addressline>Sleepy Hollow 10591</addressline>
          <addressline>archive@rockarch.org</addressline>
          <addressline>URL: <extptr xlink:href="http://www.rockarch.org" xlink:show="new" xlink:title="http://www.rockarch.org" xlink:type="simple"/></addressline>
        </address>
      </publicationstmt>
    </filedesc>
    <profiledesc>
      <creation>This finding aid was produced using ArchivesSpace on <date>2016-09-27 00:00:40 -0400</date>.</creation>
      <descrules>Describing Archives: A Content Standard</descrules>
    </profiledesc>
  </eadheader>
  <archdesc level="collection">
    <did>
      <langmaterial>
        <language langcode="eng">English</language>
      </langmaterial>
      <repository>
        <corpname>Rockefeller Archive Center</corpname>
      </repository>
      <unittitle>Rockefeller University collection of the Medical Letter publication</unittitle>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Rockefeller University</corpname>
      </origination>
      <origination label="creator">
        <corpname role="aut" source="lcnaf">Medical Letter, Inc</corpname>
      </origination>
      <unitid>FA1103A</unitid>
      <physdesc altrender="whole">
        <extent altrender="materialtype spaceoccupied">122.5 Cubic Feet</extent>
      </physdesc>
      <unitdate normal="1996/2004" type="inclusive">1996-2004</unitdate>
    </did>
    <processinfo id="aspace_4f6518ea8bae3b64eb48a7b6e5a4ac82">
      <head>Processing Information</head>
      <p>Minimal processing</p>
    </processinfo>
    <prefercite id="aspace_08d6bd5a3343d88ae174562240e1c48c">
      <head>Preferred Citation</head>
      <p>Information regarding the Rockefeller Archive Center's preferred elements and forms of citation can be found at <extref href="http://www.rockarch.org/research/citations.php">http://www.rockarch.org/research/citations.php</extref></p>
    </prefercite>
    <accessrestrict id="aspace_8e22992d16c1acad66ec2350a423e469">
      <head>Conditions Governing Access</head>
      <p>Records more than 25 years old are open for research with select materials restricted as noted. Brittle or damaged items are available at the discretion of RAC.</p>
    </accessrestrict>
    <fileplan id="aspace_b18026630ad0911a346cf5ce064ebdd5">
      <head>File Plan</head>
      <p>Former Classification: I 891-U</p>
    </fileplan>
    <otherfindaid id="aspace_80d67a066600f6ef1d33e75468f27af6">
      <head>Other Finding Aids</head>
      <p>For additional Medical Letter materials open for research see:</p>
      <p>FA241 Rockefeller University collection of the Medical Lettter publication</p>
    </otherfindaid>
    <scopecontent id="aspace_96fc3f4b0ecc38c530137eb411f39ada">
      <head>Scope and Contents</head>
      <p>Contents includes: original manuscripts, reprints, advertising and package inserts, sources check, consultatnts drafts, manufacturers replies, and bibliography.</p>
    </scopecontent>
    <bioghist id="aspace_6c159867ba2a2151b8b7399752c3890b">
      <head>Biographical / Historical</head>
      <p>The Medical Letter on Drugs and Therapeutics is an independent, non-profit publication providing unbiased critical evaluation of drugs in terms of their effectiveness, adverse effects and possible alternative medications.</p>
    </bioghist>
    <userestrict id="aspace_37e428481bbdbecee9f5c722527c7cfc">
      <head>Conditions Governing Use</head>
      <p>Use agreement is required prior to providing access. See RAC Head of Reference for assistance.</p>
    </userestrict>
    <dsc>
      <c id="aspace_722d135ab2e6b9a0415068e6118db069" level="file">
        <did>
          <unittitle>TML, 38-9 - Acarbose for diabetes mellitus</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="aspace_28628b54c48d1be9dae99a16c1673762" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_e82614db27e1688128b461f4fe8ba439" parent="aspace_28628b54c48d1be9dae99a16c1673762" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_6413d819e0f61297a55139d343bc6b2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_8e0dd5900ff39bfca71872aabc11f428" level="file">
        <did>
          <unittitle>TML, 38-55 - Acetaminophen, NSAIDs and Alcohol</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="aspace_fd46a9f6099194da9b342522028788fb" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_f495950fc998ec881d7f67857bf1c975" parent="aspace_fd46a9f6099194da9b342522028788fb" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_656f8049cade326890b44a882a172390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_92bb9fbbd017dace4f8bbbdfdcec0a7a" level="file">
        <did>
          <unittitle>TML, 38-43 - Acute reactions to Drugs of Abuse</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="aspace_9bf3b2e482e5b3ecb637e3fe99c9c58a" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_9d8525124de85e19a44264d684d60f3d" parent="aspace_9bf3b2e482e5b3ecb637e3fe99c9c58a" type="folder">8-12</container>
        </did>
        <accessrestrict id="aspace_ca3616172a78ef218806617937be4ae3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_299c68349552c9c16b93a8a4762f739e" level="file">
        <did>
          <unittitle>TML, 38-35 - New drugs for HIV</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="aspace_681688569a79a651f868792e01f85dd9" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_e3b41b42e03c9688ff31cd23acd37642" parent="aspace_681688569a79a651f868792e01f85dd9" type="folder">13-17</container>
        </did>
        <accessrestrict id="aspace_86a00cb09aea1b9f00fe35947afa8c0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c5fa85f3bd2884f1a9dfd36830a4fb4d" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="aspace_4035d8a4cf36c59c60273e228cecb389" label="Mixed Materials (A0000000075844)" type="box">1</container>
          <container id="aspace_9c4968df4544893a3b3e1777af2bd7b5" parent="aspace_4035d8a4cf36c59c60273e228cecb389" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_6490910db6cb9773d516babe0e3ba2c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_25c672276d8de231f00bfa483bb42cb2" level="file">
        <did>
          <unittitle>TML, 38-99 - Alteplase for thrombolysis in acute ischemic stroke</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="aspace_29ea015b249262032e55f7d365ab91db" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_059174cd398d124acf23304363bc4cd2" parent="aspace_29ea015b249262032e55f7d365ab91db" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_2d841e9b213eca4386b5020a0f960ab2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_520cba0819f4d1a661ffbae9d84a72d2" level="file">
        <did>
          <unittitle>TML, 38-61 - Anatrozle for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="aspace_3894aea0e8d34da3b43e0eb3d1c046e3" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_d4a158ccbe66ae66cda22a7b83b1b452" parent="aspace_3894aea0e8d34da3b43e0eb3d1c046e3" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_391e7265783eb309c372f58724caf420">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_b466c2ae20545eb902a029aabfadd4a2" level="file">
        <did>
          <unittitle>TML, 38-25 - Choice of Antimicrobial Drugs</unittitle>
          <unitdate type="inclusive">1996 March 29</unitdate>
          <container id="aspace_d5a64d22df89f24e858f40906f8757d0" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_99951f2de84beb814df0d94ac27c343b" parent="aspace_d5a64d22df89f24e858f40906f8757d0" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_abc8cefbfb0e5ceded73db45b93e2776">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_ef71891079fc8afb056a13746e052f75" level="file">
        <did>
          <unittitle>TML, 38-52 - Drugs for Cardiac Arrythmias</unittitle>
          <unitdate type="inclusive">1996 August 30</unitdate>
          <container id="aspace_894bce6c329058819dd7b440a726d6ef" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_60c2b4ee46031f0467e0fd9550920948" parent="aspace_894bce6c329058819dd7b440a726d6ef" type="folder">10-16</container>
        </did>
        <accessrestrict id="aspace_e9ba90f8f6e01a82041a2cb46e749402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_630284f8fa9310d4604f35f82942ec99" level="file">
        <did>
          <unittitle>TML, 38-52 - Azelaic acid a new topical drug for acne</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="aspace_e9c634b675d8e3824d21d7c7b7f64499" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_667850e740c6340754ad2f625de6bae8" parent="aspace_e9c634b675d8e3824d21d7c7b7f64499" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_7d350d2c114c77a5007cc5bd6bef48d0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_4b06c4e94eeae1bbd7e893099db3bb23" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="aspace_c67864a25561cead95b6ce7819b3151d" label="Mixed Materials (A0000000075845)" type="box">2</container>
          <container id="aspace_68362a33d82f6efc1ec040c4f1b4421f" parent="aspace_c67864a25561cead95b6ce7819b3151d" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_c9d5e1a415d2921805aa74b729504b02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_cdf8cc07b4cfdaccc7c2d14cfe460d41" level="file">
        <did>
          <unittitle>TML, 38-56 - Bicalutamide for prostate cancer</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="aspace_6b0bc2a5fe44c0d04e6210b45c9912b0" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_bb56f379faae0e1668a6728037902964" parent="aspace_6b0bc2a5fe44c0d04e6210b45c9912b0" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_bc8ec69f68ddfbb05692b444a9d33f73">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_8e8440ccfa5de303b70df4a8556b7da1" level="file">
        <did>
          <unittitle>TML, 38-103 - Bone Density Testing</unittitle>
          <unitdate type="inclusive">1996 November 26</unitdate>
          <container id="aspace_56a8c54210154d70c96f6d4133c9f8d9" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_f0a3cac7a87759f14d6be3183692297d" parent="aspace_56a8c54210154d70c96f6d4133c9f8d9" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_9371d9820f979006c113e8341494696d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_2bc3e056d1f8fa2492e7303d95310131" level="file">
        <did>
          <unittitle>TML, 37-109 - Dirithromycin</unittitle>
          <unitdate type="inclusive">1995 November 24</unitdate>
          <container id="aspace_8e3a591d35fd462991b5eea09092b972" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_816e7bf903f240e4fb1919569e9ba4a9" parent="aspace_8e3a591d35fd462991b5eea09092b972" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_70e63df474c05d465a52ed6834a63c2e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_404e68490aeea4bc03276bd2e1972297" level="file">
        <did>
          <unittitle>TML, 38-108 - Calcium Supplements</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="aspace_7f0bd16e7129dfc21d643131be024d5d" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_4b5ab5cacea02a302f15ca4bf1268b37" parent="aspace_7f0bd16e7129dfc21d643131be024d5d" type="folder">8-12</container>
        </did>
        <accessrestrict id="aspace_6397bcfd119b8dee01530ad0c01d2fe0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_787f855d64193a39aa5fa640c29b09f9" level="file">
        <did>
          <unittitle>TML, 38-40 - Radiofrequency cather abilation for treatment of cardiac arrhythmias</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="aspace_bb3e5db69d68a1d23cdccab68a88d413" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_555f10d429bec3f0a20f746a73a075c4" parent="aspace_bb3e5db69d68a1d23cdccab68a88d413" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_9407b24c4bbb8b9a8280fd95b434f402">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_6ee9fed32bd765fba31910157fc457da" level="file">
        <did>
          <unittitle>TML, 38-23 - Cetibuten - a new oral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="aspace_b33156872616321504a80ad2dd1280e8" label="Mixed Materials (A0000000075846)" type="box">3</container>
          <container id="aspace_b1f2f747c5323e918638afda6cf02f56" parent="aspace_b33156872616321504a80ad2dd1280e8" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_fe428baa314a27bf86569a7a685bf75c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_cf9669d33a59dba3ffbe8f50f22fca78" level="file">
        <did>
          <unittitle>TML, 38-84 - Cefepime (Maxime) - a new parenteral cephalosporin</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="aspace_0e5f4409bf7b6201f199625fbf867a00" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_9a7c29ccefbaa04449b926d63eb59cb4" parent="aspace_0e5f4409bf7b6201f199625fbf867a00" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_cd47248ae2cfc55d2fb4424654263054">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_7dd0747a03e955ecdd43cb4fc77cc296" level="file">
        <did>
          <unittitle>TML, 38-46 - Chlorzoxazone hepatotoxsicity</unittitle>
          <unitdate type="inclusive">1996 May 10</unitdate>
          <container id="aspace_a2d1c4511a983e31b19b8deca91bb92f" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_9988c6e92de40c5c03fb4f4b7bb71b70" parent="aspace_a2d1c4511a983e31b19b8deca91bb92f" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_2fb3ed462271aeec0fb14801053de435">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_9050bc8c28970ad791e377582e9c079c" level="file">
        <did>
          <unittitle>TML, 38-67 - Choice of Lipid-Lowering drugs</unittitle>
          <unitdate type="inclusive">1996 August 2</unitdate>
          <container id="aspace_1c0c7ba88328e71fbd08e5ffd94b16c5" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_9c509dc244ee9604f9b85596fa4d415d" parent="aspace_1c0c7ba88328e71fbd08e5ffd94b16c5" type="folder">6-13</container>
        </did>
        <accessrestrict id="aspace_88da501863cd117b47bcae321e4b3b00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_5c5e7299af1de05e46453f0fea0e1720" level="file">
        <did>
          <unittitle>TML, 38-21 - Cetirizine - a new antihistamine</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="aspace_3bcebfa197a01389bf99539ed18f47cc" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_ec12c443a37a92472db17238cbd95f83" parent="aspace_3bcebfa197a01389bf99539ed18f47cc" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_0f7c6d142759503d2196573bb0b89f9a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f91362447d7a3cdff68d7ebac520b38" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="aspace_283b2c4d9838c13434a5c358faeea5b6" label="Mixed Materials (A0000000075847)" type="box">4</container>
          <container id="aspace_8efd5726e3a49bdb46330f1be28c5f5c" parent="aspace_283b2c4d9838c13434a5c358faeea5b6" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_4e5c9545497b1cea799d01d6d8e16965">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c714362a04b8f852b521155e586e0af2" level="file">
        <did>
          <unittitle>TML, 38-109 - Clonidine for treatment of ADHD</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="aspace_ced8e082a66b769e362efd50fbaaf655" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_3061cac7dab9facf68de7b0025d68d6f" parent="aspace_ced8e082a66b769e362efd50fbaaf655" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_a545b57ddc41b86449988949e310c707">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_484f5bda82347b92c1fd763adae1bf8a" level="file">
        <did>
          <unittitle>TML, 38-64 - Dexfenfluramine for obesity</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="aspace_49e71105c31b9da172e7d6561ba0e052" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_f6c7e36d61f4e052cbde4e4a00bc24fc" parent="aspace_49e71105c31b9da172e7d6561ba0e052" type="folder">2-5</container>
        </did>
        <accessrestrict id="aspace_0ae4223f8a683f538d4cd77c366f1250">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d0423127d33593f9f53a6262dc9f97c" level="file">
        <did>
          <unittitle>TML, 38-87 - Docetaxel (Taxotere) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="aspace_cfae153d5bb985d281b4272f6c331d85" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_158aae409a27e310840bc51d503bf3c9" parent="aspace_cfae153d5bb985d281b4272f6c331d85" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_ed7cc80f5cac6080418667469e63fcc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_a348057f4e83121c70f8e63e18862273" level="file">
        <did>
          <unittitle>TML, 38-14 - Epoprostenol for primary pulmonary hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="aspace_f6e8826911d39d27002e9a7c2c8fe319" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_c0b3509b93f110d095b615742412c136" parent="aspace_f6e8826911d39d27002e9a7c2c8fe319" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_9060f4c1941e62cde507283711c42123">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_4fb37dc500fa2658eede9f802e9df8f8" level="file">
        <did>
          <unittitle>TML, 38-95 - Fexofenadine</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="aspace_a1603574abef7a8efd0e625916f7f729" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_27bfb0372f765d4add3af3a3e27ee5ff" parent="aspace_a1603574abef7a8efd0e625916f7f729" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_a8ff5bd8f8c9a8beb936876d0ab13404">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_64be8e3eb6b9a7f019087998bc44abd8" level="file">
        <did>
          <unittitle>TML, 37-13 - Fluvoxamine for obsessive compulsive disorder</unittitle>
          <unitdate type="inclusive">1995 February 17</unitdate>
          <container id="aspace_178001e3ac63d034c45280890aa13c8b" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_21629b92f43a87b00f453436656080fc" parent="aspace_178001e3ac63d034c45280890aa13c8b" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_695bcbd1bf632b907b932d7960966f9f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_892b6eca462f2e15ad9ec8aa8eca30aa" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="aspace_659b9cfb56237f1c2f8c1d7c3a902135" label="Mixed Materials (A0000000075848)" type="box">5</container>
          <container id="aspace_00ff1fe7068737b22de237b34dc1fb48" parent="aspace_659b9cfb56237f1c2f8c1d7c3a902135" type="folder">17-21</container>
        </did>
        <accessrestrict id="aspace_beb3673044e9a99bc1e5e6f80a600a9c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_35c106caf84841f600db741ede502382" level="file">
        <did>
          <unittitle>TML, 38-83 - Fluticasone propionate for chronic asthma</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="aspace_c642c64b3f6962249b55364d84084f21" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_b173f56416c6af6e1240d475f24cea09" parent="aspace_c642c64b3f6962249b55364d84084f21" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_f54d8351e9c7683733c760ddc9c6386f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c02c90545e46d220940cf2a507e0a28" level="file">
        <did>
          <unittitle>TML, 38-10 - Systematic antifungal drugs</unittitle>
          <unitdate type="inclusive">1996 February 2</unitdate>
          <container id="aspace_92eb70bcdc37ad3f41e2f7dbbb166b41" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_28e98f732a9fad76e4064fcfbf1dc24f" parent="aspace_92eb70bcdc37ad3f41e2f7dbbb166b41" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_24650d75f7a4fe5ddaf748532b77d1c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_af3d9dfc1b1412c493e47fcf1216a75b" level="file">
        <did>
          <unittitle>TML, 38-102 - Gemcitabine for treatment of pancreatic cancer</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="aspace_246c00f7c0fe8e78256238051ed5db2e" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_1dc14a3b2d585a63dc19783ba30b0dcb" parent="aspace_246c00f7c0fe8e78256238051ed5db2e" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_7105d2dd194378e7c1b806e1786142c0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_237f462175824d3b36e04281c83344ac" level="file">
        <did>
          <unittitle>TML, 38-47 - Glimepiride for NIDDM</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="aspace_d6d30834d6dac56cea3ae9434b1bdd01" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_b1a461ccde05c0bc965577295593a36a" parent="aspace_d6d30834d6dac56cea3ae9434b1bdd01" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_d0c68415f609b87b8e322217b54f482b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_f5f43d18d02fa3b8ac7f25b5d2f4bf4e" level="file">
        <did>
          <unittitle>TML, 38-92 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="aspace_ded7a2d5b30b2641b875bc749cf80252" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_93728e97cef154d98242caab725e4ebc" parent="aspace_ded7a2d5b30b2641b875bc749cf80252" type="folder">9-13</container>
        </did>
        <accessrestrict id="aspace_a3631f3ddc4c9deaa183f2128f324ec8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_df185de80953b9ba72734fc53563026f" level="file">
        <did>
          <unittitle>TML, 37-73 - Grapefruit juice interactions with drugs</unittitle>
          <unitdate type="inclusive">1995 August 18</unitdate>
          <container id="aspace_80f4a582ca55fec8b7584e04124415ad" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_77cbf64dbfff0f3685cba68587c196f7" parent="aspace_80f4a582ca55fec8b7584e04124415ad" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_ee2185b1e98265927be53db9e0fa2dda">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_9ea393808d7941a34a9237ff7d3e21d0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="aspace_c5fb6caef10dce2f87100f2dd8571610" label="Mixed Materials (A0000000075849)" type="box">6</container>
          <container id="aspace_33ec5e8b2ce09f859b0d783cdbb62c7f" parent="aspace_c5fb6caef10dce2f87100f2dd8571610" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_052ebcc34a91845237e97c0df53775e3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_b5728f730c61991eb3d049832355c05c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="aspace_b3bc433c0e453b1b8abe033efce7c8bc" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_9233ba4a6d7d15c4945f271faafa4d43" parent="aspace_b3bc433c0e453b1b8abe033efce7c8bc" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_8725ceb0317248c73c37ce2386f5e01b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_34fded3e81407289cef7298c43db888c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">1995</unitdate>
          <container id="aspace_e8c93cedb220cf84fc5003614d61bb85" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_421c6351198b9bb2e0148e3bd3e99bfe" parent="aspace_e8c93cedb220cf84fc5003614d61bb85" type="folder">3-7</container>
        </did>
        <accessrestrict id="aspace_fd6c1b22c3706f5ee95e16758bf6f9f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_73f114dc6e630afb990634a443031d95" level="file">
        <did>
          <unittitle>TML, 37-95 - OTC H2 Blockers for heartburn</unittitle>
          <unitdate type="inclusive">1995 October 27</unitdate>
          <container id="aspace_da7678381c39f7eb751f575d621e5fbc" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_31aaddea1d45689c76ae0a6b4a02d73c" parent="aspace_da7678381c39f7eb751f575d621e5fbc" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_6f9d54ac52d448a971ae1e70ff68a5a9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e3ff759a8063b390ff0175205e40649d" level="file">
        <did>
          <unittitle>TML, 38-6 - Rho (D) IV Immune Globulin</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="aspace_1190d95bd34c5926701fe52632d4be20" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_aa2b378ae8638f29b1ec374acd731a8a" parent="aspace_1190d95bd34c5926701fe52632d4be20" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_ce939d07fa2fe96e5b623cff81c37a02">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_343b5e9d7ba1058f32a08341d9be9f4a" level="file">
        <did>
          <unittitle>TML, 38-17 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1996 March 15</unitdate>
          <container id="aspace_f583c08cbd3b852a33a0aa43014ee1eb" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_ec385eb02c5501f54f35d9b8dc86863d" parent="aspace_f583c08cbd3b852a33a0aa43014ee1eb" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_c3bea7a676bd5b9981068ccf42242297">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_314ebfe0a12d0bad31002df2bbabf782" level="file">
        <did>
          <unittitle>TML, 37-98 - Influenza Vaccine, 1995-1996</unittitle>
          <unitdate type="inclusive">1995 September 1</unitdate>
          <container id="aspace_a8db6c9b6ecdd0080aeaa05ab0eaf024" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_d4b87cbae16c63a700e72396b73f37e8" parent="aspace_a8db6c9b6ecdd0080aeaa05ab0eaf024" type="folder">17</container>
        </did>
        <accessrestrict id="aspace_aaa5f55ecc1b4da36b3c2d152b9841b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_fa30b8e25d30bd60ee7b9207731748dd" level="file">
        <did>
          <unittitle>TML, 38-86 - Influenza Vaccine, 1996-1997</unittitle>
          <unitdate type="inclusive">1996 September 13</unitdate>
          <container id="aspace_040c03c921a578bf71e8b1a160942e43" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_d3dbb906c9429b1ed3abb10fc16532db" parent="aspace_040c03c921a578bf71e8b1a160942e43" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_5726a4d76a933c3152d68d2618f96f58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_76dcb6a56a7b5f83636afb906304e3de" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="aspace_9347095c6ee311c45812a6d39fcc065e" label="Mixed Materials (A0000000075850)" type="box">7</container>
          <container id="aspace_8f79fc0c3f97e86d4cc62d58847eeafc" parent="aspace_9347095c6ee311c45812a6d39fcc065e" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_c85f0b8357c82829d2a4eb5e651846cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_bcfc06fa9fa8a02872f2c29e1146f46b" level="file">
        <did>
          <unittitle>TML, 38-59 - Oral hypnotic drugs</unittitle>
          <unitdate type="inclusive">1996 July 5</unitdate>
          <container id="aspace_0e84a0e75f37774e2027abb43bf33c72" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_e4363a9dc483a654f238a6bc0296a290" parent="aspace_0e84a0e75f37774e2027abb43bf33c72" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_5afb2bc4dd74607653137719b41bcbd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_ca2a00af5d69b29922032ebf4abb0fa9" level="file">
        <did>
          <unittitle>TML, 38-63 - Interferon beta IA for relapsing multiple sclerosis</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="aspace_e5b4d3da2aa2fae05ba674e8a42b2fb8" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_57d855b4e97d80b107c1c5e90f08c7d6" parent="aspace_e5b4d3da2aa2fae05ba674e8a42b2fb8" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_03343319e99b7f0ef24a7fc83ce57bad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c90350a57c09afa4b1edf8990faf82c4" level="file">
        <did>
          <unittitle>TML, 38-5 - Intraconazole for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 January 19</unitdate>
          <container id="aspace_6ee84c65e88c8533301e4e86706905a2" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_81078d7de0dabb7757bbb16068c3dd91" parent="aspace_6ee84c65e88c8533301e4e86706905a2" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_a3ae42f0dfac2f6884835c0dd4cbe74b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_838bd206e5b57f1350c9a04ae42f2583" level="file">
        <did>
          <unittitle>TML, 38-100 - Latanoprost - A topical prostaglandin for glaucoma</unittitle>
          <unitdate type="inclusive">1996 November 8</unitdate>
          <container id="aspace_971df1397b824b8a7326855aaaa0389e" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_137128ffc31162a81f4a5f93fa09d2c9" parent="aspace_971df1397b824b8a7326855aaaa0389e" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_2e48e9ac6a735700c373ee378f599caa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_45a205e5a189cb71c6708535b75c4937" level="file">
        <did>
          <unittitle>TML, 38-97 - Lispro - A rapid onset insulin</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="aspace_5533bfae175352bcc6077dba3551e4eb" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_79c7eece183400c453a10303412f1ef2" parent="aspace_5533bfae175352bcc6077dba3551e4eb" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_0c7d5401af543b0c0983defbe212a6e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_2cbe2967f283fa20d7d713e0125238d8" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="aspace_bae80f770d553d71aa087e3e966cf5da" label="Mixed Materials (A0000000075851)" type="box">8</container>
          <container id="aspace_eba12a5ab2b31e80fb79cd6b90e3d1f1" parent="aspace_bae80f770d553d71aa087e3e966cf5da" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_25976cdf1f32d7fc8a1e78cb2f48d34d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_f7093bc2141bbd10998f3dc5ff41875b" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="aspace_2226dfb1930452af63308f7f13f48995" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_4a6b15f6be0cd62287041652ce2495ff" parent="aspace_2226dfb1930452af63308f7f13f48995" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_5de98fca91cbe16591ff580840223c8c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e7f67d0b2048a576bdc2a8c6ef1f5674" level="file">
        <did>
          <unittitle>TML, 38-13 - Nisoldipine - a new calcium-channel blocker for hypertension</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="aspace_cf52026c517af65db21319a2cf751607" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_19cba9e72dfd274ec6672c9cca6354af" parent="aspace_cf52026c517af65db21319a2cf751607" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_310f0f0a8b17bda4d5be0d11e8e3909a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ab086d0742f0a6f31a054d358cbefcf" level="file">
        <did>
          <unittitle>TML, 35-62 - Nedocromil for asthma</unittitle>
          <unitdate type="inclusive">1993 July 9</unitdate>
          <container id="aspace_28eb935aaa5e74098f2e7794fc983bf6" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_dd6fc66e20f795dfea00c57d845f89d7" parent="aspace_28eb935aaa5e74098f2e7794fc983bf6" type="folder">8-12</container>
        </did>
        <accessrestrict id="aspace_d876b6e0e035d2d97ee9711f878a831c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_9f3042b173404cf6a3ccd9df900d20c0" level="file">
        <did>
          <unittitle>TML, 38-1 - New drugs for osteoporosis</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="aspace_1694a846a6b3044d3ec7cd530aed221f" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_36da39db5fc36740fc211eab7abfd41b" parent="aspace_1694a846a6b3044d3ec7cd530aed221f" type="folder">13-18</container>
        </did>
        <accessrestrict id="aspace_059f4c0e348f3f79f9eac8942a1b7673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e20404fc9c2c5857d90b819cb9c70cc0" level="file">
        <did>
          <unittitle>TML, 38-53 - Prostatron</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="aspace_cd2500261967e4e1137a02c99946ecb9" label="Mixed Materials (A0000000075852)" type="box">9</container>
          <container id="aspace_90da4efe4bdced606c61f33aca903385" parent="aspace_cd2500261967e4e1137a02c99946ecb9" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_fa8555c81ed0ff184e52c7e939db327c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_cbfa8d04b93b4e3d89a843bbf9e3d7f8" level="file">
        <did>
          <unittitle>TML, 38-107 - Pallidotomy for Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1996 December 6</unitdate>
          <container id="aspace_8101d9bbfe46752b97bd7d187fb6da65" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_a508dcbbec6e548cc3d54444e1f5ccd5" parent="aspace_8101d9bbfe46752b97bd7d187fb6da65" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_6ec525e7fd9b38dcd1bce23ad46d101c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c1416d4fc58c7899cbc27ca73d15c172" level="file">
        <did>
          <unittitle>TML, 38-57 - Simethicone for gastrointestinal gas</unittitle>
          <unitdate type="inclusive">1996 June 21</unitdate>
          <container id="aspace_7fa3cfb5158ffdb87a4d6e46128ec990" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_a90ba188979e671a91ffda6bcbfcdbcb" parent="aspace_7fa3cfb5158ffdb87a4d6e46128ec990" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_76d78aedee8d1ddf219a07affe27bb10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_26af25957e59124a08f91eba499fc700" level="file">
        <did>
          <unittitle>TML, 38-106 - Sodium Phenylbutyrate for urea cycle enzyme deficiencies</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="aspace_8faabd71dc528c65874b311287800d1e" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_c8d79fe432aac91430a1ef0718d4fcb5" parent="aspace_8faabd71dc528c65874b311287800d1e" type="folder">6-7</container>
        </did>
        <accessrestrict id="aspace_8f55e867e223cf7fc8c205180e5bb1b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_4273a72d699f99aeabfcab12d5bde513" level="file">
        <did>
          <unittitle>TML, 38-72 - Terabinafine for onychomycosis</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="aspace_01b99315960ea8adef1ad68eb0877b10" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_1ba8235289d58f625b14fb1cf10549da" parent="aspace_01b99315960ea8adef1ad68eb0877b10" type="folder">8-11</container>
        </did>
        <accessrestrict id="aspace_f99d89a3af0b743be45c7d543c9a47b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_afa8fcead3849c57e46148fac07fdf16" level="file">
        <did>
          <unittitle>TML, 38-49 - Androderm (Testosterone patches)</unittitle>
          <unitdate type="inclusive">1996 May 24</unitdate>
          <container id="aspace_716bbad97f6a6b4e742dbe58b7ad82c1" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_08aa6450593b4d7e5d6c7e1338225e49" parent="aspace_716bbad97f6a6b4e742dbe58b7ad82c1" type="folder">12-15</container>
        </did>
        <accessrestrict id="aspace_6c9daad633f6ca6f23f9cb9675ec5725">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e83fc33c009862fb85873ce44225451e" level="file">
        <did>
          <unittitle>TML, 38-96 - Toptecan hydrochloride for metastic ovarian cancer</unittitle>
          <unitdate type="inclusive">1996 October 25</unitdate>
          <container id="aspace_57d9cf13977c33d0f1042621db44e630" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_313a390ad5a7444243a76bc5ec460ad7" parent="aspace_57d9cf13977c33d0f1042621db44e630" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_f4f4ca0b76dee28258679841660c3e53">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_1d1e2499f47a2c5a2498c508251c060e" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="aspace_333a3ab16510fb1b82d91d44fb76e964" label="Mixed Materials (A0000000075853)" type="box">10</container>
          <container id="aspace_c3d78ffda70396fb153b876fb5f99fa0" parent="aspace_333a3ab16510fb1b82d91d44fb76e964" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_5e026f0f926c42121383574e48a743ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_e3cd99c272218799e02c72a5e28f33c9" level="file">
        <did>
          <unittitle>TML, 38-3 - Valacyclovir</unittitle>
          <unitdate type="inclusive">1996 January 5</unitdate>
          <container id="aspace_d9e1d9dd5ebed8df669b37a3fbf421eb" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_144aa4d9b39945ce05f814c9ca2f9b75" parent="aspace_d9e1d9dd5ebed8df669b37a3fbf421eb" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_ed67782a99870c0e712a42cf95c5cfc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_2146f075bfb01adf0c99fddbe6268b26" level="file">
        <did>
          <unittitle>TML, 38-104 - Trandolapril - An ACE inhibitor for treatment of hypertension</unittitle>
          <unitdate type="inclusive">1996 November 22</unitdate>
          <container id="aspace_18415e2f381a468e7f6b5713fa63a837" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_f067ae7d6dace507c3d91e7fefe15b18" parent="aspace_18415e2f381a468e7f6b5713fa63a837" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_a1dd4aa7256167e609397b035b7478d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_7a2f268994b16b4876604d64167ade0b" level="file">
        <did>
          <unittitle>TML, 38-71 - Umbilical cord blood for bone marrow transplantation</unittitle>
          <unitdate type="inclusive">1996 August 16</unitdate>
          <container id="aspace_b679d02e782cee720cf71ca7c2ca474d" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_738e0e45578906ef5728a96c65a65952" parent="aspace_b679d02e782cee720cf71ca7c2ca474d" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_c284795ebfbae6dd142f49e2c3d64449">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c7fa6ad1765f84becedf7fbe8dae1981" level="file">
        <did>
          <unittitle>TML, 38-51 - Clarithromycine and omeprazole of helliobacter pylori</unittitle>
          <unitdate type="inclusive">1996 June 7</unitdate>
          <container id="aspace_842d657e716d69f3310210b8a2592963" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_81a0d644846fa3b74a7ac2a78dea2e88" parent="aspace_842d657e716d69f3310210b8a2592963" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_d93e4e485f03621de43519409ecd0ebb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_d2847f832cf8b7dfa8bae10d4079561b" level="file">
        <did>
          <unittitle>TML, 38-15 - New Uses of Thalidomide</unittitle>
          <unitdate type="inclusive">1996 February 16</unitdate>
          <container id="aspace_159a8042b3ae3695a8d8d1366c869c65" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_87e2fdca28498f00c86cf20750be9dc8" parent="aspace_159a8042b3ae3695a8d8d1366c869c65" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_5a934c0b2b5e5cf25f836a73de95c999">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_07f911d357717fedb196ba2a95b08c6f" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="aspace_8adf85be40c42e30551c295e0ea8143c" label="Mixed Materials (A0000000075946)" type="box">11</container>
          <container id="aspace_9bb0fcc0685f3114ac2793281903b269" parent="aspace_8adf85be40c42e30551c295e0ea8143c" type="folder">15-19</container>
        </did>
        <accessrestrict id="aspace_7ad69902cf7b5b84adb8b1470b88ef97">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_c0d2ae8c9a59eb2afc81bad688a8e0d9" level="file">
        <did>
          <unittitle>TML - Antiviral drugs - Viral Infections (Non-HIV) Handbook</unittitle>
          <unitdate type="inclusive">1996</unitdate>
          <container id="aspace_ba449efbe4a2dce5414a7be4b429763a" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_267e651781b2a5d161812bf125f05f2b" parent="aspace_ba449efbe4a2dce5414a7be4b429763a" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_42570c5418d18c7d11e5ecb6d56fc38d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_0d91fc0adca0e054072c6a3fff1ac1f6" level="file">
        <did>
          <unittitle>TML, 38-65 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">1996 July 19</unitdate>
          <container id="aspace_90e0d0bf789eef990d2bb1023220c35b" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_525beaac5c28f5030482fd8a64e2d4c8" parent="aspace_90e0d0bf789eef990d2bb1023220c35b" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_861175c1c60e1d08ff94909fca12e380">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_b6e8488842fc6d3ed56539b8c5e7c344" level="file">
        <did>
          <unittitle>TML, 38-38 - Ibutilide</unittitle>
          <unitdate type="inclusive">1996 April 12</unitdate>
          <container id="aspace_f61b4abff630d221dc1b0ff57752eb3b" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_725bf87ba6c3c35851d93201d93cbea1" parent="aspace_f61b4abff630d221dc1b0ff57752eb3b" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_d854aa1bc446941f011a8970567a2b37">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_93c5ceb8486269a6440d4a1164bd8a19" level="file">
        <did>
          <unittitle>TML, 38-91 - DHEA</unittitle>
          <unitdate type="inclusive">1996 October 11</unitdate>
          <container id="aspace_1ce6814bb291eb5bddeb9a905861c52c" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_b354d39af57d48eb473c3c19a7c5e5a1" parent="aspace_1ce6814bb291eb5bddeb9a905861c52c" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_0b753cb331038a0a1193ae254361f43e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_489aaa51c24f7c3822366d6381860b83" level="file">
        <did>
          <unittitle>TML, 38-88 - Meropenem - A new parenteral broad-spectrum antibiotic</unittitle>
          <unitdate type="inclusive">1996 September 27</unitdate>
          <container id="aspace_00ccf737eb9b30c731eb86318e8c2e81" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_0d3608c946d10809f231b95182dbe014" parent="aspace_00ccf737eb9b30c731eb86318e8c2e81" type="folder">10-14</container>
        </did>
        <accessrestrict id="aspace_06a4c2f05bc64d8b4ee6a3b07e593fe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_3a54f51aec4a83bee985f1670be2aff6" level="file">
        <did>
          <unittitle>TML, 38-39 - Methotrexate and Misoprostol for abortion</unittitle>
          <unitdate type="inclusive">1996 April 26</unitdate>
          <container id="aspace_b0a9b738edf92f3763d650f8ea927e63" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_776a3647c9847d5ce2aaf7d3f39807f0" parent="aspace_b0a9b738edf92f3763d650f8ea927e63" type="folder">15</container>
        </did>
        <accessrestrict id="aspace_6b3edef9531f4a2fde2d3628c5d7cdd0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_43193a32312eb0204d12fd64fa6b6993" level="file">
        <did>
          <unittitle>TML, 38-111 - Zafirlukast for asthma</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="aspace_65d837593cafcc17733676ef55b02690" label="Mixed Materials (A0000000075854)" type="box">12</container>
          <container id="aspace_6439ba99ee577895fb4303e986b244fd" parent="aspace_65d837593cafcc17733676ef55b02690" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_13e892949bbc4a48ce8c4285b3b1007e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_49b7007dcadc3c636c88f299dc526e0d" level="file">
        <did>
          <unittitle>TML, 31-83 - Samarium 153 lexidronam for painful bone metastases</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="aspace_466a69b62813ff8b6f21a604ea28b265" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_963a7f8c2417c44411ba430cee6f9a7a" parent="aspace_466a69b62813ff8b6f21a604ea28b265" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_592e1bece31e2f3f6b5ae1b6e1a8011e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_61b0c640e3f013a34c64133724020fa2" level="file">
        <did>
          <unittitle>TML, 38-69 - Drugs for non-HIV viral infections</unittitle>
          <unitdate type="inclusive">1997 August 1</unitdate>
          <container id="aspace_416415a029c58f954656f5c2f366cdfb" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_8579e0e00e02d03b06a4859fa1315c06" parent="aspace_416415a029c58f954656f5c2f366cdfb" type="folder">4-12</container>
        </did>
        <accessrestrict id="aspace_84c4988675afd57f7b095139aa7bfdfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_133977107f40fa3272c401b7abcc89de" level="file">
        <did>
          <unittitle>TML, 39-18 - Zileuton for asthma</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="aspace_998712f4dbcd37d413282868f1400f2d" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_95b00b6e26cb8fcfd07d0a043a56e3dc" parent="aspace_998712f4dbcd37d413282868f1400f2d" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_4717fa288dd120e806e05499350ddf6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_be46a606b805462c6cc03b6ec8b2c39e" level="file">
        <did>
          <unittitle>TML, 39-9 - Zinc for the common cold</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="aspace_29fd3df07d5cc4d40dc9bb5b36bef489" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_32d82f995cb370273af50bb2d60c6117" parent="aspace_29fd3df07d5cc4d40dc9bb5b36bef489" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_ad1088be46d6652eb0405e32258a0bf9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_1a7499e6fbd604c0b75b6d778dc5c0f9" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="aspace_431c400475254844c841519a44bee9b3" label="Mixed Materials (A0000000075855)" type="box">13</container>
          <container id="aspace_5675e57e2513c386c656024219b967ac" parent="aspace_431c400475254844c841519a44bee9b3" type="folder">18-20</container>
        </did>
        <accessrestrict id="aspace_ebe0ac100a42ac94570bd02c0e0ccdbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_c3fee2e8cf6e2d58695098807e086dab" level="file">
        <did>
          <unittitle>TML, 39-78 - Topical drugs for aging skin</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="aspace_dc79a85f41b43d3d496b5391e0dacd00" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_b463d6854e88fd0d924801a84cfc90e5" parent="aspace_dc79a85f41b43d3d496b5391e0dacd00" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_898d939f278bc6e6c335eb092f07c5a8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_393de6e6b75d4f4817695af30349dd68" level="file">
        <did>
          <unittitle>TML, 39-80 - Ropivocaine - a new local anesthetic</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="aspace_b40b9f0e0c5e9cb06cad689bf33122cf" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_17c1af03982547ad06e5bd7d3edc74c3" parent="aspace_b40b9f0e0c5e9cb06cad689bf33122cf" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_7af0a96e2cfe06eaffa6999f5bfd2c77">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_4be741eb1bacb7f18527f5b2df647302" level="file">
        <did>
          <unittitle>TML, 39-41 - Levofloxacin and sparfloxacin</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="aspace_52f3fd8e872980fb41487460ed680127" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_1fc89aefb8448ae07b0298f60bc2fc94" parent="aspace_52f3fd8e872980fb41487460ed680127" type="folder">5-10</container>
        </did>
        <accessrestrict id="aspace_7550d2d00d3b056285daa384c568544b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b81fc7aadd5fecc407e846095655da0e" level="file">
        <did>
          <unittitle>TML, 39-10 - Lasers in dermatologic surgery</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="aspace_af0970407cad71aa23ddffca0ad296d5" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_22ccef4c37df2ae4b2275a7017e53df6" parent="aspace_af0970407cad71aa23ddffca0ad296d5" type="folder">11-15</container>
        </did>
        <accessrestrict id="aspace_0f1f31dc544a7820b6b3740572840e2c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_d6a872b6263ad2beca76d2809d741c78" level="file">
        <did>
          <unittitle>TML, 39-84 - Skin surgery with lasers - an additional note</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="aspace_5461f736ab499ee2aa66dd29db0cb7fd" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_cfe2b5ac75578ce32e4035e84737d247" parent="aspace_5461f736ab499ee2aa66dd29db0cb7fd" type="folder">16</container>
        </did>
        <accessrestrict id="aspace_37b13c54d0d04ba5299304f96256cfc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_62572ae54e7b47c32783a5b7f9f92261" level="file">
        <did>
          <unittitle>TML, 39-51 - Topiramate for epilepsy</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="aspace_ede685944f844bd8acfac572ec6498fe" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_13c58cb907b06d0c39ef05e1e905c6f6" parent="aspace_ede685944f844bd8acfac572ec6498fe" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_1f453b72cb65c772c8bbcb8b965fc251">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_bbfc9de7adb6df0701f6173947f38bd2" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_18c8a0a6bc947ea0ecd3f05435207306" label="Mixed Materials (A0000000075856)" type="box">14</container>
          <container id="aspace_6af17a94074923f7698e479c24631184" parent="aspace_18c8a0a6bc947ea0ecd3f05435207306" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_63c006cdd8a94fd253916b0a5c2fcbfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6b378b12b2f16c81d85d36343d81a41b" level="file">
        <did>
          <unittitle>TML, 39-96 - Tamsulosin for prostatic benign hyperplasis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_0aabdee9d9ae73b1ec313bae7e9cfae1" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_ae3ae2f4b14c7d92dcd0509ac8d46c41" parent="aspace_0aabdee9d9ae73b1ec313bae7e9cfae1" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_62290c3388efd25a1b03329c60a4c2c5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_bf256a51de793456a4c7d083f141288c" level="file">
        <did>
          <unittitle>TML, 39-65 - Tiludronate for Paget's disease of bone</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="aspace_98dfb306fdd3205d4cca27a655550881" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_3f4a195767a37212a4e4a1e3667e8a5e" parent="aspace_98dfb306fdd3205d4cca27a655550881" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_a0af36cf2f0f39c3b6bf43a2f3d1a8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_e50c791d98c44790d8141d27cd4cfcab" level="file">
        <did>
          <unittitle>TML, 39-62 - Tizanidine for spasticity</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="aspace_f9a1a72f6d5ab5703547d58c483824a8" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_123a7ab4552a849927bee3e74ddf005f" parent="aspace_f9a1a72f6d5ab5703547d58c483824a8" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_264d6479c0b4544b7007e8c452a7cee5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_12444cf584e83734f66bfc290040544a" level="file">
        <did>
          <unittitle>TML, 39-49 - Troglitazone for non-insulin-dependent diabetes mellitus</unittitle>
          <unitdate type="inclusive">1997 May 23</unitdate>
          <container id="aspace_23e65e1fbbbef699306f19da63b9efed" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_18fdf25d2bfe799aa8b7b2c7f4428515" parent="aspace_23e65e1fbbbef699306f19da63b9efed" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_c2dbaf70c1400524b9601ade32d9aa09">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_64f0edfa5bd3b5159911a74e751d912b" level="file">
        <did>
          <unittitle>TML, 39-43 - Valsartan for hypertension</unittitle>
          <unitdate type="inclusive">1997 April 25</unitdate>
          <container id="aspace_2ce2f1d4b7d88b34c96a57c6a720975b" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_40b8547d315f3280c84a221b27f3987e" parent="aspace_2ce2f1d4b7d88b34c96a57c6a720975b" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_d5a76faf4ca30d9de5137cfcad807f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_eb014687998353d0fb60326357526127" level="file">
        <did>
          <unittitle>TML, 39-1 - Drugs for treatment of peptic ulcers</unittitle>
          <unitdate type="inclusive">1997 January 3</unitdate>
          <container id="aspace_d036f89c0f643bd81ffa1a4302d49611" label="Mixed Materials (A0000000075857)" type="box">15</container>
          <container id="aspace_c2203175a812b0452400afbc98ad4474" parent="aspace_d036f89c0f643bd81ffa1a4302d49611" type="folder">15-20</container>
        </did>
        <accessrestrict id="aspace_1fcec8ea591c0f4b6123d11e89e69ddb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_3436a17eac9c6f31692eb5d354b51a44" level="file">
        <did>
          <unittitle>TML, 39-109 - Pramipexole and Ropinirole for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="aspace_12d773aa75020400e9762317e02f143d" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="aspace_267975c1f17d3a31d5c2a98dce3ad367" parent="aspace_12d773aa75020400e9762317e02f143d" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_9f23fe9c137d23133c2b5049c5b64530">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_ea94f0229ffb76d4e8a48dbf172eec36" level="file">
        <did>
          <unittitle>TML, 39-105 - New drugs for psoriasis</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="aspace_1c0913605221bf6922a50d3466f86365" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="aspace_543aa40753e2f419a40706de2a30198f" parent="aspace_1c0913605221bf6922a50d3466f86365" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_d1471d567708b0ca9a5c6d93f5f254f0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_12f50952f7ba8eb3afd7e492d332b4a1" level="file">
        <did>
          <unittitle>TML, 39-33 - New drugs for psychiatric disorders</unittitle>
          <unitdate type="inclusive">1997 April 11</unitdate>
          <container id="aspace_c5ba16413ef041c303b9374d73e2acd5" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="aspace_786a180ea03a9eb5fac34a65d679cba0" parent="aspace_c5ba16413ef041c303b9374d73e2acd5" type="folder">9-15</container>
        </did>
        <accessrestrict id="aspace_dbaf4673299ed575f189876448054a58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_123a71748e8ade20af228276bab2d8b6" level="file">
        <did>
          <unittitle>TML, 39-117 - Quetiapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="aspace_99c37e401b22f34fe6dcebeb741bb6f9" label="Mixed Materials (A0000000075858)" type="box">16</container>
          <container id="aspace_0222428cb2bd40d08a419c6935135350" parent="aspace_99c37e401b22f34fe6dcebeb741bb6f9" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_8bbc739b2ed931419befe4ab8eb4eb63">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_498df0f2d9dce92679b2aa347629be3f" level="file">
        <did>
          <unittitle>TML, 39-17 - Reteplase (Retavase)</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="aspace_a5547146f873cb94840ee141ac303042" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_11c6d7b0cc56d5ec23a75232b6841d03" parent="aspace_a5547146f873cb94840ee141ac303042" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_b2dca34162d6868414a816046edfdff2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6ba7d8b0dcb752d130b074f42b440dd7" level="file">
        <did>
          <unittitle>TML, 39-53 - Donepezil (Aricept) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="aspace_073ec5c75c02269c59929e844bf0a282" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_681965005f342f81702f6377390f606b" parent="aspace_073ec5c75c02269c59929e844bf0a282" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_6532d645696e8a65297e0563e103f695">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_7c2e04e9e7b332289a442e6977a1f7d9" level="file">
        <did>
          <unittitle>TML, 39-81 - Diagnostic tests for HIV</unittitle>
          <unitdate type="inclusive">1997 August 29</unitdate>
          <container id="aspace_177f99cb1b19a6ea3d71d5f0f0bae9af" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_80943df86914771202e0238d29517115" parent="aspace_177f99cb1b19a6ea3d71d5f0f0bae9af" type="folder">6-10</container>
        </did>
        <accessrestrict id="aspace_9570ef3f38bf3a851322c3c3fb7d17cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_fdd2b028e08760f46ba2467c4b638924" level="file">
        <did>
          <unittitle>TML, 39-21 - Drugs of Choice - Cancer Chemotherapy</unittitle>
          <unitdate type="inclusive">1997 March 14</unitdate>
          <container id="aspace_99a7c183207cdbad2d36b413d0f3fac2" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_10f7a1a915452580af824a1a0b76248c" parent="aspace_99a7c183207cdbad2d36b413d0f3fac2" type="folder">11-16</container>
        </did>
        <accessrestrict id="aspace_28f03f207bd6c378f505103883232f68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_42935bf2b5b11b084838a1252d3b3db8" level="file">
        <did>
          <unittitle>TML, 39-77 - Bupropion for smoking cessation</unittitle>
          <unitdate type="inclusive">1997 August 15</unitdate>
          <container id="aspace_feeb9b63554ed424d384b537466d8d85" label="Mixed Materials (A0000000075859)" type="box">17</container>
          <container id="aspace_278fda095c735508201e176e787153a9" parent="aspace_feeb9b63554ed424d384b537466d8d85" type="folder">17</container>
        </did>
        <accessrestrict id="aspace_6c0f62c3539d7b57d8122eb2501ba830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_be3b6c8f67d8d9c4ef7e3226b17983fb" level="file">
        <did>
          <unittitle>TML, 39-63 - Topical butenafine for tinea pedis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="aspace_4d3ec46de0b13118781a095aaf7947a3" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_6267b00bb465509727aaa9c7e7a158be" parent="aspace_4d3ec46de0b13118781a095aaf7947a3" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_5cc6b055d5b6e621ab0c71131fdd66e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_856acb144bbba7a94b1cb63f73185f43" level="file">
        <did>
          <unittitle>TML, 39-56 - Pentosan</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="aspace_f0a886bf4dffbc344dfd87980a9038fd" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_95c6df819bf9e60f82d8b45aee6dd6a3" parent="aspace_f0a886bf4dffbc344dfd87980a9038fd" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_9279dfdd8fa0fb9cdb6e31006d0ff6a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_afd34d20934d1be77bfc49f4d1241183" level="file">
        <did>
          <unittitle>TML, 39-103 - Mibefradil - a new calcium-channel blocker</unittitle>
          <unitdate type="inclusive">1997 November 7</unitdate>
          <container id="aspace_c2da4a27c9ff0bc25b03c323a41e0ceb" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_0351e01d27b9d31f74bf6d99a022362c" parent="aspace_c2da4a27c9ff0bc25b03c323a41e0ceb" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_bc77a13d4a14fc45f23bfb7a5bb57c5d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_de42e2f43ebae331da9c0b8180abb87c" level="file">
        <did>
          <unittitle>TML, 39-59 - Midodrine for orthostatic hypotension</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="aspace_1464be3bbb45b65b71ab222fc8285625" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_77c426531a2ae2e3a8b1fecad8b6f93d" parent="aspace_1464be3bbb45b65b71ab222fc8285625" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_01d73c68e8dd39b1c0b73b6d7700c7a0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_96ceef3812b648bc28698beed66c5d75" level="file">
        <did>
          <unittitle>TML, 39-47 - Treatment of Lyme disease</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="aspace_642e9153819cf0695eb107c5b7c8f6a5" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_aafe148bfb4acb355b431252524d8d98" parent="aspace_642e9153819cf0695eb107c5b7c8f6a5" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_1456685e80bfcccf0ad9c93511c65c4d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_eaedccce6a322747a43e566f8dfc2b7d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_cfd213d5b2343901cee6450b86979949" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_e6247457ee1636006b407bb741bca0fe" parent="aspace_cfd213d5b2343901cee6450b86979949" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_640807ffbd5e5ea720da4f60f781a4b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_95b6682482a9d062317fcf262cc7f718" level="file">
        <did>
          <unittitle>TML, 39-85 - Influenza vaccine</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="aspace_08f6e9800eb230008ec5bd9a4618398a" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_6d350345bc73859b8de557cac93a7474" parent="aspace_08f6e9800eb230008ec5bd9a4618398a" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_bae55e07ca01b84992a5b395e88b6ccc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c5534af6d0a227ae1ad47876c813383" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="aspace_5ad800be0d03a73d74b4c905113971be" label="Mixed Materials (A0000000075860)" type="box">18</container>
          <container id="aspace_ed644dab1a3fc61f05052cda040b6c19" parent="aspace_5ad800be0d03a73d74b4c905113971be" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_071f86249d57b3a639f1f0ac1e82c1db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d02c5507ec798ca4d7bb6188acc62a5" level="file">
        <did>
          <unittitle>TML, 39-8 - Irinotecan for metastatic colorectal cancer</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="aspace_4146bec8a5c792da70fd26d6bf7ed530" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_9e0335a67e8aaa293f0fea40f66ddd89" parent="aspace_4146bec8a5c792da70fd26d6bf7ed530" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_36454ffdeab70b1b39646403fa3b2960">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_0cdb2a091afd3228142c89eb37d2380a" level="file">
        <did>
          <unittitle>TML, 39-118 - Imiquimod for genital warts</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="aspace_7d8263f0d316579308aae58f819a25bc" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_d071fc52a5e5480045ae243d771be125" parent="aspace_7d8263f0d316579308aae58f819a25bc" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_d975c63ad23263fd275260f9460dcf1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_f4d2ffb826a588ff6c493adbd06a92be" level="file">
        <did>
          <unittitle>TML, 39-64 - Drugs for epilepsy</unittitle>
          <unitdate type="inclusive">1997 February 6</unitdate>
          <container id="aspace_c58013d3c84a6d2021dff834832cdafc" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_a0393f5f219425ad3dae5e8d76c90be6" parent="aspace_c58013d3c84a6d2021dff834832cdafc" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_c20b70cbd97aa855e62537fb259a09f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_028b89ba84e332c879eab9899c191875" level="file">
        <did>
          <unittitle>TML, 39-66 - Fosfomycin for urinary tract infections</unittitle>
          <unitdate type="inclusive">1997 July 18</unitdate>
          <container id="aspace_f07669b0540f01e63776adeed4af66a5" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_f1beae2318cc8a0ae9717b7ec25137d9" parent="aspace_f07669b0540f01e63776adeed4af66a5" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_e0aa9d9341298313dcd22b6a4157d3bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_73ee7f93d0af26d64d0c1fc7ba0c7201" level="file">
        <did>
          <unittitle>TML, 39-86 - Systemic antifungal drugs</unittitle>
          <unitdate type="inclusive">1997 September 12</unitdate>
          <container id="aspace_93a30c8912b4a5ccbefba64f7ebdbe4f" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_8ab5254a337434f77b9bbd60fdb77097" parent="aspace_93a30c8912b4a5ccbefba64f7ebdbe4f" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_226ecab6ab43654c9c5dd63a5e3e2b52">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6bf77dfe11efd36cf8146b826560cb4c" level="file">
        <did>
          <unittitle>TML, 39-61 - Glatiramer acetate for relapsing mutiple sclerosis</unittitle>
          <unitdate type="inclusive">1997 July 4</unitdate>
          <container id="aspace_f2adfd216dcee3c812c22f5a35028e2b" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_a82852ee14271da38407e18b5f511ba8" parent="aspace_f2adfd216dcee3c812c22f5a35028e2b" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_58267fbb42c582dd03ac8830411c1803">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_f36ff800dacbd73013d42dab42cf5f5b" level="file">
        <did>
          <unittitle>TML, 38-6 - Drugs for head lice</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="aspace_8e2adeb93e3e6eb17327bc9af285277e" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_8529fb660ad884b30c1b3abb3091622f" parent="aspace_8e2adeb93e3e6eb17327bc9af285277e" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_92296119b0cbe67e59973a003090f421">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_e13f3fa0ec576057f7033815a81111e1" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="aspace_79f3068256c77e068a45025e9ff57bbf" label="Mixed Materials (A0000000075861)" type="box">19</container>
          <container id="aspace_f267f8cec79b62d664b2debc52d9f1a0" parent="aspace_79f3068256c77e068a45025e9ff57bbf" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_e7cb03a6203eb58d2833529692c66d60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_dfc2de9cdb5bf3a8437e564fa717ffbd" level="file">
        <did>
          <unittitle>TML, 39-91 - Glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="aspace_a03e5a1a0eeadcb51b055213be37034a" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_7b3976c03a8561a775b4bd14d3a6a291" parent="aspace_a03e5a1a0eeadcb51b055213be37034a" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_d913972842d3a79acf9b906df7f951e7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_95d8be151e4ef26242db019df375f791" level="file">
        <did>
          <unittitle>TML, 39-94 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1997 November 1</unitdate>
          <container id="aspace_37d17e0bd74410057b65b08aaf6ea1f9" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_f19a1cbe37672f5d2e6c46d94f6d2e69" parent="aspace_37d17e0bd74410057b65b08aaf6ea1f9" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_2db96bdb2ad3f2367bdf1559b5ea1133">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_f8696aa81da52173ff18b97bd7eb4067" level="file">
        <did>
          <unittitle>TML, 39-19 - Adapalene for acne</unittitle>
          <unitdate type="inclusive">1997 February 28</unitdate>
          <container id="aspace_eb9f36185bb65eb38737ef39863a1edb" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_5699d51d1528d8197d81d4d24f76c1c9" parent="aspace_eb9f36185bb65eb38737ef39863a1edb" type="folder">6-7</container>
        </did>
        <accessrestrict id="aspace_cefd2ab82f2cd38f2cef5b4253fea1fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_d3c8f38c2b75ab98def9cb12e7933ba3" level="file">
        <did>
          <unittitle>TML, 39-29 - Atorvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="aspace_a6e4fcecb2868d01ef8bec5e2296b4ca" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_3d3faae0a64af0fe25ce68b02a748c62" parent="aspace_a6e4fcecb2868d01ef8bec5e2296b4ca" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_f50e6cdc96d78aa80586f8c46bb4b44f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b2a72d06fe2be2cec8bad5a6a0fda27b" level="file">
        <did>
          <unittitle>TML, 39-45 - Azelastine nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1997 May 9</unitdate>
          <container id="aspace_9ea0800a0429f976ae689d3b16e2d532" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_d4697e083806e83668bae7209b531100" parent="aspace_9ea0800a0429f976ae689d3b16e2d532" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_2c8bdc164c637c083bf92b35d52554fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_36e76c3b20aacff333ba5d98cfca27de" level="file">
        <did>
          <unittitle>TML, 39-12 - Betaine for homocystinuria</unittitle>
          <unitdate type="inclusive">1997 January 31</unitdate>
          <container id="aspace_464ba653827334eed8281a869ab3e966" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_3db4c14d0a40b8d9fe56f5b6a9d46b65" parent="aspace_464ba653827334eed8281a869ab3e966" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_55bd4c86ccf4811f99aac2673693e945">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_e4ca902373c4579a78db0d3b8d513633" level="file">
        <did>
          <unittitle>TML, 39-93 - Bromfenac for analgesia</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_974433da509a9903f92cd19e54f51253" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_04c02ab473abfb3b82e4e503d3664714" parent="aspace_974433da509a9903f92cd19e54f51253" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_18bd5ce580d159e1acce03ad34266cc9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_1a9cef87a6b1f62bf27f90e19d47c4e1" level="file">
        <did>
          <unittitle>TML, 39-54 - Brimonidine - an alpha2-agonist for glaucoma</unittitle>
          <unitdate type="inclusive">1997 June 6</unitdate>
          <container id="aspace_528d164a097b9a9d7cf977206a7766e9" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_22bafcfac9d4c234f546a5912fa01885" parent="aspace_528d164a097b9a9d7cf977206a7766e9" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_c12a956b010223394c6ca9d2025942d6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_56fc5093674d1372e80ed218ae8bd368" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="aspace_d12723ee3493be4386de31969b68f74b" label="Mixed Materials (A0000000075862)" type="box">20</container>
          <container id="aspace_b179005463a7c60084e31839077a607c" parent="aspace_d12723ee3493be4386de31969b68f74b" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_12b089183fda270bbeecc135b190b589">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_1f85013ec13e639596b728f22f1aafc4" level="file">
        <did>
          <unittitle>TML, 39-13 - Safety of channel blockers</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="aspace_cceaea0ed491f1ca4eb93932f8944da4" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_ede2ca0bdf4a027e92762df58d979cd7" parent="aspace_cceaea0ed491f1ca4eb93932f8944da4" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_8a33d90a046f00da2d8b9b030020c09e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b4a11be555144c67db801913b3a95361" level="file">
        <did>
          <unittitle>TML, 39-58 - Cabergoline for hyperprolactinemia</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="aspace_202ff3c3f1d7456d36fe2b84fbec58fa" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_6b91f1f31e3c09f9e852e75ecd9a8ee8" parent="aspace_202ff3c3f1d7456d36fe2b84fbec58fa" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_300ca74e312c726f3bc6c5c2409ffa88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_8fa954deb6dc2ce7385244a3d8abc5a9" level="file">
        <did>
          <unittitle>TML - Dovonex</unittitle>
          <unitdate type="inclusive">1993</unitdate>
          <container id="aspace_54ebc2a031faebd015d0e7a72ba9ff6f" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_04b9d31823a766d21fc0831dfab75a17" parent="aspace_54ebc2a031faebd015d0e7a72ba9ff6f" type="folder">7</container>
        </did>
        <accessrestrict id="aspace_7ed0890a439df753466be5a70bc31770">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_c70f3345ad4c90f6af9d560ffb1f3777" level="file">
        <did>
          <unittitle>TML, 39-108 - Olopatadine for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="aspace_dbf569dcdfb299d4426748ce8312d12f" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_65acfa2e97385899b8b2fcb45f2c4a9a" parent="aspace_dbf569dcdfb299d4426748ce8312d12f" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_7e05d25159387c3bcb0a7a1a1a57fbe9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f25168045c3874b852fc2566864c22b" level="file">
        <did>
          <unittitle>TML, 37-1 - Drugs for asthma</unittitle>
          <unitdate type="inclusive">1996 January 6</unitdate>
          <container id="aspace_36f08d42d10e2f992791ef91069c5336" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_2ea6faea9db1dedee928d2e1fc502ded" parent="aspace_36f08d42d10e2f992791ef91069c5336" type="folder">10-14</container>
        </did>
        <accessrestrict id="aspace_5124cbd46d2a439f4f59c00468b6016b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_dbe0049fdc51d967d42b54af228c58ae" level="file">
        <did>
          <unittitle>TML, 39-32 - Intra-transurethral Alprostadil for impotence</unittitle>
          <unitdate type="inclusive">1997 March 28</unitdate>
          <container id="aspace_d2e928222d30a3daac2551fa455a2196" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_7236300dee93e39c9127a49fd4bbabb6" parent="aspace_d2e928222d30a3daac2551fa455a2196" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_108454fd852ec91b5893f1a78b4694b9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_3fff697896297fb5b3e546b99c7bb615" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="aspace_1d7fac5c3d74b9540fcf09b6f17d9cd5" label="Mixed Materials (A0000000075863)" type="box">21</container>
          <container id="aspace_617970c79c20d30e87ca4bca7f1f6ec2" parent="aspace_1d7fac5c3d74b9540fcf09b6f17d9cd5" type="folder">17-21</container>
        </did>
        <accessrestrict id="aspace_6e01c10d6e482faec33ca1e6f744b4e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_ac009d8a6eba90db98f499f6852dd496" level="file">
        <did>
          <unittitle>TML, 39-14 - More new drugs for AIDS and associated infections</unittitle>
          <unitdate type="inclusive">1997 February 14</unitdate>
          <container id="aspace_64b4ba1d4ce3592102e8788e570c0744" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_20704615223ce28f0251e1843df1c5d6" parent="aspace_64b4ba1d4ce3592102e8788e570c0744" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_1cdb7a1ff11f6e216e339e64f20c58a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_364c7d8d424593144cdef790c4e94d75" level="file">
        <did>
          <unittitle>TML, 39-111 - AIDS - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1997 December 12</unitdate>
          <container id="aspace_cbc7126c542d9191bfab33cc4d450971" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_9abc100948b4af09a2e0cbb9e4c324da" parent="aspace_cbc7126c542d9191bfab33cc4d450971" type="folder">4-9</container>
        </did>
        <accessrestrict id="aspace_a96e0ada70322de7df279993ca3ff3a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_fe5bfd483d4da9cb09abcd8d8e9114e4" level="file">
        <did>
          <unittitle>TML, 39-97 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1997 October 24</unitdate>
          <container id="aspace_8e7599f18e58d9dc635a71fcd6c1e466" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_a344fc0b703035379c950a1f4fa572b9" parent="aspace_8e7599f18e58d9dc635a71fcd6c1e466" type="folder">10-15</container>
        </did>
        <accessrestrict id="aspace_ce3e85fc72e05bedc7f21da6973965b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6568c1026445dec6f8e364671c21bd39" level="file">
        <did>
          <unittitle>TML, 39-120 - Anagrelide for essential thrombocythemia</unittitle>
          <unitdate type="inclusive">1997 December 19</unitdate>
          <container id="aspace_2542b30d04c7941a7f92cda0b30ef2b5" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_7665b3715bc217ef27d7b4d0502da721" parent="aspace_2542b30d04c7941a7f92cda0b30ef2b5" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_8df589a9af326009da84ebecd5cf8932">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b0b4f71d2ecf84b337ced4a504f89306" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_7cc17bed6954b365543b012f872fa097" label="Mixed Materials (A0000000075864)" type="box">22</container>
          <container id="aspace_2a41f8e37fe13ea3b7138462a574438f" parent="aspace_7cc17bed6954b365543b012f872fa097" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_8df622f363be5b50961c92589e209dc4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b1ac2f651904161cd98b8d42f99e3aa1" level="file">
        <did>
          <unittitle>TML, 39-94 - Ardeparin and danaparoid for prevention of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">1997 October 10</unitdate>
          <container id="aspace_953973d140d1b8dd7110839f9e0cb0c9" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_46397f05f1e4e1b7469a884ab73d6dd5" parent="aspace_953973d140d1b8dd7110839f9e0cb0c9" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_181d3a4b218653d1790e4861871f62dd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_edca2ebba2d38b14ec07a5b9c16a0276" level="file">
        <did>
          <unittitle>TML, 39-89 - Carvedilol for heart failure</unittitle>
          <unitdate type="inclusive">1997 September 26</unitdate>
          <container id="aspace_023281a62e4344c8107f09cbe2c0ccc1" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_9082c11ec68d1ef9dce26d0cddfa2984" parent="aspace_023281a62e4344c8107f09cbe2c0ccc1" type="folder">5-9</container>
        </did>
        <accessrestrict id="aspace_f5705dc19e306f206ec780b8d160e15c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_3f1ba5c10401cadfc440c87da71224cb" level="file">
        <did>
          <unittitle>TML, 39-57 - Topical penciclovir for herpes labialis</unittitle>
          <unitdate type="inclusive">1997 June 20</unitdate>
          <container id="aspace_19500cd81ba642f95dd0b5c526c2e608" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_e8aa5f0a0e07716d988cc3f66171284d" parent="aspace_19500cd81ba642f95dd0b5c526c2e608" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_053d8eeeb8327c9a50460b4a07f88f4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_6311bd1ab3c17838b525980881eb7804" level="file">
        <did>
          <unittitle>TML, 38-17 - Drugs for migraine</unittitle>
          <unitdate type="inclusive">1995 March 3</unitdate>
          <container id="aspace_b6aa59850f2d332f2165c719224bae79" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_d60b40af45e20403bc23129bd76e347a" parent="aspace_b6aa59850f2d332f2165c719224bae79" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_3d255045a576ae1c355c7f2fcc48b4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2022</p>
        </accessrestrict>
      </c>
      <c id="aspace_d46efc5621917384073357b190321659" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_cfe176f565067add544fc32973cb858b" label="Mixed Materials (A0000000075865)" type="box">23</container>
          <container id="aspace_a49d9ca290ad8fad5d18b7b17d15e289" parent="aspace_cfe176f565067add544fc32973cb858b" type="folder">17-21</container>
        </did>
        <accessrestrict id="aspace_663777121320adda427992b307d1db2f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_fa4a7928ccfffaadb72cf4771e4d8edc" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Pain</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_b90a6b0ce42e0a17ef36653a28029744" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_dd7b628dbf72eda90d4eaec80ef2b1ae" parent="aspace_b90a6b0ce42e0a17ef36653a28029744" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_702b01fd73a7deda0a72869d6f566a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_318ae2efe1275c93a47e9ae522f706ea" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_db07284dff89d5ae15fffdeabaace25f" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_d50cc5555c6982968260e72be178c2e1" parent="aspace_db07284dff89d5ae15fffdeabaace25f" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_f2ea2b6f0f794d84b25ea1befb0a8255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b4b3b22e307f4ce6c5d2eb8f6d664d9c" level="file">
        <did>
          <unittitle>TML, 38-5 - Olanzapine for schizophrenia</unittitle>
          <unitdate type="inclusive">1997 January 17</unitdate>
          <container id="aspace_62c98480b10f1b8507b524e54d37406f" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_729d2d30b8c5cd1a812c29ac586fca85" parent="aspace_62c98480b10f1b8507b524e54d37406f" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_54d3d516459a5d0fc04e78b00339b8f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_b5cf0dfe90fdcc6067f140e30b6809d1" level="file">
        <did>
          <unittitle>TML, 38-113 - Mirtazapine - a new anti-depressant</unittitle>
          <unitdate type="inclusive">1996 December 20</unitdate>
          <container id="aspace_d02cf12074383d967bdf94176efdc662" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_72e4fb7dcc3bf85956c8760a2da86b45" parent="aspace_d02cf12074383d967bdf94176efdc662" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_6a61863bdf42f359838de02eb3140260">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_c2e1fc197d7490d826da206b516a38a5" level="file">
        <did>
          <unittitle>TML, 40-5 - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1997</unitdate>
          <container id="aspace_d0d922c4bcb127d6c016b90e1bb464d4" label="Mixed Materials (A0000000075866)" type="box">24</container>
          <container id="aspace_45cf0656e06cdf9431083ec026a2139e" parent="aspace_d0d922c4bcb127d6c016b90e1bb464d4" type="folder">10-16</container>
        </did>
        <accessrestrict id="aspace_5d151812a70ad7aab1e31b15864a8198">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2023</p>
        </accessrestrict>
      </c>
      <c id="aspace_fc12244326436c163ce3062f2ee5441e" level="file">
        <did>
          <unittitle>TML, 40-59 - Clopidogrel for reduction of artherosclerotic events</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="aspace_85188aa880df0bf8d2879f3b154d197d" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_9749e945b2760c474d3e4e10fe921d70" parent="aspace_85188aa880df0bf8d2879f3b154d197d" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_010c90cf26351f4881154a4f6ad41ad3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_b00d90227ff22e5ebe7df4b968c6ec73" level="file">
        <did>
          <unittitle>TML, 40-113 - Citalopram for depression</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="aspace_7dd39949746b65c9b86be6ba9b5820fa" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_66a14df2bf0e6af8d7dccb04ea219471" parent="aspace_7dd39949746b65c9b86be6ba9b5820fa" type="folder">4-8</container>
        </did>
        <accessrestrict id="aspace_e132e378e63282bf8014cd21bd84bf26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_85788caeb20c27238d916bb497645405" level="file">
        <did>
          <unittitle>TML, 40-52 - Anthrax vaccine</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="aspace_564023957afa03a19926a6d8d97e2669" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_85846fbd45bfb03ee188d891edb4cf7d" parent="aspace_564023957afa03a19926a6d8d97e2669" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_0a33ad6cdce119b325c656b5c6f11151">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_7481cf56a926bcaa665f596bebcba058" level="file">
        <did>
          <unittitle>TML, 40-63 - Ginkgo Biloba for dementia</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="aspace_a32eca00f3b19c48549406d4183d356e" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_55a276c06801e9308d277d68f34bb221" parent="aspace_a32eca00f3b19c48549406d4183d356e" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_16e326bcc4bc4a1b019667382b3e42a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_276f7a6dda26470f835e467b2e300373" level="file">
        <did>
          <unittitle>TML, Sildenafil - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_f57c05ea048fe6b4dcfb4d89c030e9e1" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_41b2ceeb8712165baf122094b29aa26f" parent="aspace_f57c05ea048fe6b4dcfb4d89c030e9e1" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_c072f69e2c5f4579df7b9a32a2d6638a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d9d5a14ea3c38a9bcf53eea15278788" level="file">
        <did>
          <unittitle>TML, 40-69 - Hyaluronan injections for osteoarthritis of the knee</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="aspace_aa973368daae0dd952bd84e37abd095e" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_731130d42f3b50fb1c1405e392d4a64f" parent="aspace_aa973368daae0dd952bd84e37abd095e" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_548bd13d1ee4dd091a7071fb17973086">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_e605d151c50d15b7436fa8b95fabcc04" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="aspace_3a09f1036d1e0ddffe6b9d5d0deb179c" label="Mixed Materials (A0000000075867)" type="box">25</container>
          <container id="aspace_fb59c39e0de1b033a90c572bbd3095e6" parent="aspace_3a09f1036d1e0ddffe6b9d5d0deb179c" type="folder">20-21</container>
        </did>
        <accessrestrict id="aspace_72272d08b8d2095400f484d84b5c8623">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a2c45fce823914fd5f240eb8ce64a6d3" level="file">
        <did>
          <unittitle>TML, 40-57 - Fenoldopam - Severe Hypertension</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="aspace_fe8f00b9631f203b6b3e4d43b2b92c38" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_98b48cf1f1b07dab340a48243878ec8b" parent="aspace_fe8f00b9631f203b6b3e4d43b2b92c38" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_e61fbc122231a69d11de05471824b4f7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_58fc0933c16d75f16f20c226741f40fc" level="file">
        <did>
          <unittitle>TML, 40-21 - Drugs that cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">1998 February 13</unitdate>
          <container id="aspace_309c4f8223b7b70d2c808dca234156ba" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_c47bd76e89fc566c1932592d6adc2199" parent="aspace_309c4f8223b7b70d2c808dca234156ba" type="folder">2-5</container>
        </did>
        <accessrestrict id="aspace_cd18c294101a7fb036bca53986751b48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f466040faafb3cd515b6f7e5924186a3" level="file">
        <did>
          <unittitle>TML, 40-47 - Advice for Travelers</unittitle>
          <unitdate type="inclusive">1998 April 24</unitdate>
          <container id="aspace_c3f6436b8108483e2627820797651dcb" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_47f2a89882352b2a4c02c0ba36d980af" parent="aspace_c3f6436b8108483e2627820797651dcb" type="folder">6-9</container>
        </did>
        <accessrestrict id="aspace_d3ea0598c816f490bd7b26c48572450a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_d9d7051c247d055cb3a4caa57119bc34" level="file">
        <did>
          <unittitle>TML, 40-68 - Fenofibrate</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="aspace_738753f153319a3e4129f1aed6193d25" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_743132c160ef6494394cfc3de157e5ce" parent="aspace_738753f153319a3e4129f1aed6193d25" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_a905e6ecf288f2137eb025ea245ec0aa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_0902f98f4048374d057a60de2d1b7855" level="file">
        <did>
          <unittitle>TML, 40-30 - Trovafloxacin</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="aspace_1af14e9cb1081ad73f88417651a533f0" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_5a97d850229959e06548c778714db8ba" parent="aspace_1af14e9cb1081ad73f88417651a533f0" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_d64cfc2f0c18fe44c79492b16479dde8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_40a127b41aba4ab1210aebb60355f7eb" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_ef57ccd7b81f4a42386a6b757ca15753" label="Mixed Materials (A0000000075868)" type="box">26</container>
          <container id="aspace_087786f23b24cca19a342ba87ef9971d" parent="aspace_ef57ccd7b81f4a42386a6b757ca15753" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_aa2e94224c5f71c8078141e7e709d476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_2821241f88ab33b4108c2fb8ef546a03" level="file">
        <did>
          <unittitle>TML - Tuberculosis - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_ba715445ed6a188cffed871d42c41216" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_a5e74187a5c4430c5b1c7dfad43ba997" parent="aspace_ba715445ed6a188cffed871d42c41216" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_0fedc35030a79ffd7934a9d9c5acbe14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a5e3fba9d86330d4c75e3f31b4844108" level="file">
        <did>
          <unittitle>TML, 40-51 - Sildenafil - An oral drug for impotence</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="aspace_3c7a0d5c1142abd1482e44366f500945" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_3d9d1da91950acc84d970267f04a0e26" parent="aspace_3c7a0d5c1142abd1482e44366f500945" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_c2a74a29c84ba08cf5bbb6cb60889b41">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_41484f1614916c304d00c6a0e2776c25" level="file">
        <did>
          <unittitle>TML, 40-67 - Sucralose - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">1998 July 3</unitdate>
          <container id="aspace_05bbf407de01b1dbd8bbbbbba72e39d6" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_30df73f1e7433567bdea77e776b30979" parent="aspace_05bbf407de01b1dbd8bbbbbba72e39d6" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_9e54423aecee12c7635588555d8c357f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_18a33071dfc9246e7c9a4f9970fc624f" level="file">
        <did>
          <unittitle>TML, 40-17 - Grepafloxacin - a new fluoroquinolone</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="aspace_8911225635d23599aa8550834915fe08" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_fc5c402f0152711a7702b3b8273992d2" parent="aspace_8911225635d23599aa8550834915fe08" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_bc7dcf48bb1a978d5d8891678f65f0b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_95bd003fd739d4b3a6ffdfb96fae1bc6" level="file">
        <did>
          <unittitle>TML, 40-55 - Repaglinide for type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1998 May 22</unitdate>
          <container id="aspace_ad5106fdc08b76bf3f0b1e338513e8b9" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_f2e11ad5afbab260d7ebc7ffe0c74996" parent="aspace_ad5106fdc08b76bf3f0b1e338513e8b9" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_ea7f89c9aaeab7997ab0ab65a3fbabdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_c689105113c5b23ebb896f340bf02ea0" level="file">
        <did>
          <unittitle>TML, 40-62 - Crystal Ear hearing aid</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="aspace_c45141fc20908eda847c7691d0460132" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_994291ce5dc9faa0c5bad9cd7e82e93d" parent="aspace_c45141fc20908eda847c7691d0460132" type="folder">13</container>
        </did>
        <accessrestrict id="aspace_dc4b7b184944400de9cfe92635a05ead">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_705d7bf07e8ff402ef32c0df389a3828" level="file">
        <did>
          <unittitle>TML, 40-89 - Antiplatelet</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="aspace_bd6e92a8f6133fdf20c79c48441ff93e" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_61a40a0112849b2a771ed44adb8a5817" parent="aspace_bd6e92a8f6133fdf20c79c48441ff93e" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_ae0c798c535816e3564f3b350306c0eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_cc4045365330c91030e2afc2941ff362" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="aspace_6ef32c9ca1ae10c9998d1d321f17e06a" label="Mixed Materials (A0000000075869)" type="box">27</container>
          <container id="aspace_d0d8f4f25165dc96f5b655997f1d8755" parent="aspace_6ef32c9ca1ae10c9998d1d321f17e06a" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_d3830363a0deac040fb1a2187fcc43a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_74cd9f3df4304220a489f3cd523e97f4" level="file">
        <did>
          <unittitle>TML, 40-109 - New drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="aspace_47064197ce98164f53e824296eb0326b" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_ceead95ed7293c5a5604ec1dcf478781" parent="aspace_47064197ce98164f53e824296eb0326b" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_78f65a64160f8c684e6ad4a73eb82afd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_8f7886d013678b0f444c0e7ce3af676b" level="file">
        <did>
          <unittitle>TML, 40-65 - Rituximab for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">1998 June 19</unitdate>
          <container id="aspace_165a3db63a7d2bfb7b1083fbb13b5413" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_8f42d4121c0aa81cb46792b165556694" parent="aspace_165a3db63a7d2bfb7b1083fbb13b5413" type="folder">2</container>
        </did>
        <accessrestrict id="aspace_8e2b80b72a52938a5c321da498c8b722">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_236c02b396ea229adb1f079d93029f01" level="file">
        <did>
          <unittitle>TML, 40-32 - Sibutramine for obesity</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="aspace_cd1160ae25304a541c94f0df62a12c64" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_0a83719e2450b776a2d722023143e7da" parent="aspace_cd1160ae25304a541c94f0df62a12c64" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_83216716b614ac8cc38fcaa01b43355e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_34d5d1374a9121f748a24968ebe6c128" level="file">
        <did>
          <unittitle>TML, 40-27 - Zolmitriptan for migraine</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="aspace_2bd8bd5c23777833528523be47a44a77" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_076bd89d4006f37b0dd8a9f1d0ebb4a1" parent="aspace_2bd8bd5c23777833528523be47a44a77" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_9f78fcde35549e85ae6f6ddddad23091">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f1f292c6e674c3d7e6f2610c2dbf9aec" level="file">
        <did>
          <unittitle>TML, 40-73 - Becaplermin - Platelet-derived growth factor for diabetic ulcers</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="aspace_1521fd2f0f960d99a2a99fbc091a6122" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_a1b6016d562a50a95f3e39130b3e7a1f" parent="aspace_1521fd2f0f960d99a2a99fbc091a6122" type="folder">9</container>
        </did>
        <accessrestrict id="aspace_a90cd7de6fbf79e2a9a41d8e6d5f1884">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_fae1826f224dc5554dd9d77d43d63320" level="file">
        <did>
          <unittitle>TML, 40-19 - Arbutamine for stress testing</unittitle>
          <unitdate type="inclusive">1998 January 2</unitdate>
          <container id="aspace_93420da343cdd882651ecbe28da418cd" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_5e33c4fc20b61ec5f1dd36bd407dad00" parent="aspace_93420da343cdd882651ecbe28da418cd" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_3cf800c016782dc93e3a36b622f7b36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_b4e4ab750a7b095f09a475bb6f5bb4c1" level="file">
        <did>
          <unittitle>TML, 40-75 - Vitamin supplements</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="aspace_f6faa010a7844d3b290f0490c6a38c9e" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_bf941e0dbf7bbf80a0382dcdae0ce9ba" parent="aspace_f6faa010a7844d3b290f0490c6a38c9e" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_59259d5d91da3a2acb6cb86529f69bd9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_06914f95afdacb00ca224c63b35cc3e5" level="file">
        <did>
          <unittitle>TML, 40-92 - Gliadel wafers for treatment of brain tumors</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="aspace_76c64728ae85e0bae7781b84af306b62" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_f1306adb60caae502c1e6ccf161539ce" parent="aspace_76c64728ae85e0bae7781b84af306b62" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_e29a7c4b92a2feed9fd0b7e0a0bb8f72">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f35a3fcbf2b099a50baf329b7d2a8f36" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_d48ce246caf616260220fc844bc0b98e" label="Mixed Materials (A0000000075870)" type="box">28</container>
          <container id="aspace_5cf9b9d08cc9fc4aaf2a1dbbcfafcc38" parent="aspace_d48ce246caf616260220fc844bc0b98e" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_0093f9f9cae39c07366f1e9c0c119fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_bc19dc00f1b6834157cb02e6fcfef4a4" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_ad52e654ba21467b1c203e63d00c0e50" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_61ddec5334e029693367e8fe24711565" parent="aspace_ad52e654ba21467b1c203e63d00c0e50" type="folder">1-5</container>
        </did>
        <accessrestrict id="aspace_530223b01deda9e053da32d105382b18">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_559cb584a41d6690a7e856498ab89795" level="file">
        <did>
          <unittitle>TML, 40-106 - Trastuzumab for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="aspace_6f654a98cc26d0820dea25b84d484823" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_65bdf71eb72f2b0c874c0ffeff9e4c06" parent="aspace_6f654a98cc26d0820dea25b84d484823" type="folder">6-7</container>
        </did>
        <accessrestrict id="aspace_cf7ce77fd85e6bc2a2e126d922cb2364">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_ece2250f2916521ae284b1830da4848e" level="file">
        <did>
          <unittitle>TML, 40-114 - Three new drugs for HIV infection</unittitle>
          <unitdate type="inclusive">1998 December 4</unitdate>
          <container id="aspace_53538eb89a9638eb9a7aff5ff168e746" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_c81b0971cb04538f3868393236ea44c6" parent="aspace_53538eb89a9638eb9a7aff5ff168e746" type="folder">8-11</container>
        </did>
        <accessrestrict id="aspace_4e7f5d2236f53f8ccc2b28a5bf8873c1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_7dd5458e0da29270a7d0b887632c23ac" level="file">
        <did>
          <unittitle>TML, Sexually Trasmitted Diseases - HAT</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_6dcd9c5426137645c78254cd58dccfe5" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_0f7c66f56633c827b8b758e2bdf61df3" parent="aspace_6dcd9c5426137645c78254cd58dccfe5" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_0b261ea329af56d20325ac31bcf03cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_6e5b03bb37f1b1e46c63603fddb7f5a0" level="file">
        <did>
          <unittitle>TML, 40-53 - Dolasetron</unittitle>
          <unitdate type="inclusive">1998 May 8</unitdate>
          <container id="aspace_11b1b93d0ad9c48335e4b520330c0878" label="Mixed Materials (A0000000075871)" type="box">29</container>
          <container id="aspace_313bf91da933cd69708641b84f45c20f" parent="aspace_11b1b93d0ad9c48335e4b520330c0878" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_2f191b313a6f595b28c9d77fec25b021">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_b33fb65d9a2e71bddfa4f269d47aeef6" level="file">
        <did>
          <unittitle>TML, 40-18 - Irbesartan for hypertension</unittitle>
          <unitdate type="inclusive">1998 January 30</unitdate>
          <container id="aspace_5d4339570232e7387ec5343bfa098ab3" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_94b0d28ca371201e8ce97e08be77d6d2" parent="aspace_5d4339570232e7387ec5343bfa098ab3" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_5fe32f0354336c745f49eaad8ec99c60">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_6332598d843148b2b6fcca7483c23ff2" level="file">
        <did>
          <unittitle>TML, 40-33 - The Choice of Antibacterial Drugs</unittitle>
          <unitdate type="inclusive">1998 March 27</unitdate>
          <container id="aspace_35510f14095e101e804777e4c33e43b5" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_7f42d5c1f95d39632532337afb13768c" parent="aspace_35510f14095e101e804777e4c33e43b5" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_4de55d18dd59d1c77f9f4fdd38e7a4d2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_6062e376e8011b03bf27092730e8219d" level="file">
        <did>
          <unittitle>TML, 40-93 - New monoclonal antibodies to prevent transplant rejection</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="aspace_babc5c911de58294af1ac0a6ad29aed0" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_91841a609af75cd400b609f488eaeb70" parent="aspace_babc5c911de58294af1ac0a6ad29aed0" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_a10e4c82bc99d39cee6a7ddd1ca31b10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_de828b3fc932777396bebd27f5fab7dd" level="file">
        <did>
          <unittitle>TML, 40-117 - Choice of lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">1998 December 18</unitdate>
          <container id="aspace_373e38f0e938cb4e96e98dfc304bbabd" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_57440321d9f3df99079632707a94743f" parent="aspace_373e38f0e938cb4e96e98dfc304bbabd" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_ec87238d62e4af8195602bcb6756e8f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_0bba41a40cc25a8da0e7a635fb7e3df8" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_4c0879a3053cffb7a11d95d19a57e128" label="Mixed Materials (A0000000075872)" type="box">30</container>
          <container id="aspace_c5ee287d3a74a1f98fca3bafaa758dda" parent="aspace_4c0879a3053cffb7a11d95d19a57e128" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_e69b8784cca126a51aa694fe76fa93ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_13029629c9a2c8c4645ba910bddc0ec5" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_e26d8d9c85d3662f0b81fd9287c21cb2" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_2d82a73c9c3b3f81860024cd1b6a88de" parent="aspace_e26d8d9c85d3662f0b81fd9287c21cb2" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_efd535a28d84b26cb3f39bdbca07f951">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_c768307fb6b27100b14034cebd5227a9" level="file">
        <did>
          <unittitle>TML, 40-43 - Toremifene and Letrozole for advance breast cancer</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="aspace_05f2b5d5dc84dc9065d0fd4769d103a5" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_be4a7f4cad3c551c98a767d00f74b330" parent="aspace_05f2b5d5dc84dc9065d0fd4769d103a5" type="folder">4-8</container>
        </did>
        <accessrestrict id="aspace_4fead382cbe8272480e24c54bdac4aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_edbc39d29ce93f5d2d89c1070b90a888" level="file">
        <did>
          <unittitle>TML, 40-95 - Brinzolamide for glaucoma</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="aspace_20bbef6a6b4c2f5ad8fc17085bed3710" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_36dc0c0fecd6b18ebc9e1aeb74017c33" parent="aspace_20bbef6a6b4c2f5ad8fc17085bed3710" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_4761d1070aff6ae3d4f74655713baaa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_6d7c66707bdf53045a7ff953d6e108d3" level="file">
        <did>
          <unittitle>TML, 40-45 - Tigabine for epilepsy</unittitle>
          <unitdate type="inclusive">1998 April 10</unitdate>
          <container id="aspace_c87ac7d618476b3cc7dbdd8aad763d9a" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_6d03e8c901654d05d8676e48556476a1" parent="aspace_c87ac7d618476b3cc7dbdd8aad763d9a" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_94fdedf900cf20f12d378b25deedc2ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a07a54028f90ac0076d2802b57942911" level="file">
        <did>
          <unittitle>TML, 40-64 - A new rabies vaccine</unittitle>
          <unitdate type="inclusive">1998 June 14</unitdate>
          <container id="aspace_fef867cc19365bab4938f84bc7e8b266" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_ee514dbefb9512bd54501821e7d5b071" parent="aspace_fef867cc19365bab4938f84bc7e8b266" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_47ed997eea8759fcee2c1c993e8bbb47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_3bd95f95656aa72b9a953a7b60fc1ff8" level="file">
        <did>
          <unittitle>TML, 40-29 - Raloxifene for postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">1998 March 13</unitdate>
          <container id="aspace_a78e81cfe0f93add612b707ea812931e" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_02197abf3822e9ce4186ac43e61599b9" parent="aspace_a78e81cfe0f93add612b707ea812931e" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_072da8fc19d0e0c642d2808e0b9452ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_fa4c88d1fa307e4c1c36721c687359e5" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="aspace_d16849bb3175e6fea19ed2270578eebc" label="Mixed Materials (A0000000075873)" type="box">31</container>
          <container id="aspace_a7af01e1885fca0e4bc052b59d4e3852" parent="aspace_d16849bb3175e6fea19ed2270578eebc" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_4326873ad2b2259141a757cbab189cb2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_b31307f7682d799e34699487a403a926" level="file">
        <did>
          <unittitle>TML, 40-60 - Tolcapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">1998 June 5</unitdate>
          <container id="aspace_445b81c1308b1ea89ac0892daddac1d3" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_282d84f5f40ed604a20c6b0721a0b167" parent="aspace_445b81c1308b1ea89ac0892daddac1d3" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_2802926a9875868eb77bbf4162293dea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_c0f605353f7f9186d9e181b0e5a7b35c" level="file">
        <did>
          <unittitle>TML, 40-15 - Budesonide turbuhaler for asthma</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="aspace_2be9351c3fdc325a0b39166c996625b7" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_ee7f9d2accc5c5bdd104944dcc143e57" parent="aspace_2be9351c3fdc325a0b39166c996625b7" type="folder">3-8</container>
        </did>
        <accessrestrict id="aspace_63c818b79b8463447ba0a35c3ed08e0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_fc1c9413add7682bf34765d07e37871c" level="file">
        <did>
          <unittitle>TML - Cholesterol-Lowering - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_72ba8c0eef7e2ca2ba376a77f9a97f6e" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_e46cde687ed41a69d2e9d52b430d4788" parent="aspace_72ba8c0eef7e2ca2ba376a77f9a97f6e" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_263b366a38ae16d96e1447c8e1c8953b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_9212aaed4209e15330e340d1c8675d23" level="file">
        <did>
          <unittitle>TML - Parasitic Infections - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_932fea74d98a6719ada30217e3e9916e" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_5cad1003973698ecc7369b72a7935b14" parent="aspace_932fea74d98a6719ada30217e3e9916e" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_5db4f9b0242f10ed336d20896e08899c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_367ee47d6747fc683d4571ad991fcb28" level="file">
        <did>
          <unittitle>TML - Malaria - Drugs for parastic infections</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_fcb678e55ad6ed16ef5b6c245ada2f3e" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_58a018d0e8f2f118be18ef7bd0b86d27" parent="aspace_fcb678e55ad6ed16ef5b6c245ada2f3e" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_e3f66807c02c01517706efbf9eeaff5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_d64c5c233f60d11993a1dd5cef9c5ec4" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_b5990c9509457fca8f369fb1a9f0b747" label="Mixed Materials (A0000000075874)" type="box">32</container>
          <container id="aspace_d20324cf4187a97a66b165df987287ef" parent="aspace_b5990c9509457fca8f369fb1a9f0b747" type="folder">17</container>
        </did>
        <accessrestrict id="aspace_f6a6fff3786ff1d521cdf342567849ee">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_3d41d005cf4c13e14913cd67a32a5047" level="file">
        <did>
          <unittitle>TML - Antimicrobial drugs - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_ef79d3b70089b36abe802a6e34e542bd" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_46b912d5c674d2892a40db3866b74348" parent="aspace_ef79d3b70089b36abe802a6e34e542bd" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_8075ff059f0d4d931fa3535cefb097fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a70dd9355ee98a30aebc26b8daacffc8" level="file">
        <did>
          <unittitle>TML - Psychiatric Symptoms - Reprints</unittitle>
          <unitdate type="inclusive">1998</unitdate>
          <container id="aspace_08937a10d76a91696b1ea6742232a39e" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_f65a516a6cda00f63811e1e489959305" parent="aspace_08937a10d76a91696b1ea6742232a39e" type="folder">3</container>
        </did>
        <accessrestrict id="aspace_9dfab18fed33b99b2f9c6ca42c51a487">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_878b0cb8e4fc058b68a1ed9db09469eb" level="file">
        <did>
          <unittitle>TML, 40-109 - Candesartan</unittitle>
          <unitdate type="inclusive">1998 November 20</unitdate>
          <container id="aspace_72f90080001b93996b962f93d38c7832" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_c252b1478a0c657856f45cc4a3ef8e1f" parent="aspace_72f90080001b93996b962f93d38c7832" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_ba7cc6a8281cf2cb771c412c8f89cd3f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_e61911867cf616602aa72255f38dc9ba" level="file">
        <did>
          <unittitle>TML, 40-77 - Interleukin-11</unittitle>
          <unitdate type="inclusive">1998 July 31</unitdate>
          <container id="aspace_7eca1810970e880c9b1942d081097f26" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_cd357db94ee762167b230e11d6f3ffbf" parent="aspace_7eca1810970e880c9b1942d081097f26" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_4f66d0ee0cc0c75d98d5ce57dfee6a86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_4f7233bf7c77fcfc22d806ea70169968" level="file">
        <did>
          <unittitle>TML, 40-85 - Cefdinir</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="aspace_3f22321c65ef62be7ebf8d2b5765a3d0" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_9ddd87a8711dd49e7cf2abf505d3e443" parent="aspace_3f22321c65ef62be7ebf8d2b5765a3d0" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_028c35e32d1addf3672d48cb03ad70d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_910ff3d576f61dcba1783abe6210dff1" level="file">
        <did>
          <unittitle>TML, 40-79 - Drugs for pain</unittitle>
          <unitdate type="inclusive">1998 August 14</unitdate>
          <container id="aspace_db60ed213c383a0b1c296af78085a051" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_fa216680fd2e14b4c82ce1ab4fac311a" parent="aspace_db60ed213c383a0b1c296af78085a051" type="folder">13-17</container>
        </did>
        <accessrestrict id="aspace_72993e3876c2683037ab6df23f908193">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_960c1722fd9da508635b32ac38c60f80" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="aspace_7e4e0456c78fce95e3ab9cf4bc0bd277" label="Mixed Materials (A0000000075875)" type="box">33</container>
          <container id="aspace_d2aad0162fc7013076a9b3347959f269" parent="aspace_7e4e0456c78fce95e3ab9cf4bc0bd277" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_c3d8c6875a01ba6968c3fea93fe65185">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_8e8879c55ee8242081f7f64851b4db08" level="file">
        <did>
          <unittitle>TML, 40-87 - Risedronate</unittitle>
          <unitdate type="inclusive">1998 August 28</unitdate>
          <container id="aspace_6cb7e1b26f255185c6b7f158e5f26139" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_d84536dba88866eb0c2ac4ff05ba345d" parent="aspace_6cb7e1b26f255185c6b7f158e5f26139" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_54d5c0c828c3316a8382b3f15461804c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_5d664f33dcd2cabbe962a4227379c390" level="file">
        <did>
          <unittitle>TML, 40-94 - Lepirudin for heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">1998 September 25</unitdate>
          <container id="aspace_01247fee7c40a36298efb99aa5deb5a6" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_4a432a287b58e5d45838429fb76ea484" parent="aspace_01247fee7c40a36298efb99aa5deb5a6" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_df311ee9e0d78fb33b148774389da7c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_3d76a36572332e4c480702f762cc9918" level="file">
        <did>
          <unittitle>TML, 40-25 - Propecia and Rogaine Extra Stength for Alopecia</unittitle>
          <unitdate type="inclusive">1998 February 27</unitdate>
          <container id="aspace_9e649993867a6ae46c8575787f6ecea0" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_9bc507cc6dbf62136059ad949395cd2b" parent="aspace_9e649993867a6ae46c8575787f6ecea0" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_c3ab3185c9cf9153482322e821491aa5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_affe7599f3c787d823e95823bfc0cbfc" level="file">
        <did>
          <unittitle>TML, 40-106 - Capecitabine for metastatic breast cancer</unittitle>
          <unitdate type="inclusive">1998 November</unitdate>
          <container id="aspace_a46f14b99b372459d101db4f61e285ac" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_389028d07c53e9477145e5004414a35b" parent="aspace_a46f14b99b372459d101db4f61e285ac" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_544789c77c743995f3e1041b8e18aab6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_2e2e66929019d8531954a7ad095700fb" level="file">
        <did>
          <unittitle>TML, 40-13 - Cerivastatin for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">1998 January 16</unitdate>
          <container id="aspace_16f4638cd662671729edb84777dfde19" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_7620d2c8899f8190c29348d8a4e5823d" parent="aspace_16f4638cd662671729edb84777dfde19" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_c00a8622a08054369fa43b3f435559cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_4043d39a1cb0cf7a9edea397c7574337" level="file">
        <did>
          <unittitle>TML, 40-101 - Tolterodine for overactive bladder</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="aspace_54ed3f9b512bd47a673a3cc4f7df2bc8" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_da9f6a10875edcdb895f4689a2a8c762" parent="aspace_54ed3f9b512bd47a673a3cc4f7df2bc8" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_5ed653620eb193653bb7be17c3823301">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_e5341af61e6a0539c242e29242b615c6" level="file">
        <did>
          <unittitle>TML, 40-102 - An Emergency Contraceptive Kit</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="aspace_1df64a8e0d2980f55d3c18b573ca2629" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_0a96d7c2ab2fe3333cf7f7d1475e3f05" parent="aspace_1df64a8e0d2980f55d3c18b573ca2629" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_5f3dbedbdfcd288cd297f8d578fd4ced">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_3f39fb343e118836671bfce7c8c9e0be" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="aspace_c852fbc8caa6cbd6ce1e492d1ae03574" label="Mixed Materials (A0000000075876)" type="box">34</container>
          <container id="aspace_c28ed6486ee46aac3ccef716d21f0766" parent="aspace_c852fbc8caa6cbd6ce1e492d1ae03574" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_a3bdebd3c863cd5e8915acd5b9e97a95">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_e43a7710b28863a0de4803cfd4c0b542" level="file">
        <did>
          <unittitle>TML, 40-71 - Montelukast for persistent asthma</unittitle>
          <unitdate type="inclusive">1998 July 17</unitdate>
          <container id="aspace_e6bd1ecd5d9e5dee172363714e4b4415" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_7b083f5cdef9756541a5ba2f55441691" parent="aspace_e6bd1ecd5d9e5dee172363714e4b4415" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_4b8fa308ff1db3b9b6869466f7f0fe98">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f487b7ea1e7909af55b4d7eeee8db68c" level="file">
        <did>
          <unittitle>TML, 40-103 - Thalidomide</unittitle>
          <unitdate type="inclusive">1998 October 23</unitdate>
          <container id="aspace_7d131e6adf9c1599da060ed452767a56" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_736cd1ed8ac57bacf69eb55db59d34da" parent="aspace_7d131e6adf9c1599da060ed452767a56" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_afd021cfb4388a63de5e218998fd47c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_31cfa0b79a02b7866aa0dc7e48743280" level="file">
        <did>
          <unittitle>TML, 40-97 - New Triptans and other drugs for migraine</unittitle>
          <unitdate type="inclusive">1998 October 9</unitdate>
          <container id="aspace_8d81b8a77bd506065009cbb874198d87" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_b2837c5bbea1481aa1ff5d37a3e4ef26" parent="aspace_8d81b8a77bd506065009cbb874198d87" type="folder">7-12</container>
        </did>
        <accessrestrict id="aspace_43083e8c7ccdb0aa74b842657cd508ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_f35138cee47bea646beb32b2995d4598" level="file">
        <did>
          <unittitle>TML, 40-91 - Influenza vaccine, 1998-1999</unittitle>
          <unitdate type="inclusive">1998 September 11</unitdate>
          <container id="aspace_fd5bd586f7ea96b8708339a494d35f36" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_ae175d2b16ba938340c85c50d509a897" parent="aspace_fd5bd586f7ea96b8708339a494d35f36" type="folder">13</container>
        </did>
        <accessrestrict id="aspace_a29dd57181aa1c5e6c3a1e5d3b488af7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_7c2b7e050833f74d66d0b600d186eae5" level="file">
        <did>
          <unittitle>TML, 40-105 - Creatine and Androstenedione - two "dietary supplements"</unittitle>
          <unitdate type="inclusive">1998 November 6</unitdate>
          <container id="aspace_68dc17bb68c8c8bd1f28fef5925c3cc9" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_d6b47af6a4e95ef0c32ef2c3f3fc26ed" parent="aspace_68dc17bb68c8c8bd1f28fef5925c3cc9" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_bcbeeba99d41f442379b4633e1dc7778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_a4342729d9ef2567742167972402009f" level="file">
        <did>
          <unittitle>TML, 39-107 - St. John's Wort</unittitle>
          <unitdate type="inclusive">1997 November 21</unitdate>
          <container id="aspace_8d8dcc0d520af393c1467bfa74029b4d" label="Mixed Materials (A0000000075877)" type="box">35</container>
          <container id="aspace_b88349b9a6ce056cc9e0494bf990457e" parent="aspace_8d8dcc0d520af393c1467bfa74029b4d" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_f27838dbfd9cecfa9e71bf77f07fe682">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2024</p>
        </accessrestrict>
      </c>
      <c id="aspace_ddfb397d4b944785854d8ea719c202bd" level="file">
        <did>
          <unittitle>TML, 41-73 - Malathion for treatment of head lice</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="aspace_63cf726c9ee4dc9e505fb34ce7a68761" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_a68b98ef79bda1091c8ee14f1327c6e8" parent="aspace_63cf726c9ee4dc9e505fb34ce7a68761" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_854b0f58396665c4e2d4a0465f949fd7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_35b97709b422b46ecdc94c987c5952ec" level="file">
        <did>
          <unittitle>TML, 41-39 - Advice for travelers</unittitle>
          <unitdate type="inclusive">1999 April 23</unitdate>
          <container id="aspace_e66db5630192c63b000f0a17661645e5" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_3a09255cb57ae3dd73a439d20a9d92a7" parent="aspace_e66db5630192c63b000f0a17661645e5" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_04ad6f830bf72709637049c7b301499d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_f916a9e5c338ff7fc1707311815267f1" level="file">
        <did>
          <unittitle>TML, 41-30 - Modafinil for narcolepsy</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="aspace_d982586ce44cc0f1f47c4a4dc2ceffd3" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_49d3562da7cd03542dd9ec3902792f6e" parent="aspace_d982586ce44cc0f1f47c4a4dc2ceffd3" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_113f676d893d247079b5e4ff614aec1e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_2fc16ae414cf9dd501de68ee706014d5" level="file">
        <did>
          <unittitle>TML, 41-51 - Levalbuterol for asthma</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="aspace_f3c0af7cffb09d5d5eafb47ea4e6c773" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_5ea7644d9198dc56a0fe95021ab51665" parent="aspace_f3c0af7cffb09d5d5eafb47ea4e6c773" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_17d7935132e18e8bac890aeefcb5960f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_3922b9c381c0b19cb3d63cbe803305a6" level="file">
        <did>
          <unittitle>TML, 41-16 - Mometasone furoate nasal spray for allergic rhinitis</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="aspace_5d14495a2d5a74ecc2e11d910a98bdc0" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_d501950201482a57489ac63783b77963" parent="aspace_5d14495a2d5a74ecc2e11d910a98bdc0" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_481e161096febedcc11b1ed837e0109b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_4d4ebb415f82a62d6c6b5091a9afeb7a" level="file">
        <did>
          <unittitle>TML, 41-50 - Vaccine for rotavirus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="aspace_c48e7604174c6ff4ea360e74c852ccf8" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_90ac0a10d62b103320a7541bb1948dd4" parent="aspace_c48e7604174c6ff4ea360e74c852ccf8" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_b72eb586cf031b15f2ce8b6037f013b2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_65d972dc57e884b250ec76744f2d84f9" level="file">
        <did>
          <unittitle>TML, 41-91 - Two neuraminidase inhibitors for treatment of influenza</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="aspace_0c7aa37494cc59027850dde38bc38efd" label="Mixed Materials (A0000000075878)" type="box">36</container>
          <container id="aspace_45b0184959369868d87e1c30eb2a33b4" parent="aspace_0c7aa37494cc59027850dde38bc38efd" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_6e3fe48fdf68db20082fc8bad62e904f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_26fd68ebafc0d8085fe92d2eb77fcbf6" level="file">
        <did>
          <unittitle>TML, 41-93 - Zaleplon for insomnia</unittitle>
          <unitdate type="inclusive">1999 October 8</unitdate>
          <container id="aspace_89b59452faa052a5cd5caa099c3a6087" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_f4f341c2d0e98d5f0e8b37edd37a7b4d" parent="aspace_89b59452faa052a5cd5caa099c3a6087" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_b25acf713bbbe8621cf294856e16ba28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_ec877eb8397cacf7d82d77f65b127412" level="file">
        <did>
          <unittitle>TML, 41-1 - Tamoxife for the prevention of breast cancer</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="aspace_6d479143b4aff90b6789d790af450197" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_f41fe77415a3073c6ff336da9f627ad7" parent="aspace_6d479143b4aff90b6789d790af450197" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_5090105f2f60079c4d3f971adf860516">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_94ff8cec3e58b5c4d7bd8582a705f051" level="file">
        <did>
          <unittitle>TML, 41-123 - Temozolomide</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="aspace_a938e1b63f5b98c8f63ab128b57d3107" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_6f004729a02776e9b66a853c0f9b2853" parent="aspace_a938e1b63f5b98c8f63ab128b57d3107" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_7a64776358d5df180bb0a5ddbff0bef7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_a4b43b9f4b92e02c161ee56d03e178c9" level="file">
        <did>
          <unittitle>TML, 41-53 - Interferon plus ribavirin for chronic hepatitis C</unittitle>
          <unitdate type="inclusive">1999 June 4</unitdate>
          <container id="aspace_db6c400fc6f08b534574c14ab45312b4" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_e36d66bccacc94c16f528de5821111ff" parent="aspace_db6c400fc6f08b534574c14ab45312b4" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_af177345fcae67c9d255185c0a10e870">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_024012e8b7f7de531d716961ead029ce" level="file">
        <did>
          <unittitle>TML, 41-49 - Miglitol for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="aspace_f5e755de27b155aed5c527c0bf13509e" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_b86896dc0c7be1e64c883c102a36244e" parent="aspace_f5e755de27b155aed5c527c0bf13509e" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_d6f81a58c2dc3eaf1f79b5dc23f9a66b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_a9621527ed50246d7a862b61f10afb79" level="file">
        <did>
          <unittitle>TML, 41-110 - Rabeprazole</unittitle>
          <unitdate type="inclusive">1999 November 9</unitdate>
          <container id="aspace_2abd47af4a3005758280405ccfce4639" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_177fe0b37169524bb0b9e915d642b60c" parent="aspace_2abd47af4a3005758280405ccfce4639" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_fa2239be1fca64f3de4ed0688d43b5a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_fcec222c26512f8ebe8b672bf459fbe9" level="file">
        <did>
          <unittitle>TML, 41-21 - Rifapentine for tuberculosis</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="aspace_2c91c3227a2839dc9e7f54532d4059aa" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_1f3f8860c0570c341c308bcc95d298cc" parent="aspace_2c91c3227a2839dc9e7f54532d4059aa" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_5eabb94693fe31a0f053df4c9645327d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_c2530250616ca691ba7d71e8d92ca5e1" level="file">
        <did>
          <unittitle>TML, 41-109 - Quinupristin (Dalfopristin)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="aspace_887584971aa255b863dff08bbea07a93" label="Mixed Materials (A0000000075879)" type="box">37</container>
          <container id="aspace_beaa17fbc0cb714b3b6c6f1d740a39c6" parent="aspace_887584971aa255b863dff08bbea07a93" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_96db099c24d150d666b7ebe07b50d611">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_e80acff708763c79ba27fdf7b90311e5" level="file">
        <did>
          <unittitle>TML, 41-71 - Rosiglitazone for Type 2 diabetes mellitus</unittitle>
          <unitdate type="inclusive">1999 August 13</unitdate>
          <container id="aspace_471ed63cc46636a1c147f29a97f50889" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_91803c09c4c02b4763b78ac2e0406060" parent="aspace_471ed63cc46636a1c147f29a97f50889" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_165ec4ab5ea0c075fdbea5fe2e192f3d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_703b499487840917db1eeb7a3bbf97c3" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Rheumatoid Arthritis</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_9fb390028dc201469727b0736234578d" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_31e56cf11bcef1caae770c36f1cf5398" parent="aspace_9fb390028dc201469727b0736234578d" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_15f525d3017c59fe2b80a8ae96ac839d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_d1121bbf04acf6873bc6f6be66e80e1c" level="file">
        <did>
          <unittitle>TML, 41-59 - Rofecoxib for osteoarthritis and pain</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="aspace_e4fa1712ef6e130adac3b59dd689e859" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_d9608a830ab1349ed2ea690c7ae2943d" parent="aspace_e4fa1712ef6e130adac3b59dd689e859" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_11221f9e1bc9230aebbe4b8afe4c8c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_755deaec93a3a8f46413cdb9d38a9847" level="file">
        <did>
          <unittitle>TML, 41-84 - Pneumococcal vaccine</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="aspace_c33735e34ecbb32ed74065e9fd332055" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_d3f039f9bca2a4fa5717033b38d8e7f6" parent="aspace_c33735e34ecbb32ed74065e9fd332055" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_ad40d9598ad03e97e0de7ff5b12324c2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ee2e8ec8ef4a025a102da4125d330c6" level="file">
        <did>
          <unittitle>TML, 41-20 - Homeopathic products</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="aspace_a9896d8ae0bb8833cd6135813bc26c89" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_482e13f5999a9475f19082cbe54e73a9" parent="aspace_a9896d8ae0bb8833cd6135813bc26c89" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_1d27c989e3d0f4c9ca2d59fcac0ed578">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f8ace5b9ab967ce17459254fb17ca75" level="file">
        <did>
          <unittitle>TML, 41-55 - Orlistat for obesity</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="aspace_8c6693af183c4b3405372b33ad8e295e" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_ece8fb9696af7c6017abca58d0d0b364" parent="aspace_8c6693af183c4b3405372b33ad8e295e" type="folder">17</container>
        </did>
        <accessrestrict id="aspace_3afad4f5d733d9716d22ba16c44983fc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_b2928e0b146edbf6a03684604b2f6230" level="file">
        <did>
          <unittitle>TML, 41-69 - Prosorba column for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="aspace_03ff14a0e9dace6fcfd1cf185b312307" label="Mixed Materials (A0000000075880)" type="box">38</container>
          <container id="aspace_8234ccdff30cace1c225e20eb144ef8e" parent="aspace_03ff14a0e9dace6fcfd1cf185b312307" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_f89d8a299f3aa1cb78fdeda3584f26e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_e394fdb910a180949b33fcfe30e8b17c" level="file">
        <did>
          <unittitle>TML, 41-23 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">1999 March 12</unitdate>
          <container id="aspace_0e74a9157d09e1c14a4d22be679119d7" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_3200eb78f6d4b573e7e404f4e5031eca" parent="aspace_0e74a9157d09e1c14a4d22be679119d7" type="folder">1-6</container>
        </did>
        <accessrestrict id="aspace_a85ce10fe729a0b9b0f29f163788bcd8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_1a3e95e6f5eb2cbf5b0cdb530d4df8b2" level="file">
        <did>
          <unittitle>TML, 41-113 - Drugs for non-HIV viral infection</unittitle>
          <unitdate type="inclusive">1999 December 3</unitdate>
          <container id="aspace_86baa33d0bd71ec533acb8c8d1edd403" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_85b7318ef251991e63cc9596c33ccafa" parent="aspace_86baa33d0bd71ec533acb8c8d1edd403" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_ddc058cf574899e5d0347e37efa9598e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_e42d2f63edb58feb20931053061b1339" level="file">
        <did>
          <unittitle>TML, 41-112 - Pioglitazone (Actos)</unittitle>
          <unitdate type="inclusive">1999 November 19</unitdate>
          <container id="aspace_674c65b8bc2490088d38e8097338debe" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_5169f14e50e4b0870addf780256705d5" parent="aspace_674c65b8bc2490088d38e8097338debe" type="folder">11</container>
        </did>
        <accessrestrict id="aspace_2bf75590065032d73df0e0fa13732a7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_28427104a307e9895b1500110c4ba78c" level="file">
        <did>
          <unittitle>TML, 41-43 - Suncreens - Are they safe and effective</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="aspace_5f1cc8edd81a6ea81217169076756e44" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_91401841dfa71952478e7d2d63084dc2" parent="aspace_5f1cc8edd81a6ea81217169076756e44" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_d50144a362c7ab5f8c046503c10ecf2a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_a4c7b991a97b85bed8305af27776e491" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="aspace_ae33dfd4f3ff8b5c45fdf47aa1a8aed7" label="Mixed Materials (A0000000075881)" type="box">39</container>
          <container id="aspace_3c8b5654be27104910ce38ed4c25c859" parent="aspace_ae33dfd4f3ff8b5c45fdf47aa1a8aed7" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_9b77ea87c2f2795c19e71f426864b471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_efd202ef6564adfebc4106108c9561f2" level="file">
        <did>
          <unittitle>TML, 41-56 - Cholesterol-lowering margarines</unittitle>
          <unitdate type="inclusive">1999 June 18</unitdate>
          <container id="aspace_36cff8745e0a76a2498252a185fef956" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_e34cdb7a389eeb7372096595e24c4d56" parent="aspace_36cff8745e0a76a2498252a185fef956" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_6304e26af10a0e94e7ef043fee53ad70">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_5422bbde47d91ace2df22b5b7527a0e6" level="file">
        <did>
          <unittitle>TML, 41-105 - A new ACE inhibitorand two new angiotensin receptor blockers for hypertension</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="aspace_082b09b282b4e50efb21dd54516d725f" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_89838904387f9ecb994bbd33c5268fd3" parent="aspace_082b09b282b4e50efb21dd54516d725f" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_e16a540da639162df21cb6fa8cf623e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_087aeda452bdc8c1f70b599b752d152a" level="file">
        <did>
          <unittitle>TML, 41-67 - A new conjugated estrogen</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="aspace_fe1e920e0c058a4c039343e0eeacc9d2" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_e7153859c726fb9ce0db094b3cd5eab0" parent="aspace_fe1e920e0c058a4c039343e0eeacc9d2" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_3dd21eec3f06c65a80aa71eae6b88575">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_e1ba3784eccce1db97752b63119a9737" level="file">
        <did>
          <unittitle>TML, 41-15 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="aspace_89b7363abcba075f5d8b0fe882781711" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_be12da0f61af1b8a6704e4bd6f66f72e" parent="aspace_89b7363abcba075f5d8b0fe882781711" type="folder">9</container>
        </did>
        <accessrestrict id="aspace_a078c6c919634b8920e26478d73bef6a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_ee9f72d21997962aa5e1d76e60f28954" level="file">
        <did>
          <unittitle>TML, 41-68 - Laser hair removal</unittitle>
          <unitdate type="inclusive">1999 July 30</unitdate>
          <container id="aspace_8c6094cc03b6c1a414ee5658eba7b758" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_9c7b75ce938be5284a379b2dbad1e29c" parent="aspace_8c6094cc03b6c1a414ee5658eba7b758" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_0797b526bde059f59517ea165bdcb518">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f4d6a53975d9232738144f364667da0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Parkinson's Disease</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_2e9e02d374824ffd3e05d53a511781c7" label="Mixed Materials (A0000000075882)" type="box">40</container>
          <container id="aspace_da571ce3304eef7c8c0951743dc66c85" parent="aspace_2e9e02d374824ffd3e05d53a511781c7" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_ca7184a59b6ddfe5ef00a19434c19c48">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_5db523527161519d86f176dd07137b4b" level="file">
        <did>
          <unittitle>TML, 41-5 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">1999 January 15</unitdate>
          <container id="aspace_a1f9ed73ad3ac28f7aa2db844ef040c6" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_f6827bdc0ccf512d6b809208e23c094a" parent="aspace_a1f9ed73ad3ac28f7aa2db844ef040c6" type="folder">1-5</container>
        </did>
        <accessrestrict id="aspace_24b467056399b27bd316ca395f5c8a5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_3c1f55d592280bce047dbd773f816697" level="file">
        <did>
          <unittitle>TML, 41-12 - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="aspace_ac77c14aa632519b200397d288d555b3" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_a5ed61cbc23666757c3817e52c8a0b4f" parent="aspace_ac77c14aa632519b200397d288d555b3" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_a82b9541fad7707df8ff8e0ecec045a1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_a5ef95fdd53a4ad00be13d575b720a90" level="file">
        <did>
          <unittitle>TML, 41-32 - Valrubicin for bladder cancer</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="aspace_abd9bb077893d5afa4107cf34c70ad2e" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_c077572ece38099cab34fc09144fc4bc" parent="aspace_abd9bb077893d5afa4107cf34c70ad2e" type="folder">9</container>
        </did>
        <accessrestrict id="aspace_1246d47b99a5b28275ca7ac909e04e17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_c9b5394af1307b91512bebaa47987a03" level="file">
        <did>
          <unittitle>TML, 41-19 - Infliximab (Remicade) for Crohn's disease</unittitle>
          <unitdate type="inclusive">1999 February 26</unitdate>
          <container id="aspace_baa51e8f27730a3c6eaf48420eba057e" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_50e8d80a933fadbb9c48b1c8cb83c340" parent="aspace_baa51e8f27730a3c6eaf48420eba057e" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_bceed6a85bb227d8a5c9b54693104fa7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_9431f5004a39b8a0d9a05be98633933b" level="file">
        <did>
          <unittitle>TML, 41-82 - Influenza vaccine, 1999-2000</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="aspace_d1d1810a0e025a004e6e07dd3b8d7e2d" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_91c8f211af2c93a934cda6f2e124cfd6" parent="aspace_d1d1810a0e025a004e6e07dd3b8d7e2d" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_cab250b6e8f335e1e9356ce49870aa0f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_aa75d744d2b7b8eae4e0c83305434171" level="file">
        <did>
          <unittitle>TML, 41-81 - Spironolactone for heart failure</unittitle>
          <unitdate type="inclusive">1999 September 10</unitdate>
          <container id="aspace_bbade5b22b7d96965431498fb8a8651d" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_d0c86c18e944a89c2e30d4fbfa84d513" parent="aspace_bbade5b22b7d96965431498fb8a8651d" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_4baffc7980c89aadb8cef585c345f731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_12a411c26719cadf670414ea9db35b3a" level="file">
        <did>
          <unittitle>TML, 41-2 - Growth-hormone-releasing factor for growth hormone deficiency</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="aspace_c1472d7621fa9b5f4406c287a700eb8c" label="Mixed Materials (A0000000075883)" type="box">41</container>
          <container id="aspace_41935ec91837cccde24ae1e20396d1c9" parent="aspace_c1472d7621fa9b5f4406c287a700eb8c" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_f46608e112550ebc9f422dd17a55e3b3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_50fdbec047db8cdec50f09ae8f09ce33" level="file">
        <did>
          <unittitle>TML, 41-18 - Saw Palmetto for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">1999 February 12</unitdate>
          <container id="aspace_f65b7eea8d81ec2e3460d116d13cafca" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_b9cf5efac59daef1ee9e985e6e2f2e20" parent="aspace_f65b7eea8d81ec2e3460d116d13cafca" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_ebda9b553416d292abf3337874edf243">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_12974761e15d5b5a631f8a1708a1d0e6" level="file">
        <did>
          <unittitle>TML, 41-107 - SAMe for depression</unittitle>
          <unitdate type="inclusive">1999 November 5</unitdate>
          <container id="aspace_990566f403e23b44d390681d518787b0" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_9a322ad827ee7a7b33d3647bb5b45322" parent="aspace_990566f403e23b44d390681d518787b0" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_9f6ccc892b5225ac4e542904aba616bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_2891c6463578c91c35a01dfbc0867c34" level="file">
        <did>
          <unittitle>TML, 41-3 - Palivizumab (Synagis) for prevention of RSV infection</unittitle>
          <unitdate type="inclusive">1999 January 1</unitdate>
          <container id="aspace_fea00e17cc762b492ca00917dbdf5efa" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_687962fbb2bf4268f2947852cac73fd1" parent="aspace_fea00e17cc762b492ca00917dbdf5efa" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_b084224a8b4665a510e8da9d5962cae8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_aa2d0e7ffb5da88f1ad0bda04c4f91da" level="file">
        <did>
          <unittitle>TML, 41:47 - Generic Drugs</unittitle>
          <unitdate type="inclusive">1999 May 21</unitdate>
          <container id="aspace_780e59ce56b61c032c86e290606ac35c" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_8bfccb6cc2a9966ea0e5d52c05b6557b" parent="aspace_780e59ce56b61c032c86e290606ac35c" type="folder">10-15</container>
        </did>
        <accessrestrict id="aspace_d25ac57dbed224f7c437f5c406d80bfb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_d463206ca7312a03520c55b4035d6d7c" level="file">
        <did>
          <unittitle>TML, 41-64 - Amprenavir - a new HIV protease inhibitor</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="aspace_4d955051f70d9c90a4de413430f5f253" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_c14a59e57b858750269b33fcf83a8ed9" parent="aspace_4d955051f70d9c90a4de413430f5f253" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_bebb6703e7e1148e21f6bff4883b5f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_dacba7e70abbc68ca64fcd4963a6f95a" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="aspace_4b2e4307518dae3e5fb901d3f94bc816" label="Mixed Materials (A0000000075884)" type="box">42</container>
          <container id="aspace_87f20ddfb8ee4206ef6b04f002593000" parent="aspace_4b2e4307518dae3e5fb901d3f94bc816" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_a555f10f258ebdc237376c5bf299600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_813dc879c0e4261b5ae728f45f81e536" level="file">
        <did>
          <unittitle>TML, 41-75 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">1999 August 27</unitdate>
          <container id="aspace_889e927438c10c1758fe6a41ab55adcb" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_5394d5d154f78881fbb56e2f99cf9b1a" parent="aspace_889e927438c10c1758fe6a41ab55adcb" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_64327b946a10f94bc40f30737c8f1cd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_bdc50b4955f16ee4564f9a2f1ecc15ee" level="file">
        <did>
          <unittitle>TML, 41-95 - The Choice of antibacterial drugs</unittitle>
          <unitdate type="inclusive">1999 October 22</unitdate>
          <container id="aspace_324210f2c0d44edc8eca1370766e961b" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_3052325e5034258e333807c5fe6cb12b" parent="aspace_324210f2c0d44edc8eca1370766e961b" type="folder">4-8</container>
        </did>
        <accessrestrict id="aspace_6b1bb72d82bf5bc8c23cfe7d730b6597">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_9edd35ab1f22644cf6c65fedb0f5fd9d" level="file">
        <did>
          <unittitle>TML, 41-63 - Cosmetic use of botulinum toxin</unittitle>
          <unitdate type="inclusive">1999 July 16</unitdate>
          <container id="aspace_2b51c0dd5b33a89b1cead2f93c238661" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_1422f27f79b7acda491a7905cc104793" parent="aspace_2b51c0dd5b33a89b1cead2f93c238661" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_dfa20e59cc18902aef49d7b5c22d5eb5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_cadd4aba2aafedf04d2457bcd20ecb68" level="file">
        <did>
          <unittitle>TML, 41-29 - Lyme disease vaccine</unittitle>
          <unitdate type="inclusive">1999 March 26</unitdate>
          <container id="aspace_9c01fa14862bbc61b54401f8f65b6237" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_2eea13dce96725bcc18ebb7ff9d1eefb" parent="aspace_9c01fa14862bbc61b54401f8f65b6237" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_ebb5315c0e462b0e2629b5dcb90203c8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_bb27af27ca7507bfd777f78da0d17147" level="file">
        <did>
          <unittitle>TML, 41-121 - Rapid diagnostic tests for influenza</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="aspace_d74751cb57d37ae1fbdd62656d8a2fbe" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_b4f9255a0094c6791a7310407771ddd1" parent="aspace_d74751cb57d37ae1fbdd62656d8a2fbe" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_86662934e660af89d7aeaa4e4d013446">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_cf44b51a4bbfd2f5063743b63c4a93e3" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="aspace_4085046abfe2f9a6a104c46e3602a655" label="Mixed Materials (A0000000075885)" type="box">43</container>
          <container id="aspace_5180c3f5ba13ff459d44ec4a00505e76" parent="aspace_4085046abfe2f9a6a104c46e3602a655" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_53ace92e24d776a3c07d0e679ac418eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_98fd7e915d5c04bccf9bfee05be98149" level="file">
        <did>
          <unittitle>TML, 41-85 - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">1999 September 24</unitdate>
          <container id="aspace_4c06b756aa8e13c42242783e8e706eea" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="aspace_451365e67196797bab9ba8bce8fb2d58" parent="aspace_4c06b756aa8e13c42242783e8e706eea" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_4fa538c8b0c22de3e0eea7db981ae287">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_47b865bf089a172b75b4d43ce7a1e447" level="file">
        <did>
          <unittitle>TML, 41-33 - Depression and anxiety</unittitle>
          <unitdate type="inclusive">1999 April 9</unitdate>
          <container id="aspace_e9b4374b61f3dd1c821bc3d88622eab9" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="aspace_70e397bd9e756c992d4504b816bb0091" parent="aspace_e9b4374b61f3dd1c821bc3d88622eab9" type="folder">4-13</container>
        </did>
        <accessrestrict id="aspace_b0f422d658f31862e120da53fa05b6f9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_71225c0666898a85e784b2cb281888c6" level="file">
        <did>
          <unittitle>TML, 41-122 - Corneal surgery for correction of refractive errors</unittitle>
          <unitdate type="inclusive">1999 December 17</unitdate>
          <container id="aspace_29174dc3e811c54f1b92f43a80d958bd" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="aspace_205356d6fb396606a88923c066b9408f" parent="aspace_29174dc3e811c54f1b92f43a80d958bd" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_383c5c203f77ebf4dd9e3dfe67c24cf7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_45f2b2be0a5f877794d8dab41d1e2c89" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_9a1c3a996dd18e2c34d172d51c18a9ff" label="Mixed Materials (A0000000075886)" type="box">44</container>
          <container id="aspace_30bc8536166ff65aade291d93699b078" parent="aspace_9a1c3a996dd18e2c34d172d51c18a9ff" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_149a9e74e2c2eb4d35105c1043e77fd1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_59f39d33e558df2c7a53b2df2d17a4ae" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_79be58a3b351b2ae2b86b62d2a1e45b3" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="aspace_2ed95a49638990e0cfb6d88875d0dfb3" parent="aspace_79be58a3b351b2ae2b86b62d2a1e45b3" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_6cab2eae0fd66d97ea7c349b2f4718db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d82b612550e56f5febd997b649248f6" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_864c727301c70d9268c57c1b3634c53e" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="aspace_4e9028101cce69663cc1fc78820c6861" parent="aspace_864c727301c70d9268c57c1b3634c53e" type="folder">4-9</container>
        </did>
        <accessrestrict id="aspace_9ea5dcafb096eb9d1dba6ab8571932c7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_729c9bb0e1660ceb032fe6da8350333c" level="file">
        <did>
          <unittitle>TML - Drugs of Choice for cancer chemotherapy</unittitle>
          <unitdate type="inclusive">1999</unitdate>
          <container id="aspace_27b2b057a9025b93887b121778fc18df" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="aspace_76fb19b6a72bb9ab20a6ecd45d53f293" parent="aspace_27b2b057a9025b93887b121778fc18df" type="folder">10-16</container>
        </did>
        <accessrestrict id="aspace_5ad67e35d3361f03756bfe78c6e60019">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_737148b055ba101acbd8ee7df7c07e4c" level="file">
        <did>
          <unittitle>TML, 41-44 - Cilostazol for intermittent claudication</unittitle>
          <unitdate type="inclusive">1999 May 7</unitdate>
          <container id="aspace_4c9a829ab7afb49673045613529ed9d1" label="Mixed Materials (A0000000075887)" type="box">45</container>
          <container id="aspace_cd78775780561d6da045dca575c2c45d" parent="aspace_4c9a829ab7afb49673045613529ed9d1" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_91985532c77a98b2be6619b3829a2c87">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_6e0f28a2b5a8cac84be32ec338816dac" level="file">
        <did>
          <unittitle>TML, 41-11 - Celecoxib for arthritis</unittitle>
          <unitdate type="inclusive">1999 January 29</unitdate>
          <container id="aspace_863fa50ebf5ae35b98561300ae7bd371" label="Mixed Materials (A0000000075888)" type="box">46</container>
          <container id="aspace_01d4d52bdcc989624de6f2b1fcbd678d" parent="aspace_863fa50ebf5ae35b98561300ae7bd371" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_5220646ffa341e43aaef650d57ef5cbb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_47ee2aa0e1414311aab659a0b7791d48" level="file">
        <did>
          <unittitle>TML, 41-61 - Drug interactions</unittitle>
          <unitdate type="inclusive">1999 July 2</unitdate>
          <container id="aspace_d52fa0b6c0509110f2f90fd311b69fa4" label="Mixed Materials (A0000000075945)" type="box">103</container>
          <container id="aspace_00f750aff11f4e8f62b5ea5d54ace79c" parent="aspace_d52fa0b6c0509110f2f90fd311b69fa4" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_2310dca3aaada449df04e476753e097f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2025</p>
        </accessrestrict>
      </c>
      <c id="aspace_ca7a582ccc3762635c6b2b1ab49c2e38" level="file">
        <did>
          <unittitle>TML, 42-51 - Ciclopirox (Penlac) nail lacquer for onychomysis</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="aspace_2d0238d7f49d01a63feac6fdca75b6e2" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_a6fd2f6f62b49197f3dd2f47cf56f89f" parent="aspace_2d0238d7f49d01a63feac6fdca75b6e2" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_9580c594e1986354a883d0b4d0b71bc3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_4b13f0ecb976a0758dff29129231c5ab" level="file">
        <did>
          <unittitle>TML, 42-70 - Cevimeline (Evoxac) for dry mouth</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="aspace_e22ccea9a321ffe98922edbb25d8e0a4" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_7625e9fe8c5aec5789c5e814e2dbffe1" parent="aspace_e22ccea9a321ffe98922edbb25d8e0a4" type="folder">3</container>
        </did>
        <accessrestrict id="aspace_ab5ca835a64facd8b0328a6bddeaa9db">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_65fedbec948e0fc83c65d93e86ad6afd" level="file">
        <did>
          <unittitle>TML, 42-13 - Sirolimus (Rapamune) for transplant rejection</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="aspace_df00159967a901e45b6716b627e1d20d" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_7644c5c083fe561455f285566b0cbeb6" parent="aspace_df00159967a901e45b6716b627e1d20d" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_7082abcbc2a52e308ef67322853d8731">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_43b3f1afcb8ce7fdcc73ea538a9dcaef" level="file">
        <did>
          <unittitle>TML, 42-56 - Drug interactions with St. John's Wort</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="aspace_7424abd597470542652a57d04d032c78" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_e2b4463dc7c486d5178b9ecda9f40fb2" parent="aspace_7424abd597470542652a57d04d032c78" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_fc05579a4affa53f15f6bf7701c8c36c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_13d9761c756a2fe7adb0ccd2bd89e5c3" level="file">
        <did>
          <unittitle>TML, 42-27 - Curosurf</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="aspace_6ce7e7f5e59b67dd011e39e9d6ce1989" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_39489a78d17c959ef294a70f7410f436" parent="aspace_6ce7e7f5e59b67dd011e39e9d6ce1989" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_a42091b45287859d025abbb92f4814dc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c1fd925b81d971c06ec273ef08f3cb74" level="file">
        <did>
          <unittitle>TML, 42-81 - Photodynamic therapy with veterfporfin (Visudyne) for macular degeneration</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="aspace_3ca75a517b37657540e936e510ef9610" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_00df7654d8feb19bf513ebcb07fb82f0" parent="aspace_3ca75a517b37657540e936e510ef9610" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_25831287c40dd007e7ad4f179aa90da2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_259c3ccf591bab51ffdaba3a9994e765" level="file">
        <did>
          <unittitle>TML, 42-57 - Drugs for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2000 July 10</unitdate>
          <container id="aspace_f6f69b0ce9a1771ef6871e7e284645cf" label="Mixed Materials (A0000000075889)" type="box">47</container>
          <container id="aspace_5ed5d73a4f2e3ad5a3bf3ae142dd1f3c" parent="aspace_f6f69b0ce9a1771ef6871e7e284645cf" type="folder">16-20</container>
        </did>
        <accessrestrict id="aspace_162cb0e7647f4a98954f5445c257c882">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_62b6871b865b6d75c47266161b21cb21" level="file">
        <did>
          <unittitle>TML, 42-113 - Phenylpropanolamine</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="aspace_2d63ea563d7e2ce5e1d7eb28be4d5040" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_649f14e13aab6836c25aec9d5042771c" parent="aspace_2d63ea563d7e2ce5e1d7eb28be4d5040" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_3a8380c96fc7714fa7d33e8fc9eda5f1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_7e8cf0d2095db89bdcf602dcfa388b37" level="file">
        <did>
          <unittitle>TML, 42-94 - Zonisamide (Zonegran) for epilepsy</unittitle>
          <unitdate type="inclusive">2000 August 1</unitdate>
          <container id="aspace_46efbb0b9db89ed7d9fdd9e384f49de1" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_2fd4a4ea8ae959054a262d705cb3cad0" parent="aspace_46efbb0b9db89ed7d9fdd9e384f49de1" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_af9a344f43755a6c943435e3e709888a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_505b60f40ff960c724ff856e304ce951" level="file">
        <did>
          <unittitle>TML, 42-10 - Emergency Contraception - Plan B</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="aspace_34214adbc5c687abbfc3a8c097aa0862" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_14b3cac9012ca377ef8cfd7b001af6a5" parent="aspace_34214adbc5c687abbfc3a8c097aa0862" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_3cd71612bf2f98b55022fa5ad125e9e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_86b41328d3a3f3bd0b39258221d169af" level="file">
        <did>
          <unittitle>TML, 42-42 - Oral contraceptives</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="aspace_1da3b864f9d4bf9a679ccd96d9350760" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_45068886e2da64b3768ef850bcf9f8cb" parent="aspace_1da3b864f9d4bf9a679ccd96d9350760" type="folder">6-11</container>
        </did>
        <accessrestrict id="aspace_362a441b3fc8d8a82b31585a57ea0665">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_5af9d8711bf691d44ab3b1e5bb256681" level="file">
        <did>
          <unittitle>TML, 42-17 - Phytoestrogens</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="aspace_e17863f852f2a4f696ffe2bbdc254062" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_689fa305bc87108ae849021fab0a8f1b" parent="aspace_e17863f852f2a4f696ffe2bbdc254062" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_b6923da0f1e80e36ed724d7930240ab0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_408be2b8c6034a613b1211f2ecf9b661" level="file">
        <did>
          <unittitle>TML, 42-29 - Calcium citrate vs Calcium carbonate calcium supplements</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="aspace_cd3e67ccc4e1c6bf45de7d385becf25e" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_8407e165d386b32b2cdfbc30e54f0b28" parent="aspace_cd3e67ccc4e1c6bf45de7d385becf25e" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_f012aa712ae69a791944518eafe15ae9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_3335c85c5f584c0623918d305860bba9" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="aspace_24e04a388a73640f618deac6a459bad0" label="Mixed Materials (A0000000075890)" type="box">48</container>
          <container id="aspace_06f2715069a1f4c7d372cb372f357627" parent="aspace_24e04a388a73640f618deac6a459bad0" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_55427e8bb48ad2b8315333c1ff339476">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c6d41dc2321b4992a2ce79264290f903" level="file">
        <did>
          <unittitle>TML, 42-47 - Meloxicam (Mobic) for osteoarthritis</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="aspace_180768eec16741c531d6377fe7dae766" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_8c94b20c1b681fd665f448ee2f07875e" parent="aspace_180768eec16741c531d6377fe7dae766" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_a4945089c03fcb0a219bdaccf387431a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_1ff03efd208b21a2efb1beeeca59fbe2" level="file">
        <did>
          <unittitle>TML, 42-41 - Dofetilide for atrial fibrillation</unittitle>
          <unitdate type="inclusive">2000 May 15</unitdate>
          <container id="aspace_dcba024856cd6e5d1ad54a216b401e92" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_c97009dcf39aaf8f2358c1c038213347" parent="aspace_dcba024856cd6e5d1ad54a216b401e92" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_f05aa84b2f28b6ffb33fe96ec43cd992">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_97e9932d34799dd8520be9e13f8a01ce" level="file">
        <did>
          <unittitle>TML, 40-102 - Colesevelam (Welchol) for hypercholesterolemia</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="aspace_bda19bbefc26127d6343e546460f8256" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_c5047fca57fde43c8ae09147d2162d03" parent="aspace_bda19bbefc26127d6343e546460f8256" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_349dee1a0f2981a7afaffa486ad92400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_b1e989f44b7978ab2b1aaaf201f34aeb" level="file">
        <did>
          <unittitle>TML, 42-108 - Docosanal cream (Abreva) for recurrent herpes labialis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="aspace_90d829bb2c07234fa66cb9d4773faf9e" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_ce6cb90a89d57df0401440f555cab293" parent="aspace_90d829bb2c07234fa66cb9d4773faf9e" type="folder">6</container>
        </did>
        <accessrestrict id="aspace_086b94bfdd5ebcae1564c66a07d71bf4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_e0e61fb5a1e14299b5769bb3645966af" level="file">
        <did>
          <unittitle>TML, 42-106 - Temecteplase (TNKASE) for thrombolysis</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="aspace_ccef040f4ded44c7904852f1475647c1" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_72359eab4862fcc7565ba1beb36edd81" parent="aspace_ccef040f4ded44c7904852f1475647c1" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_6881f1eb6305a22e4485bcca7bf92f20">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_3d342507f2c128f34587c4f458c47ae3" level="file">
        <did>
          <unittitle>TML, 42-113 - Valproate and other anticonvulsants for psychiatric disorders</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="aspace_ee47940c9a6ef53889758d64ad562977" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_e6ccd172775c44a6247a40c306659887" parent="aspace_ee47940c9a6ef53889758d64ad562977" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_175706ce1b1be1373cdbf4234daea11e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_89f1be4de95ddec6822bda7f0e83b385" level="file">
        <did>
          <unittitle>TML, 42-8 - Prevention of malaria</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="aspace_4ff60f3379a353911b5805f71caff484" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_b19ee81877426e540dede285ff63ef48" parent="aspace_4ff60f3379a353911b5805f71caff484" type="folder">15</container>
        </did>
        <accessrestrict id="aspace_9af6ac60aa40dc6005ce4edb57dc6970">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_da557a8aeefe93b11b7b65ef3275ee26" level="file">
        <did>
          <unittitle>TML, 42-37 - Lyme disease</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="aspace_c27bd5f20c5ea99450d9ef381b06d79a" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_3f834ab2584f527319ec0b5052dbbf9d" parent="aspace_c27bd5f20c5ea99450d9ef381b06d79a" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_50f594b6d9dec7b83b3b83386b475dcd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_b9d25758af7747ace6aaf80757aac85f" level="file">
        <did>
          <unittitle>TML, 42-18 - Aspirin for primary prevention of cardiovascular disease</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="aspace_b82076215200994bd6ae07afe1a54f8e" label="Mixed Materials (A0000000075891)" type="box">49</container>
          <container id="aspace_638bed670b07cec7b622e61e07d48b93" parent="aspace_b82076215200994bd6ae07afe1a54f8e" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_bd7e6d6a5d2765181060a6c4e5bc8024">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_8827ef8acb277df2d477589d43015ed3" level="file">
        <did>
          <unittitle>TML, 42-73 - Drugs for pain</unittitle>
          <unitdate type="inclusive">2000 August 21</unitdate>
          <container id="aspace_0632a90587e0ed84e3fb1a8343cd0dc0" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_9a5bdfe246e1a68ddc6b42826b54bb29" parent="aspace_0632a90587e0ed84e3fb1a8343cd0dc0" type="folder">1-6</container>
        </did>
        <accessrestrict id="aspace_45351d67ab671d76012768894632e65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_7ca68fc3cc569b193dc410a094f9a61f" level="file">
        <did>
          <unittitle>TML, 42-19 - Drugs for Asthma</unittitle>
          <unitdate type="inclusive">2000 March 6</unitdate>
          <container id="aspace_56b2ffe7b89b1036f0b358bb09ed973b" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_9039d7b7335f49c53c975986e553f089" parent="aspace_56b2ffe7b89b1036f0b358bb09ed973b" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_843840cc3a1f4f944dcd68fb679ac778">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_11f2fac87764b93bfe43bd87321c6e78" level="file">
        <did>
          <unittitle>TML, 42-49 - Androgel</unittitle>
          <unitdate type="inclusive">2000 June 1</unitdate>
          <container id="aspace_6eb9daf25225e3f0f2ca0df75a7be0b9" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_4ecf25d692fa06d0bf1ca74df66d50ec" parent="aspace_6eb9daf25225e3f0f2ca0df75a7be0b9" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_373b10f2aaf453294914d4fe78b9487f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f519c54c8f624fc16003fa1c04fa88f0" level="file">
        <did>
          <unittitle>TML, 42-97 - Drugs for prevention and treatment of postmenopausal osteoporosis</unittitle>
          <unitdate type="inclusive">2000 October 16</unitdate>
          <container id="aspace_d9b529fe321f255aae8936e59bcd11fd" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_9fb5375f7e5df4a8b9184d66cf269539" parent="aspace_d9b529fe321f255aae8936e59bcd11fd" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_f6c66097c55fc7906c4f0813a2f589d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_da9eaff7a676c3ce93fb52a83c4df992" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="aspace_579f4e36e696bdf8ef7ad2989c100210" label="Mixed Materials (A0000000075892)" type="box">50</container>
          <container id="aspace_c52df36ef2da5b44d94f0bbfbd342b25" parent="aspace_579f4e36e696bdf8ef7ad2989c100210" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_0b717ab0083f68384631636b834fec64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f307fe5a6bafa6083a914965f47c224f" level="file">
        <did>
          <unittitle>TML, 42-93 - Rivastigmine (Exelon) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="aspace_1ff5a202c2c657e1ef646c06339a3971" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_81b228564c2e54f612276414a8e3affe" parent="aspace_1ff5a202c2c657e1ef646c06339a3971" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_dc26934d88198182e177b592f4868a43">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0d88056c01b79b6a4d890ffb52ef26d7" level="file">
        <did>
          <unittitle>TML, 42-31 - Bexrotene</unittitle>
          <unitdate type="inclusive">2000 April 3</unitdate>
          <container id="aspace_4892876647769c6cedc70b7bc5b9ffbd" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_015f0ccedd404d60446cbe906c308ccb" parent="aspace_4892876647769c6cedc70b7bc5b9ffbd" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_9a8c86a85c6d5ea077e55d9b7597d55f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_78aad480d71976b1ac63856f8414b2de" level="file">
        <did>
          <unittitle>TML, 42-116 - Portable Defibrillators</unittitle>
          <unitdate type="inclusive">2000 December 11</unitdate>
          <container id="aspace_ba65db46c26d705ad23ebed514bfb3ec" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_12148d1f7b09a138a501ab3d9229bad6" parent="aspace_ba65db46c26d705ad23ebed514bfb3ec" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_da50ccc68a37dbb555145dfbcf8f1e7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_8856ac6d297ba039f5f59b8393406463" level="file">
        <did>
          <unittitle>TML, 42-111 - Drugs that may cause cognitive disorders in the elderly</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="aspace_4e47d211d8a01958d595ce1701fd6760" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_98b025f147f3dd55a361138160c60996" parent="aspace_4e47d211d8a01958d595ce1701fd6760" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_2247b3013b5d4bd66554d265282ec46f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_d791d0f324ea7d0ebc4dcab430fc3a36" level="file">
        <did>
          <unittitle>TML, 42-36 - Substituting for troglitazone (Rezulin)</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aspace_b0192814834e647e1ee2f1c51f06c348" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_c9e36ee4faacfe039a0ca016c42cea92" parent="aspace_b0192814834e647e1ee2f1c51f06c348" type="folder">11</container>
        </did>
        <accessrestrict id="aspace_35757c84324de4837de836a4d664e4bd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_390553fd7a4eea2f5cbee5002f2322bc" level="file">
        <did>
          <unittitle>TML, 42-109 - Atovaquone - Proguanil (Malarone) for malaria</unittitle>
          <unitdate type="inclusive">2000 November 27</unitdate>
          <container id="aspace_c167ac83e615829a6dc654467ddf86f4" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_e2443846c74e38864420a0db036446fe" parent="aspace_c167ac83e615829a6dc654467ddf86f4" type="folder">12-15</container>
        </did>
        <accessrestrict id="aspace_717bd1e1f90c70ff656382467cc26f89">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_102174d0143d0b7b46d5dbdfb6ee2e6c" level="file">
        <did>
          <unittitle>TML, 42-39 - Ketotifen and Pemirlostat - New drugs for allergic conjunctivitis</unittitle>
          <unitdate type="inclusive">2000 May 1</unitdate>
          <container id="aspace_22d0d79001379ae56a15a6db5d66e45b" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_ece9e32eb2c8a43b43d225ec45fa6867" parent="aspace_22d0d79001379ae56a15a6db5d66e45b" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_c0dedfa65ff00b42eaec283e7dbe5ee3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_968dfa06d929ab040463fb621fb94e15" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_5fb7e60bf0bf775d912311b069b941ea" label="Mixed Materials (A0000000075893)" type="box">51</container>
          <container id="aspace_ebedec628f31b5fb80b2d3a00c4a70c9" parent="aspace_5fb7e60bf0bf775d912311b069b941ea" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_a7608b2e6d21017e82cac99f4c300d04">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ffb773729eccb5c024461cb32728a1f5" level="file">
        <did>
          <unittitle>TML - HAT - Systemic antifungal</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_cadfc7737cca72bf329f298e8c7143b5" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_d567e4f702c9655df87f8b6a639aae87" parent="aspace_cadfc7737cca72bf329f298e8c7143b5" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_fc274c9d6d48168ac3a11ea6067869e0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_b5adf750afaa8fb0be9aa2061a43e3b8" level="file">
        <did>
          <unittitle>TML, 42-96 - Eflornithine cream for facial hair reduction</unittitle>
          <unitdate type="inclusive">2000 October 2</unitdate>
          <container id="aspace_8ba7792ce1efc0b8f3351079be23a434" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_25c483be703e6b6c06bfec4e1ad6f1c6" parent="aspace_8ba7792ce1efc0b8f3351079be23a434" type="folder">3</container>
        </did>
        <accessrestrict id="aspace_97998d665049bfafbdf7f044ef962ac2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c88b481d9cf92fe516e086aa696f2759" level="file">
        <did>
          <unittitle>TML, 42-67 - Gemtuzumab for relapsed acute myeloid leukemia</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="aspace_62733ecde3ddc4fae3388aa393f5df3d" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_5f31430e5e26c3c3543be576f7ac548f" parent="aspace_62733ecde3ddc4fae3388aa393f5df3d" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_8158423ad1861ed096a1f762bea5ed19">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_d316d036d1c1c8b5e65cc5a3309c50cf" level="file">
        <did>
          <unittitle>TML, 42-52 - Atkin's diet</unittitle>
          <unitdate type="inclusive">2000 June 12</unitdate>
          <container id="aspace_a21b4434d3c10c1d5a5469374681185e" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_74d94df648fc001d40b27e90510a4888" parent="aspace_a21b4434d3c10c1d5a5469374681185e" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_0024c5f9b90643b42da0ff940f490484">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f039186b802088d6736b63d8692ff877" level="file">
        <did>
          <unittitle>TML, 42-71 - Hypnotic drugs</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="aspace_3d9e49f0f6fab765359ae9bd56e4cfbb" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_ee0cb18569262ceb01b0d5dab277b6af" parent="aspace_3d9e49f0f6fab765359ae9bd56e4cfbb" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_66081d4df14137512de48118dd485bfc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ddaac639270ba0e3369ea6c5bef18c02" level="file">
        <did>
          <unittitle>TML, 42-79 - Influenza update 2000-2001</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="aspace_52440c5f319c0c7a4fdcb58af661d8f6" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_e3fad28ec6d60b4d06e8a29ec066363c" parent="aspace_52440c5f319c0c7a4fdcb58af661d8f6" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_2370a9ec5de5c8b19f6823b89c720366">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_3b89f483901c2a204aeb8a707d5f619e" level="file">
        <did>
          <unittitle>TML, 42-35 - Exemestane for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aspace_1e5579db18b6b86e675c9771ea155c54" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_8c739cea5920bedb1341c2d06164e6dd" parent="aspace_1e5579db18b6b86e675c9771ea155c54" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_908ae2bf04aa596e7e5c1b4a0b435a1a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_5b4d37f27c36f2cf78b12c02f16d9dd0" level="file">
        <did>
          <unittitle>TML, 42-12 - Epirubicin for adjuvant therapy in node-positive breast cancer</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="aspace_e52637315a93428d4a013b39ae94472e" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_34b0e26f0aad7d97d65372fb31d7744c" parent="aspace_e52637315a93428d4a013b39ae94472e" type="folder">18-20</container>
        </did>
        <accessrestrict id="aspace_231c8f3761cd29bf8b9da59c1db76773">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ea21c93279b7213ac4ebcf26ac90ac01" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aspace_c8a63c577d336d58b5075c9e48d7e846" label="Mixed Materials (A0000000075894)" type="box">52</container>
          <container id="aspace_4cf24c1fd9582ca417ccd63b995f95a1" parent="aspace_c8a63c577d336d58b5075c9e48d7e846" type="folder">21</container>
        </did>
        <accessrestrict id="aspace_ecde6f626cda50967973b161a20fcc74">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0670855c3da978011ef91e63b94b8614" level="file">
        <did>
          <unittitle>TML, 42-33 - Oxcarbazepine and Levetiracetam - Two new drugs for epilepsy</unittitle>
          <unitdate type="inclusive">2000 April 17</unitdate>
          <container id="aspace_b20c24206d26242c0a177a91e23a4949" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_01dc8be5b6ac30b40aa0c3f20d4143c2" parent="aspace_b20c24206d26242c0a177a91e23a4949" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_b1545fba52ccf81c38c8688169dab34a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_b9f3b0c3756751d471fc83952e9cdb9e" level="file">
        <did>
          <unittitle>TML - HAT - Adverse Effects</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_042fbbd4ad97e26c7081b8c03a6913ec" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_9fcc44f642816afdc3ad8abf5f7dd107" parent="aspace_042fbbd4ad97e26c7081b8c03a6913ec" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_f035a5812a9a5ba9f187b537f909316a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f64e1cb70a81058fe2a570f1ccb8c4a" level="file">
        <did>
          <unittitle>TML - Perinopril - A new ACE inhibitor for hypertension</unittitle>
          <unitdate type="inclusive">2000 May 26</unitdate>
          <container id="aspace_bf15d3d7ab0e610806723f5ccd433e9e" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_a1b08eca16ce46f62b0bd5cceb9e3dd5" parent="aspace_bf15d3d7ab0e610806723f5ccd433e9e" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_8e19dab12d3196a7486bcf0f13a7475f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_9370ffe6e8855002d778fc797c644238" level="file">
        <did>
          <unittitle>TML, 42-65 - Pantoprazole (Protonix)</unittitle>
          <unitdate type="inclusive">2000 July 24</unitdate>
          <container id="aspace_b2d175f2a565db09038be711f3c32082" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_5841fa81afaede73a7783a69d94fe311" parent="aspace_b2d175f2a565db09038be711f3c32082" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_a1015b3acc8c847466def1105f15644b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_354614b4cdeb7c25dce7323acfe3837f" level="file">
        <did>
          <unittitle>TML, 42-15 - Gatifloxacin and Moxifloxacin - Two new fluoroquinolones</unittitle>
          <unitdate type="inclusive">2000 February 21</unitdate>
          <container id="aspace_6f961af39816abea1d56e7e59e8be720" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_e8d9affced41a18f908db3163f98fda1" parent="aspace_6f961af39816abea1d56e7e59e8be720" type="folder">13-18</container>
        </did>
        <accessrestrict id="aspace_5bf74d558644f64e23255ce061463c78">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ee26dc57604d2e8beb15f5282094c199" level="file">
        <did>
          <unittitle>TML, HAT - Antimicrobial Dosage</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_f933801238ab26dd2aa06cd76350df72" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_5f89b5a0101eb25c42fb91e73ff84512" parent="aspace_f933801238ab26dd2aa06cd76350df72" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_11c3455a2f2e87c2b16773aa9e6aea7c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_a088080df443869d26625b88cfb8357c" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="aspace_4cc885a1a2f6c71f314d851ca6d89f9f" label="Mixed Materials (A0000000075895)" type="box">53</container>
          <container id="aspace_643842124d3948ced963a5d23bd7a635" parent="aspace_4cc885a1a2f6c71f314d851ca6d89f9f" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_204852f90f3648c6b6e5e6274cb652ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_4786db2a3aa9c724f7f60dcf4fcf9164" level="file">
        <did>
          <unittitle>TML, 42-105 - Glyburide - Metformin (Glucovance) for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2000 November 13</unitdate>
          <container id="aspace_80b982200dfc0050921543e15b4e96b6" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_e64b730664d3aec0e50e1779c8813ff1" parent="aspace_80b982200dfc0050921543e15b4e96b6" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_19470d2540faf3143d53c5e0f0f04553">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_ff8898d4bdb05f23855cdb33eaefc878" level="file">
        <did>
          <unittitle>TML, 42-53 - Alosetron (Lotronex) for irritable bowel syndrome</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="aspace_c5ce4437b81083d2f460abc2e23a3b82" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_da7c70d9e6b07bc316ba76022bd6d06c" parent="aspace_c5ce4437b81083d2f460abc2e23a3b82" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_a92fba8d7b374bd5ed2b6377d7f5dfcf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c83dbfe7a53fd4d335c81b6902eff92d" level="file">
        <did>
          <unittitle>TML, 42-25 - Conjugated pneumococcal vaccine for infants and children</unittitle>
          <unitdate type="inclusive">2000 March 20</unitdate>
          <container id="aspace_5597a49515f1ee63d71c3c125160af59" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_27f5c05a06d2fa1b95071167e8b46f78" parent="aspace_5597a49515f1ee63d71c3c125160af59" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_aee461894cb0482b20c2792522b46e12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0c6944c64d3e895d17a92cb7a840b2cc" level="file">
        <did>
          <unittitle>TML, 42-69 - Meningococcal vaccine - College students</unittitle>
          <unitdate type="inclusive">2000 August 7</unitdate>
          <container id="aspace_7feb62aa79be8f209644eda09eca8e1f" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_94ead14d273aa0291018bd6d8e9641bb" parent="aspace_7feb62aa79be8f209644eda09eca8e1f" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_df37cebc2f1268161ba89264e0aa24c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f8521e46162fc0e16135537e8fe60e0e" level="file">
        <did>
          <unittitle>TML, 42-80 - A new long-acting methylphenidate</unittitle>
          <unitdate type="inclusive">2000 September 4</unitdate>
          <container id="aspace_d05e1bb247ba3473753309e85e048a89" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_4cbf656ed5a0d4cb7474664f637696d8" parent="aspace_d05e1bb247ba3473753309e85e048a89" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_a4aa4fa7be7331aba5f8a5db5ecf9418">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_77d873ab9fa6653d75e07ecd29388474" level="file">
        <did>
          <unittitle>TML, 42-17 - Entacapone for Parkinson's disease</unittitle>
          <unitdate type="inclusive">2000 January 24</unitdate>
          <container id="aspace_dbc3599e2b62354cc5b877b28fc4c6ac" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_b5d6630c9a65f8a507fd1e570c0dcd56" parent="aspace_dbc3599e2b62354cc5b877b28fc4c6ac" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_c4cc72e54e77645b47ebceda334dae90">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_2c3c36361f7d26d6245b10967d53cba6" level="file">
        <did>
          <unittitle>TML, 42-45 - Linezolid (Zyvox)</unittitle>
          <unitdate type="inclusive">2000 May 29</unitdate>
          <container id="aspace_a99586aa7c4cd136806f09eaf1aa54a8" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_5fdfc44df0b1cdd468767cef3178529c" parent="aspace_a99586aa7c4cd136806f09eaf1aa54a8" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_134bd94a116d4a00868b6be7c821b669">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_f3db800fbd8c30fd18c0ce7421c0675c" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="aspace_9ac09ccb75d56278e883d7fb2176d904" label="Mixed Materials (A0000000075896)" type="box">54</container>
          <container id="aspace_eced809bd2df378f386773697938ab3e" parent="aspace_9ac09ccb75d56278e883d7fb2176d904" type="folder">19-21</container>
        </did>
        <accessrestrict id="aspace_6357a8604ec2f14301f33a46a3a3ee64">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_c29c016865d236b6f578b647c46a6676" level="file">
        <did>
          <unittitle>TML, 42-1 - Drugs for HIV</unittitle>
          <unitdate type="inclusive">2000 January 10</unitdate>
          <container id="aspace_b73c55321c2f2c5e21f58496f1669dc6" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_de24566892b7eeecdc688524cddc511e" parent="aspace_b73c55321c2f2c5e21f58496f1669dc6" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_8e3afc9c0897bcf7957059afb787d613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ef84e9be7c32e14ccb4cf39bfd45359" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_c3ae3376be34e9795eba740f1af7feac" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_931085e91decd229ca6880bc8942fb76" parent="aspace_c3ae3376be34e9795eba740f1af7feac" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_9bb37702887fbb2a3b6b04978a2797eb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_cc6bb16d28e33a08e3172f055c9bc2b1" level="file">
        <did>
          <unittitle>TML, 42-11 - Aggrenox - A combination of antiplatelet drugs for stroke prevention</unittitle>
          <unitdate type="inclusive">2000 February 7</unitdate>
          <container id="aspace_75c0ba60a97aba0b8f667be779536f08" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_c3ef535896a909c714c5464b865657ff" parent="aspace_75c0ba60a97aba0b8f667be779536f08" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_b6c3f76765c91d59d07d1942830fb182">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_7fc91d920ef13c04bcd488ff67fb27eb" level="file">
        <did>
          <unittitle>TML - 42-54 - Beta Blockers for heart failure</unittitle>
          <unitdate type="inclusive">2000 June 26</unitdate>
          <container id="aspace_473903563eb25ba53fa7056fb4d12d99" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_cc9e57b8b225071a02089acb2c7af1ac" parent="aspace_473903563eb25ba53fa7056fb4d12d99" type="folder">9-13</container>
        </did>
        <accessrestrict id="aspace_ddd4e956f4e4703f485c6e09538b3de5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_2659d96c29ea4c72cecf071a3ffe82cf" level="file">
        <did>
          <unittitle>TML, 42-83 - Drugs of Choice - Cancer chemotherapy</unittitle>
          <unitdate type="inclusive">2000 September 18</unitdate>
          <container id="aspace_851f9e7336f526564a6c799a34e8207d" label="Mixed Materials (A0000000075897)" type="box">55</container>
          <container id="aspace_12bdfeb91a8a53332b463c40a882e7d3" parent="aspace_851f9e7336f526564a6c799a34e8207d" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_fdc72de4846ddb965722a850fb816e7f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_85452dc178e1dadec0332fe42563215d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_4f2710e3778a9dea197d75a34e69920a" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_e95551d1d15a71e827877000eb771e24" parent="aspace_4f2710e3778a9dea197d75a34e69920a" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_f9bcd6fc9775a8cd44d753ed67359607">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c48a5236a35ed8f3ce7136401b6da9e" level="file">
        <did>
          <unittitle>TML, 42-101 - Mifepristone (RU 486)</unittitle>
          <unitdate type="inclusive">2000 October 30</unitdate>
          <container id="aspace_ddb876a10c1468d56deecaa8f5a4d227" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_eb0081b2b36593c601a4a5eb62367862" parent="aspace_ddb876a10c1468d56deecaa8f5a4d227" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_512097af868e6310c2ef7aa3a3ab7af5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_41cb55e32ff2281af228fcf98e48db43" level="file">
        <did>
          <unittitle>TML - Osteoporosis - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_2dace31ef56fb7d32b3a7faade2081c3" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_c91299d44bbc21929d2b23231e1793a1" parent="aspace_2dace31ef56fb7d32b3a7faade2081c3" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_a1eb04973eb4447d22f3324b1056f9bf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_669d4a856fe8af2c5b04130d94fa8d3e" level="file">
        <did>
          <unittitle>TML - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_dd1fb154af30c6247c7e6925a05613b6" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_675ecbf86b600d1979bb2fd55b512d76" parent="aspace_dd1fb154af30c6247c7e6925a05613b6" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_38e2af006895a52bd2de3eb894293ec3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ec6c4e753e63df5926b6bb8dc0ec41d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_dbf454516ceed8c7ea166ce91623ab6f" label="Mixed Materials (A0000000075898)" type="box">56</container>
          <container id="aspace_ea46e371fdbc11b2bd5c06ab1e989889" parent="aspace_dbf454516ceed8c7ea166ce91623ab6f" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_d8d94d63528159d44953c7215892b5f2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_1716a9979d5479baf368216eb3017f50" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Drugs for Parasitic infections</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_1a1b23ac2b62adb3f36fc15b43b99565" label="Mixed Materials (A0000000075899)" type="box">57</container>
          <container id="aspace_7de9db65c96706a5170f1598f397f8bc" parent="aspace_1a1b23ac2b62adb3f36fc15b43b99565" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_7be18115960dc69ccd463738ce3438d7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_296856f8c0a6139989dec83e2967a3f6" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_a4f976baba904575a1efcb8a60d3df05" label="Mixed Materials (A0000000075899)" type="box">57</container>
          <container id="aspace_d705e5ec15f33770c0a19e8888768076" parent="aspace_a4f976baba904575a1efcb8a60d3df05" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_44a20fdcc0c5ee5bc8f27d1eb7439095">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_41a4f1b5ec21dcacfcb1590a26be0255" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2000</unitdate>
          <container id="aspace_e007677ed8d98946840cabf35a0230b5" label="Mixed Materials (A0000000075900)" type="box">58</container>
          <container id="aspace_33fa0f3da059925d68167ccac7bffd16" parent="aspace_e007677ed8d98946840cabf35a0230b5" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_aae3719b7a851cb67c17470197b044d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2026</p>
        </accessrestrict>
      </c>
      <c id="aspace_8d745390980b9c7fe7639600ac855496" level="file">
        <did>
          <unittitle>TML, 43-92 - Antimicrobial prophylaxis in surgery</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="aspace_603ff9d95f75409f554a8a0d32a51c55" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_b47b21226a7148c862e2e2502c197703" parent="aspace_603ff9d95f75409f554a8a0d32a51c55" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_08c08b71a5f549bb03c9e539391bf0c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_c8e27cfe3b70673df671446dc0f171dd" level="file">
        <did>
          <unittitle>TML, 43-43 - Choice of Lipid-lowering drugs</unittitle>
          <unitdate type="inclusive">2001 May 28</unitdate>
          <container id="aspace_2c8fd8c038bf8c405789943be93747d3" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_9ff78c7e0f0524fcb51a9db9fa3635ab" parent="aspace_2c8fd8c038bf8c405789943be93747d3" type="folder">4-10</container>
        </did>
        <accessrestrict id="aspace_12c485e70ce77057b564f5f005de3180">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_b12b140d39cce8b86f62018ce31197dd" level="file">
        <did>
          <unittitle>TML, 43-1 - Lopinavir - Ritonavir - A protease-inhibitor combination</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="aspace_c99dbbcc2125ca1e046080e831520214" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_79aed3e3d03a525e99e1f5e9afe55e9b" parent="aspace_c99dbbcc2125ca1e046080e831520214" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_cb4f314cadf4551b7cb834b70eadf1cc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_f3e4fd1faa4faa99ba52ed68b8dde6c9" level="file">
        <did>
          <unittitle>TML, 43-87 - Drugs and vaccines against biological warfare</unittitle>
          <unitdate type="inclusive">2001 October 19</unitdate>
          <container id="aspace_70f55aea082a522b9fc05fd34f6f02d6" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_f488bce005410523bab92395dfb165c8" parent="aspace_70f55aea082a522b9fc05fd34f6f02d6" type="folder">14-17</container>
        </did>
        <accessrestrict id="aspace_19d192e97e549e2b446276124a3eb6b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_f8fecc1cfd922fa2df867ba43e2d95e6" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="aspace_8d13c3640cddcacb58c499026687faf8" label="Mixed Materials (A0000000075901)" type="box">59</container>
          <container id="aspace_9a2917fa9d4757f20bf1d18c36deab85" parent="aspace_8d13c3640cddcacb58c499026687faf8" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_bf0a0b9053f30a04f40935cc85ba1264">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_3283e79cbed2dd24ba8423865f0e23c0" level="file">
        <did>
          <unittitle>TML, 43-37 - Bivalirudin (Angiomax) for angioplasty</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="aspace_7269a968ae6ee7f15ffcd55e8c56a77c" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_875e57d66566a1ea15e401d01d4974b6" parent="aspace_7269a968ae6ee7f15ffcd55e8c56a77c" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_f2c531fe46fbd0a55fbf3a371d0cfb12">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_b08aa5d6ed86fd5fceee0126fd84fd06" level="file">
        <did>
          <unittitle>TML, 43-9 - Beta-Blockers</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="aspace_1c0fce3bfafd8e02715a4b5ff30a3d92" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_4d7f8e8c6a015930708c8cbab81c292a" parent="aspace_1c0fce3bfafd8e02715a4b5ff30a3d92" type="folder">2-6</container>
        </did>
        <accessrestrict id="aspace_6048933eb3a55f5f2d6a90721d4dd65f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_efb930d3872ae9d77c1298a07d7d5921" level="file">
        <did>
          <unittitle>TML, 43-62 - Balsalazide (Colazal) for ulcerative colitis</unittitle>
          <unitdate type="inclusive">2001 July</unitdate>
          <container id="aspace_320fff41721a44d09b032e9a9420a8b7" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_f313fcf0a589de006e280259ae8fecf2" parent="aspace_320fff41721a44d09b032e9a9420a8b7" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_a454b4aa29b54507db7a4b31bd4c8d5f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_b522bd1a5159bd2d2194d2263cc22904" level="file">
        <did>
          <unittitle>TML, 43-11 - Argatroban for treatment of heparin-induced thrombocytopenia</unittitle>
          <unitdate type="inclusive">2001 February 5</unitdate>
          <container id="aspace_e5e34b4c2a73bb84d427b0d5895c86ee" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_9ff490951db324f3e3268c113472b42a" parent="aspace_e5e34b4c2a73bb84d427b0d5895c86ee" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_a20e6edf2b912e65b1924e6cbfaf7256">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_46514d81205269c17a4b19d49a573235" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cardiac Arrhythmias</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_b7d69afbadb2ec0f44160d0f39d27d05" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_9090ed0ffc901cbc1ccf5751ba42891c" parent="aspace_b7d69afbadb2ec0f44160d0f39d27d05" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_0ac715d063832982eec2283c964a4110">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_6dc4850ed3f15e6085336df184251532" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Osteoporosis</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_7cf4db6aa170fc27c3f5160e61ef8900" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_2b38e1095488700bbf59c10f7ac8436e" parent="aspace_7cf4db6aa170fc27c3f5160e61ef8900" type="folder">16</container>
        </did>
        <accessrestrict id="aspace_a5d61d385919f6ecefd5058c2bf3e8d5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_02fc378d7f3b4b93e45c3eef89379858" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="aspace_50697322fc7fccfd1e39f8837204638d" label="Mixed Materials (A0000000075902)" type="box">60</container>
          <container id="aspace_50b6424d0da77cd943c1c8f7016ae0e9" parent="aspace_50697322fc7fccfd1e39f8837204638d" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_a1e5c73ef6115e61a317948cb85a9927">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2c6bff42d1f14c6a829324e9782c498a" level="file">
        <did>
          <unittitle>TML, 43-69 - Choice of Antibacterial drugs</unittitle>
          <unitdate type="inclusive">2001 August 20</unitdate>
          <container id="aspace_d8ce8fa8063969fe516dc6a24f6d5d4e" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_af0bc7a269a0bfdacf76d4752762b476" parent="aspace_d8ce8fa8063969fe516dc6a24f6d5d4e" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_5b52a18cd7491854824957b6528aa161">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_6bf6928a0695a21bf35c621f43a5b338" level="file">
        <did>
          <unittitle>TML - Antimicrobial prophylaxis and Endocarditis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_59399ea57948d38188e948868cfd2ab8" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_c28b9be5ac77acfca1bda9da1d0ca4fd" parent="aspace_59399ea57948d38188e948868cfd2ab8" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_7c855f662c00758a77e6169900e656ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_e83ae1dbb9d2dcd79b2efc11e8415787" level="file">
        <did>
          <unittitle>TML - AIDS - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_a2bd7c10dd2eeb81fd38e6c9c2dbc0f9" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_eedad61276f8085898bb0b742dd15a7e" parent="aspace_a2bd7c10dd2eeb81fd38e6c9c2dbc0f9" type="folder">7-11</container>
        </did>
        <accessrestrict id="aspace_6f3b8da68a968edcf7612c6c7ab0d96d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_c6e64d3eb72280cbc65604fd0d1ef63b" level="file">
        <did>
          <unittitle>TML, 43-91 - Post Exposure Anthrax prophylaxis</unittitle>
          <unitdate type="inclusive">2001 October 29</unitdate>
          <container id="aspace_028ce9e078b6ca43d7b2eea796d6b309" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_9863595f6af0874dfa9d92c039dea4d8" parent="aspace_028ce9e078b6ca43d7b2eea796d6b309" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_c107fed35cdd31085f732308990ad842">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_41aa0763a7e36f6ce380706ce01181e3" level="file">
        <did>
          <unittitle>TML, 43-54 - PEG-Intron for chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="aspace_ef86f0bf4d0a06730b86f826f6a1fb0b" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_a926be0b39a27da466a1b9fae262aa41" parent="aspace_ef86f0bf4d0a06730b86f826f6a1fb0b" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_10b78f31b326647359759629918503ac">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_21f79f7c6b4acd8a596b33dacb48841b" level="file">
        <did>
          <unittitle>TML, 43-110 - Insulin Glargine - a new long-acting insulin</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="aspace_12c4d18aeb7a24ecb30ac60e6643925a" label="Mixed Materials (A0000000075903)" type="box">61</container>
          <container id="aspace_a0158adb1189f6ecc8e6b0306074b87c" parent="aspace_12c4d18aeb7a24ecb30ac60e6643925a" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_ce544613fec94a632b764ccaa6155e27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2eed515acb400c24339036029a7a8f49" level="file">
        <did>
          <unittitle>TML, 43-29 - Nateglinide for Type 2 diabetes</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="aspace_8795fe2ae07e39e4196c353ec0575d0a" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_e315481ace5d301b2c1b1d4a8bc19fdb" parent="aspace_8795fe2ae07e39e4196c353ec0575d0a" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_7bf007b3c2f616cf82e76b675923a0ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ccba2cedcccf56cdefa0e205fc19e877" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Cancer</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_79f2b6a283acf8be01600d7d77aabe85" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_3a052198234cf9d0624535ef91bf4484" parent="aspace_79f2b6a283acf8be01600d7d77aabe85" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_d687a473729a78247a1c380123065159">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_8b4de852b3dcabc7ad6e003cb57745bf" level="file">
        <did>
          <unittitle>TML, 43-100 - Nesiritide for decompensated congestive heart failure</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="aspace_df4b4c059a93503dca6fc316d3ec8308" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_8ce26d0c539dd2e1f24b6e6d6cbe973e" parent="aspace_df4b4c059a93503dca6fc316d3ec8308" type="folder">6-9</container>
        </did>
        <accessrestrict id="aspace_60722a1253dc5c989a1fb84363bf8347">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ae81e26ee03016b7e8a19efe2323b2b6" level="file">
        <did>
          <unittitle>TML, 43-35 - Non-Sedating Antihistamines</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="aspace_e948d3f58c5f5b8a5906cf1599fc2952" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_9b3821e8c40bc5a198d68e9ef8f3e85b" parent="aspace_e948d3f58c5f5b8a5906cf1599fc2952" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_e3c9df3f442f047a5b6b393b36042f5b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ebbf6e65860c02f436f6ca0982c14e3e" level="file">
        <did>
          <unittitle>TML, 43-17 - Drugs for hypertension</unittitle>
          <unitdate type="inclusive">2001 March 5</unitdate>
          <container id="aspace_1ab47e86a99f0f8e3d23d7237556a233" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_efec2aac6ed5bb768d240ec20dfb3cc6" parent="aspace_1ab47e86a99f0f8e3d23d7237556a233" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_3e2fa8d34c5d3f85b91b8b755235d673">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_dc20397e0f8fc97006ecdf0d5f679b73" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="aspace_fa73066f33e6e2b12a5ba52fd60a1e01" label="Mixed Materials (A0000000075904)" type="box">62</container>
          <container id="aspace_cea39a86344f4908131949b339486155" parent="aspace_fa73066f33e6e2b12a5ba52fd60a1e01" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_bedf8436e8ecc88cef43b4466703321f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2a3e11c7291578855058677f583ba4cc" level="file">
        <did>
          <unittitle>TML, 43-62 - Botulinum Toxin Type A for cervical Dystonia</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="aspace_5d2fb58beaeb051d5e3da677daa456a2" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_b8847cf52f55a7ab5efbc76fb8835fe2" parent="aspace_5d2fb58beaeb051d5e3da677daa456a2" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_1faf2fbe4c747499b17f777c7da8d367">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_7aeba34ec44547fe9581d43a0fc4043e" level="file">
        <did>
          <unittitle>TML, 43-6 - Nebulized Budesonide for Asthma in children</unittitle>
          <unitdate type="inclusive">2001 January 27</unitdate>
          <container id="aspace_fceedaaf9b398aa60afd31b63b46346c" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_d47fb79eef5963b56d573fca16378365" parent="aspace_fceedaaf9b398aa60afd31b63b46346c" type="folder">3-7</container>
        </did>
        <accessrestrict id="aspace_d1f83bcd9d1dba630ab83fe624589365">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9011b2319d9d385461bdca83ff03a269" level="file">
        <did>
          <unittitle>TML, 42-2 - Cool Click - a needle-free device for growth hormone delivery</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="aspace_9621a9e38d1d1b8d4b2608eba3883e16" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_4c5c985e59acd528363a0e76e415c46e" parent="aspace_9621a9e38d1d1b8d4b2608eba3883e16" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_d1142cfc576dc71445c5513786f60e47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_43f128e719abd7716a8b552dab41b4ca" level="file">
        <did>
          <unittitle>TML, 43-84 - Cord Blood Banks</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="aspace_d9383e280964f5eac0f407c3abe66573" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_fce9a6ac78a0c41d231b5ed6e163eb5d" parent="aspace_d9383e280964f5eac0f407c3abe66573" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_d355e32a24f6cffb35162f5a565f8aad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2ca4ec46f32a50a21f55760304d5080b" level="file">
        <did>
          <unittitle>TML, 43-59 - Initital treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="aspace_ed3e2aac3f1f61e0a1e34f338284cdf3" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_70682d697c65f5e5b7254185ddd16eb9" parent="aspace_ed3e2aac3f1f61e0a1e34f338284cdf3" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_12449f363aa33b967622999d1c656f25">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_f4881e412a79293a02fce06ab7ada62d" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_a1be81fd15ab8fbf158cdd62995646d8" label="Mixed Materials (A0000000075905)" type="box">63</container>
          <container id="aspace_5c58521541232ec09c440f1e6b2346c5" parent="aspace_a1be81fd15ab8fbf158cdd62995646d8" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_762520a711ae5cf2f881c37d75c585e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_076a7f8b55c4644de3dc62c6db843a72" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Treatment of Parkinson's disease</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_eddb7b9e6270b3a25ef88e1f3340840c" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_6098b9ee5049244b73f3195fe9833a88" parent="aspace_eddb7b9e6270b3a25ef88e1f3340840c" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_0e6e931602cabb1fe060a758f1e09d3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_98d5e522f0e12ef676f68b6296b375c4" level="file">
        <did>
          <unittitle>TML, 43-61 - Lung Cancer screening</unittitle>
          <unitdate type="inclusive">2001 July 23</unitdate>
          <container id="aspace_159a495935d31ad2c2e46ce37e87c68c" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_92fbe04cc7471705aa8ea8f301f35513" parent="aspace_159a495935d31ad2c2e46ce37e87c68c" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_1fa9376a18b8cabf3a1ced8db4bc6995">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_bbfbf04fd92af083cfe5f2803138df54" level="file">
        <did>
          <unittitle>TML, 43-7 - Mirena</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="aspace_cf6ff02e17ca10ff20a2f5394db505dd" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_d098a0628940416d19a2dc1818aa8072" parent="aspace_cf6ff02e17ca10ff20a2f5394db505dd" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_6eb2c131de0d820a3d57bfd6b90300e6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_3b86dfd5896dc8ed385111ad16cbd218" level="file">
        <did>
          <unittitle>TML, 43-109 - Darbopoetin (Aranesp) - a long acting erythropoietin</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="aspace_ff48d9d99ae1615a0b11cb236728ce47" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_0ce358ca6ca666f00aa7a2d227016c57" parent="aspace_ff48d9d99ae1615a0b11cb236728ce47" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_f505d3982f99b3e642ccbf40fbd75883">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f9927bdf850374dd901cc030c68dc7c" level="file">
        <did>
          <unittitle>TML - Drugs for chronic heart failure</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="aspace_b6df109bcca5fc5862da910498986a8b" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_36671fe1e19d1e0e736713241466e8b5" parent="aspace_b6df109bcca5fc5862da910498986a8b" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_6be4b2a90096d23f4c7270994aa74f17">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_97fc093a6a8e4909bb2c604168b0b754" level="file">
        <did>
          <unittitle>TML, 43-58 - Caspofungin (Candidas) for aspergillosis</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="aspace_674002a59140bd2918a764527dc947f7" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_da8bb18544ff159b9457db9e21640b1d" parent="aspace_674002a59140bd2918a764527dc947f7" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_f836855e02f4d6fe9f63b628886a4c85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_6da20ff4a72dc0604ae511c5634291e7" level="file">
        <did>
          <unittitle>TML, 43-55 - A new snake antivenin</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="aspace_c39ad41d58cddd238dc3ce16dbe7ef3a" label="Mixed Materials (A0000000075906)" type="box">64</container>
          <container id="aspace_6d24d6be5961ea6f97f5f615d903003a" parent="aspace_c39ad41d58cddd238dc3ce16dbe7ef3a" type="folder">19-20</container>
        </did>
        <accessrestrict id="aspace_f08173f37c2607c4d273372be7fedab1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ede8d569017eb650ffb86947aa817ebe" level="file">
        <did>
          <unittitle>TML, 43-110 - Zometa (Zoledronic Acid) for injection</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="aspace_a6ff503839af7bc593dc8ddfb15c67b5" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_4968913f210953887aaefb518d3a04e4" parent="aspace_a6ff503839af7bc593dc8ddfb15c67b5" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_3a54c329c0d6d0bc229bdd0616332d9d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_a2f1959db87c3ed2aeb2a70eafd0d767" level="file">
        <did>
          <unittitle>TML, 43-51 - Ziprasidone (Geodon) for schizophrenia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="aspace_d13912019fc71fe2f055b2e259b6fbe2" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_a5b2c5ae4df23f62960b878bfb2a8015" parent="aspace_d13912019fc71fe2f055b2e259b6fbe2" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_810ad5d825ba01f69c55af09b52e33af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_8068f52546b65b321ac2f5fa6a731f4c" level="file">
        <did>
          <unittitle>TML, - Drugs for depression and anxiety</unittitle>
          <unitdate type="inclusive">2001 February 14</unitdate>
          <container id="aspace_de99d4154b9143ff1d0a730ac76b3d49" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_841c92e1df7a5f62f0f9cd5babd10c49" parent="aspace_de99d4154b9143ff1d0a730ac76b3d49" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_67940cb71724cb07bb1c047808a223cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_55a8ca16b598343eb87537a2d296ecd1" level="file">
        <did>
          <unittitle>TML, 43-15 - PC-Spes</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="aspace_7ed5764d3716e36e3f04aad220fecd79" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_02e085960bf631d6cd1b31af27b4dc05" parent="aspace_7ed5764d3716e36e3f04aad220fecd79" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_75c2794ebd1f11660bcef03019daccd2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ebe0e5315e3cdfa6495aed9cdada44d6" level="file">
        <did>
          <unittitle>TML, 43-83 - Metadate (Extended-Release Methylphenidate)</unittitle>
          <unitdate type="inclusive">2001 October 1</unitdate>
          <container id="aspace_f90ccf25c48b7d46b5fab404f4fb67a0" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_55ad06a8b6c5012d05c69d2555f56378" parent="aspace_f90ccf25c48b7d46b5fab404f4fb67a0" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_07f8b933648e23ed47138c1bef096df8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_833ebff3fb7c7c45c0c064414304d04f" level="file">
        <did>
          <unittitle>TML, 43-49 - Gleevec (STI-571) for chronic myeloid leukemia</unittitle>
          <unitdate type="inclusive">2001 June 11</unitdate>
          <container id="aspace_81b8190d3c57ed3c77f532d83281f14d" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_786808fdbe12cc888068800afbb57930" parent="aspace_81b8190d3c57ed3c77f532d83281f14d" type="folder">17-18</container>
        </did>
        <accessrestrict id="aspace_8a48c9bb323707808cd2699c098b90df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_e579c81ba72fe1f002ea554c42ec0eb7" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="aspace_567bc58c8f2b76b09e97a156d4bb51fb" label="Mixed Materials (A0000000075907)" type="box">65</container>
          <container id="aspace_dc98314becc37ffaca1ba95c7cdf9b27" parent="aspace_567bc58c8f2b76b09e97a156d4bb51fb" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_5b72b0c715fd854e87ba957e71353a88">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2c8e55774a1bb77e5eb47e4cd5592dca" level="file">
        <did>
          <unittitle>TML, 43-79 - Substituting for Cerivastatin (Baycol)</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="aspace_098d321fec42a20c019ae599d3515a46" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_647e70efc0b5ef2f9a82961b4f32e02d" parent="aspace_098d321fec42a20c019ae599d3515a46" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_45e2eef135b65b2a4bc8bfac6895eae6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_a3e98844edbadfd1126f96dcee9fa072" level="file">
        <did>
          <unittitle>TML, 43-89 - Insulin Aspart - a new rapid-acting insulin</unittitle>
          <unitdate type="inclusive">2001 October 15</unitdate>
          <container id="aspace_f37bea113d668afad3f413b41e508519" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_8bb4ceb0ca9a2c16af755c6ba4023958" parent="aspace_f37bea113d668afad3f413b41e508519" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_95db9e419544c222951aae12dd139e45">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_2330e815d4bdfd9c12c459306864dcca" level="file">
        <did>
          <unittitle>TML, 43-103 - Drugs for HIV infection</unittitle>
          <unitdate type="inclusive">2001 November 26</unitdate>
          <container id="aspace_ce8aa58565b15cb7c1075b6f5dae8e99" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_d36fe17c94366d1d48ed111c72b79d87" parent="aspace_ce8aa58565b15cb7c1075b6f5dae8e99" type="folder">4-7</container>
        </did>
        <accessrestrict id="aspace_ba5d1519c239af0bb83357cd9431cc00">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_c9e718e37292bcb43f7c0f24dd8175bb" level="file">
        <did>
          <unittitle>TML, 43-26 - Once-a-Week Alendronate (Fosamaz)</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="aspace_8f3aaa34ffda3077674e078aca9ac21b" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_1b4750787a9d3ca99cf6cebf47b3f0a8" parent="aspace_8f3aaa34ffda3077674e078aca9ac21b" type="folder">8</container>
        </did>
        <accessrestrict id="aspace_3aaad115d37c1f7c6a8b419cea0284e4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ce9f44342b0f523de0bfcb639e0134e8" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Migraine - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_27627586df0717aaf8725a73083f7424" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_b75b882c42f51bac066611d5e25a6dbc" parent="aspace_27627586df0717aaf8725a73083f7424" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_9d4ad8765f4f79883181f256eb7f9879">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_8c50daa78ebe0875cf14c75e503ea1c1" level="file">
        <did>
          <unittitle>TML, Drugs of Choice - Pain</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_a1f1bf6b854ec89b118efb7c804560fd" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_a07f3abcbd1a9487d97ed31dd1eb9d8f" parent="aspace_a1f1bf6b854ec89b118efb7c804560fd" type="folder">11</container>
        </did>
        <accessrestrict id="aspace_3b2728fff814b6aa47a93b6386e34381">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_468e734f765a9be3853dd86c21c17c5d" level="file">
        <did>
          <unittitle>TML, 43-25 - Direct-to-Consumer advertisements for Glucophage XR</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="aspace_3dd34e17508fb80e5d3706a9134d10dd" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_a6ae35d4116325cde503a8c95bd71a22" parent="aspace_3dd34e17508fb80e5d3706a9134d10dd" type="folder">12</container>
        </did>
        <accessrestrict id="aspace_82bce5eadd0f640bbbd014ce96f624b7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d63b61dd440fbe48748ed3adaaa153a3" level="file">
        <did>
          <unittitle>TML, 43-13 - Palivizumab update</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="aspace_f0810e070a7c7982d6146dfe0a3ce02a" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_54cd3ec1c35624371df2d13303d7bb10" parent="aspace_f0810e070a7c7982d6146dfe0a3ce02a" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_a7dd4884d34880dfc26867a2d2428bf1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_07c5a88addbecee925056539789a95ce" level="file">
        <did>
          <unittitle>TML, 43-14 - Tinzaparin for treatment of deep vein thrombosis</unittitle>
          <unitdate type="inclusive">2001 February 19</unitdate>
          <container id="aspace_c2ad6565352be9aaf359555cf9e7c40a" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_b956bc6ea8e04a6f76ffbc7006f8740a" parent="aspace_c2ad6565352be9aaf359555cf9e7c40a" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_e9948bb5cd6966ff6405e6dc4196d47e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_3c99102c3cbe6573776800745f8ae469" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="aspace_74f2ce03f6d2b98b9607a6e9c9fd4fc5" label="Mixed Materials (A0000000075908)" type="box">66</container>
          <container id="aspace_b27ccad16be13af483e0f33625ed63e4" parent="aspace_74f2ce03f6d2b98b9607a6e9c9fd4fc5" type="folder">18-20</container>
        </did>
        <accessrestrict id="aspace_0e83e8dd8e86709df7f972ac81515598">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_c6baca4f86fe997597684780a50afb04" level="file">
        <did>
          <unittitle>TML, 43-39 - Formoterol (Foradil Aerolizer) for asthma</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="aspace_8d2e01d1e8ae6ba570888dd07eb37216" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_6dcc329225e4aa5ca2933b3cfcd2bb12" parent="aspace_8d2e01d1e8ae6ba570888dd07eb37216" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_a04d9293e94b60a9e39c9b4189abc925">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_21563c371ed6d15964e3cc6b122e8325" level="file">
        <did>
          <unittitle>TML, 43-31 - Advair "Diskus" - A combination of fluticasone and salmeterol for asthma</unittitle>
          <unitdate type="inclusive">2001 April 6</unitdate>
          <container id="aspace_67c228b04e58b5f267ad2aa53c63874e" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_821d08e8b79d952573e1914eb959a51f" parent="aspace_67c228b04e58b5f267ad2aa53c63874e" type="folder">2-5</container>
        </did>
        <accessrestrict id="aspace_591f5ce0464ac805e58c930e1f206114">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_a56fc8ba008f5ec96cb059f94525d216" level="file">
        <did>
          <unittitle>TML, 43-5 - Fluoxetine (Sarafem) for premenstrual dysphoric disorder</unittitle>
          <unitdate type="inclusive">2001 January 22</unitdate>
          <container id="aspace_bd56c2927691b3668dacf8c25f3715e7" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_cb0bb1eca006e80ff2c90a9a068dd0bb" parent="aspace_bd56c2927691b3668dacf8c25f3715e7" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_516c40c3c42f23a1ef834fac3280423d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_29dd0d00d8ca1ffa9497a61ade7fcac7" level="file">
        <did>
          <unittitle>TML, 43-57 - Levothyroxine</unittitle>
          <unitdate type="inclusive">2001 July 9</unitdate>
          <container id="aspace_f3f029768bf1b1fdc69fdb108daaa51a" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_33cf241912fc2bc632365a3b99baf9a3" parent="aspace_f3f029768bf1b1fdc69fdb108daaa51a" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_5e4d50d8e1cee2179d409a4d58ebfe39">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d2d95b76affb3a4c9b22a381ae08576d" level="file">
        <did>
          <unittitle>TML, 43-28 - Detrol LA and Ditropan XL for overactive bladder</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="aspace_b54137d9bea52f5e6e95c447cbf9b7e5" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_db01fb1553a6ef5b528b58d98b553989" parent="aspace_b54137d9bea52f5e6e95c447cbf9b7e5" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_c2a600b167a1d8ec49922e49f096e4ab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_bf76f78ab4a4977fe44b60003b8f05f2" level="file">
        <did>
          <unittitle>TML, 43-27 - Prozac Weekly</unittitle>
          <unitdate type="inclusive">2001 April 2</unitdate>
          <container id="aspace_9289bc522ff46654e8711a308f933938" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_71684364196c2c860e5e85d978e2b51d" parent="aspace_9289bc522ff46654e8711a308f933938" type="folder">14</container>
        </did>
        <accessrestrict id="aspace_154ff78d3302dfb71a0c20f63e7f510f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d6b0a2f70273ff0516f8b345cdc4f512" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_6dea73a159fae1161a797b2245cd16c9" label="Mixed Materials (A0000000075909)" type="box">67</container>
          <container id="aspace_5466cce523ad63c6ee2c1c946ae667cc" parent="aspace_6dea73a159fae1161a797b2245cd16c9" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_81584269571599c2534c39747bee7f6e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ab3c9b20ba673d3a09626a2131dfbd70" level="file">
        <did>
          <unittitle>TML - Drugs for migraine</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_44a782ccc0b31b7a9ce3b58a58b16083" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_37e035f22b6ebf2016ebb85f875cf3c3" parent="aspace_44a782ccc0b31b7a9ce3b58a58b16083" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_33ca4d5589e42adbdeba4c14888b39e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_ce9d0ae7e21eaea0c4687dae309cfee9" level="file">
        <did>
          <unittitle>TML, 43-67 - Twinrix - A combination Hepatitis A and B vaccine</unittitle>
          <unitdate type="inclusive">2001 August 6</unitdate>
          <container id="aspace_e7f3a8d0ccf9dfbe39e88d3c28772fee" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_39880fa5dcfa39b07e97b869d6b5cebe" parent="aspace_e7f3a8d0ccf9dfbe39e88d3c28772fee" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_c860c07bca67d0f682cba26ca6577767">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_50348bc86f79794dd7d3880f772dc9fb" level="file">
        <did>
          <unittitle>TML, 43-81 - Influenza prevention 2001-2002</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="aspace_8ed4abe28178af7c12e5a22306117345" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_bc7e586aa7a00534f038df90aaa7d6b9" parent="aspace_8ed4abe28178af7c12e5a22306117345" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_1bbd28b63a91d7783c47a3da12aa5197">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_3b16d2ad8da51e66ff96ab39df1d0aac" level="file">
        <did>
          <unittitle>TML, 43-33 - Topical tacrolimus treatment for atopic dermatitis</unittitle>
          <unitdate type="inclusive">2001 April 16</unitdate>
          <container id="aspace_b85d44a912c5cba486c9d13af177781a" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_9bef2ae9dbdb7215a00dc0036bb44f43" parent="aspace_b85d44a912c5cba486c9d13af177781a" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_524857adc52fa0f183b069d3ae7050b5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_41122ea5a6e7981f0132dc387c47d526" level="file">
        <did>
          <unittitle>TML, 43-42 - Glucowatch Biographer - A noninvasive glucose monitoring device</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="aspace_dfb2004bb0ec42c9545fef7887335614" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_efa63986345e7f8acdce171735f0eda2" parent="aspace_dfb2004bb0ec42c9545fef7887335614" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_8a2f04b8e85fd19c93d31127f994912c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_1f33fb25dbc24b2e3a9cc4123daa4b4c" level="file">
        <did>
          <unittitle>TML, 43-99 - Cardiovascular Safety of COX-2 Inhibitors</unittitle>
          <unitdate type="inclusive">2001 November 12</unitdate>
          <container id="aspace_7a65c4fdb7ae9e7488c8bbf49506652b" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_03aa48e66a1ea89e95fa6d58f80f4178" parent="aspace_7a65c4fdb7ae9e7488c8bbf49506652b" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_ed26092ce8449e46cf63b80b2a291816">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c5905505fca4831e512fb2648100be7" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension and Heart Failure</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_61327200e4c512a3f6ada3f7bb6de38a" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_52494a9334c897038dc4f0a905fe0035" parent="aspace_61327200e4c512a3f6ada3f7bb6de38a" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_75c6bb282a1bebd46a6a30af50403e35">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d83158c1d6d2339140e8e837daa705b4" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="aspace_fe74c2bccdd5377d3efc8dbef8400788" label="Mixed Materials (A0000000075910)" type="box">68</container>
          <container id="aspace_919b30649024ef13c1facf5a2d7e644a" parent="aspace_fe74c2bccdd5377d3efc8dbef8400788" type="folder">19-21</container>
        </did>
        <accessrestrict id="aspace_a70ce5ed30190ec1d7686f21b89b6372">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_45a1a372dc6189c488cbf6dbf95adb8d" level="file">
        <did>
          <unittitle>TML, 43-23 - Over-the-Counter (OTC) Cough Remedies</unittitle>
          <unitdate type="inclusive">2001 March 19</unitdate>
          <container id="aspace_7131221814585e0398a1242021b3e880" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_659bb68cba0287d0cc7c643c5608dbc6" parent="aspace_7131221814585e0398a1242021b3e880" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_a1903924a041556ee7b26f4c2b26ac5e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_4cdec89511203afd4fe2dc98bb7107a3" level="file">
        <did>
          <unittitle>TML, 43-3 - Drugs for Vulvovaginal Candidiasis</unittitle>
          <unitdate type="inclusive">2001 January 8</unitdate>
          <container id="aspace_a63ae4b4c209152c0f19fc8539977de9" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_baea31ffd0ac9bf9c71b52e97f66fcb1" parent="aspace_a63ae4b4c209152c0f19fc8539977de9" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_721d15062edf16474f8c9615e7343c9b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c93f14bdbe03244367dc9260f841c8a" level="file">
        <did>
          <unittitle>TML, 43-40 - Epoetin - Erythropoietin (Procrit; Epogen) Revisited</unittitle>
          <unitdate type="inclusive">2001 May 14</unitdate>
          <container id="aspace_7ba68e3db509f8c80ec5a6e61d99216d" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_afb710210a19f9a5dd801734e7141ef0" parent="aspace_7ba68e3db509f8c80ec5a6e61d99216d" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_0834865471315b83cd87445af0b5d964">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_8c1db8b64ee78c1dea2315fd90476615" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_fb3ff603f26b0746d21316373f51db3a" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_de72d0846fc355fb4382800400e07d95" parent="aspace_fb3ff603f26b0746d21316373f51db3a" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_0b08c7f91d343d75d562eb65c74f54bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_42c85fbc002a3352f01a11a7e4a6f54d" level="file">
        <did>
          <unittitle>TML, 43-36 - Esomeprazole (Nexium)</unittitle>
          <unitdate type="inclusive">2001 April 30</unitdate>
          <container id="aspace_7914ca256fe0af2377da39d4b788f37f" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_15bbcf61b3b8293b5d3e734338d6014b" parent="aspace_7914ca256fe0af2377da39d4b788f37f" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_cc2db5a946dc97445662edf403135cfe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_dde7a8f4a1c15dd762a0160728804b73" level="file">
        <did>
          <unittitle>TML, 43-111 - Update on glucosamine for osteoarthritis</unittitle>
          <unitdate type="inclusive">2001 December 10</unitdate>
          <container id="aspace_dc261f33a1145d4038aadc73792cc3b6" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_bbba00ed6e9c91c696bd4fbdcf525548" parent="aspace_dc261f33a1145d4038aadc73792cc3b6" type="folder">15-17</container>
        </did>
        <accessrestrict id="aspace_5b2a4f2cbe109ddd0b02adec46206e8d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9666394f9b7e1594ab6d9d740833bf6d" level="file">
        <did>
          <unittitle>TML, 43-53 - Galantamine (Reminyl) for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2001 June 25</unitdate>
          <container id="aspace_e2284b7cfe007e6e7b4f3d46b4f36341" label="Mixed Materials (A0000000075911)" type="box">69</container>
          <container id="aspace_7e879a98aef67678df5dc1aefc6e0d1a" parent="aspace_e2284b7cfe007e6e7b4f3d46b4f36341" type="folder">18-20</container>
        </did>
        <accessrestrict id="aspace_64351c947d34d22cef39ad4007296824">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9e514faa1eb026a69873e6b610137535" level="file">
        <did>
          <unittitle>TML, 43-80 - Oxycodone and Oxycontin</unittitle>
          <unitdate type="inclusive">2001 September 17</unitdate>
          <container id="aspace_ab3300dcefebd5e3524b2a50e19c8e02" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_cc0b9a9f568624d86bfbe33caa7f5995" parent="aspace_ab3300dcefebd5e3524b2a50e19c8e02" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_71c26f172f9a9a3876c7b24d11cc0db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_9bf44e00458f50d0ecc17dc1d13c078a" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Asthma - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_657e5b0dc4fc3f28b83f0aef9a8935f1" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_825d022d4de2d31c08c8beb2a0b3da3b" parent="aspace_657e5b0dc4fc3f28b83f0aef9a8935f1" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_753a55d97a80d113ee2476718a3d1661">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_0dc13b68cd4edd9b7be7bd34aad97ff0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Hypertension - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_ac9f95f9b87c106fe8631a2e940fd5a3" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_2d3b8a68f5347ca6ec35010cea5ee805" parent="aspace_ac9f95f9b87c106fe8631a2e940fd5a3" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_d504ebc62c5421f5e1d907042650019a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_28985057e383ceb12ff871b5d26e61da" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Epilepsy - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_d066361bb2175d550810b80e4149bdbd" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_9a78d208ac3ca67442925a22b6e92fcd" parent="aspace_d066361bb2175d550810b80e4149bdbd" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_22fbfc715602ec37fdf0114b7cb13cbe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_e9eaa9b717e217af3529d05e6f9fbd9e" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Arthritis - Reprints</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_50a3442b7c104b3d50f9e5eafe13369e" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_79e60e33e11f20c6912739a22a466b9e" parent="aspace_50a3442b7c104b3d50f9e5eafe13369e" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_b5d06faa04330361ca1ca75b21c017fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_a8579ee641a8d372e5b92c341780d2f0" level="file">
        <did>
          <unittitle>TML - Drugs of Choice - Depression and Anxiety</unittitle>
          <unitdate type="inclusive">2001</unitdate>
          <container id="aspace_e89ecf9c95ea1bfe3b6e4555bc77f8d1" label="Mixed Materials (A0000000075912)" type="box">70</container>
          <container id="aspace_e766224fea24cc513bbabc93bcd41fe2" parent="aspace_e89ecf9c95ea1bfe3b6e4555bc77f8d1" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_85e3914a93c77fea32c035bd079cdf38">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2027</p>
        </accessrestrict>
      </c>
      <c id="aspace_d1091da187ca03263e9fbe06a0c8e8b9" level="file">
        <did>
          <unittitle>TML, 44-105 - Adefovir (Hespera) for chronic Hepatitis B infection</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="aspace_0da9c76dd12e3d0170e60c2045a3cdcd" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_23a00d60cf5b5b19ce942a9a85b6891a" parent="aspace_0da9c76dd12e3d0170e60c2045a3cdcd" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_5e9a358af553725b2b7a0e754e583db4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a52ad11ec1e3f4d9273267e959212194" level="file">
        <did>
          <unittitle>TML, 44-67 - Alosetron (Lotronex) revisited</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="aspace_7e21a8379e2cce2a781a05b4d60b7a44" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_32cd8b39b8de5c7d9cfef6ea16c489e3" parent="aspace_7e21a8379e2cce2a781a05b4d60b7a44" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_44f937981b03e47fe5b48832e2bc3c06">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_524bcd1ef0983fc228db57fdceccbd8a" level="file">
        <did>
          <unittitle>TML, 44-1 - Prevention and treatment of injury from chemical biological warfare</unittitle>
          <unitdate type="inclusive">2002 January 7</unitdate>
          <container id="aspace_e54bd91184eb61afb09a319e099754b2" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_365403bdfb47345f8e61e67954c92590" parent="aspace_e54bd91184eb61afb09a319e099754b2" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_41a008738c8b0cf8972cf6b24432d838">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_bad1e6f9e4ec0f760e77c31253787c34" level="file">
        <did>
          <unittitle>TML, 44-18 - Anakinra (Kineret) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="aspace_18b27463911d10d6e3b744300128ef74" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_a57ebd174d5ac61cf5cc3669720ff226" parent="aspace_18b27463911d10d6e3b744300128ef74" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_5283c1dbc9ae363bd049db90b8c9f8d8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_ba78803aaafb030f1962308400163490" level="file">
        <did>
          <unittitle>TML, 44-19 - Almotriptan (Axert) and Frovatriptan (Friva) for migraine</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="aspace_d6507e6f1ed211ac8772a4d076560cbf" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_42ca79c05a40bd64379e771cea242342" parent="aspace_d6507e6f1ed211ac8772a4d076560cbf" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_261eac7e701cc4253a133eadd4895b0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_bb6077375b3a6ffeb4bb53556a4f4c3c" level="file">
        <did>
          <unittitle>TML, 44-110 - Hemolysis from Ceftriaxone</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="aspace_e3afb8db3bd67f15d02da1d33c830de5" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_ecfabf519ae9094757f645c3d193cc2b" parent="aspace_e3afb8db3bd67f15d02da1d33c830de5" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_06663a53b51c9f32469146874e6a53fd">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a4e45a144c74f16ab14378047e5576f1" level="file">
        <did>
          <unittitle>TML, 44-6 - Budesonide (Entocort EC) for Crohn's disease</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="aspace_ec6c3bb43104a5865da81dbd08532ffa" label="Mixed Materials (A0000000075913)" type="box">71</container>
          <container id="aspace_07732e680efb80c624b89cc30eb1c9f9" parent="aspace_ec6c3bb43104a5865da81dbd08532ffa" type="folder">20-21</container>
        </did>
        <accessrestrict id="aspace_344623fd522ad204005bd4713a3a7eaa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_9f13d0adec34e41920a5e68ddd64292c" level="file">
        <did>
          <unittitle>TML, 44-109 - Dustateride (Avodart) for benign prostatic hyperplasia</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="aspace_c15cca97037caf74426828c33fc3b45c" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_a4ba2c2a017456e0971f20af0ba7867b" parent="aspace_c15cca97037caf74426828c33fc3b45c" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_867284bb3e82161ed3ce13cf85bb50cf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_9263ee3a396996d1f6c92f91c990e8b4" level="file">
        <did>
          <unittitle>TML, 44-55 - Yasmin - an oral contraceptive with a new progestin</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="aspace_6db738b548267fe614c57807942690e0" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_309c1535b062fa8d878da60ae3b2fb04" parent="aspace_6db738b548267fe614c57807942690e0" type="folder">2-7</container>
        </did>
        <accessrestrict id="aspace_c400e4bb55cfe7ea165cfb2d2dc99c6b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_fec2a29720e66cc581b066877ffa632d" level="file">
        <did>
          <unittitle>TML, 44-8 - Othro Evra - A contraceptive patch</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="aspace_52ceeea06f51ddd9d1492870b68c3b62" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_6f5d9966a029646175f46a7954531dd3" parent="aspace_52ceeea06f51ddd9d1492870b68c3b62" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_f89be5a42a6e7c9142c05161a1bb4330">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_ea19cfea9c41aa789e87a27139849cc9" level="file">
        <did>
          <unittitle>TML, 44-42 - Copyright violations</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="aspace_ddb9062931f606a6b18ef6aa80a80dc5" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_ed832e33d61c7f8cbf50464c70118e70" parent="aspace_ddb9062931f606a6b18ef6aa80a80dc5" type="folder">10</container>
        </did>
        <accessrestrict id="aspace_ec1aa5a5bbffa7071d0ee4e1725ec096">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_573b9aa7949c2b6064549d58f22d1ef4" level="file">
        <did>
          <unittitle>TML, 44-89 - Generic drugs</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="aspace_a06d06b74b73d880b234a5caa1872d3b" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_63f05efa08c76a284f56086400f14df0" parent="aspace_a06d06b74b73d880b234a5caa1872d3b" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_5b1243a2f3ac837601682945b4ad6a9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_eca6e6e8880da77ade266c114c4c3ef8" level="file">
        <did>
          <unittitle>TML, 44-77 - Gefitinib (Iressa) for advanced non-small cell lung cancer</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="aspace_12b2b0b78879a474233be79c6c230eda" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_a89584db8c0dfd2eddb3002c3db10306" parent="aspace_12b2b0b78879a474233be79c6c230eda" type="folder">14-16</container>
        </did>
        <accessrestrict id="aspace_e52979497dde6f1c31a59d9d3764a403">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a5125bf7e9b481c9cf3b474c751ee55e" level="file">
        <did>
          <unittitle>TML, 44-103 - GHB for nacolepsy</unittitle>
          <unitdate type="inclusive">2002 December 9</unitdate>
          <container id="aspace_bdf2835b5e3ddc3213c4f0993e3c3dd8" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_78f9284739313a088ccb225ae2885e0e" parent="aspace_bdf2835b5e3ddc3213c4f0993e3c3dd8" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_0fce222a44f0f4d669d6446bfe4d0948">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_5f1f43a60e3a918e61f1524dd78e1670" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_00fc73fee7c218da90623fb389c329b8" label="Mixed Materials (A0000000075914)" type="box">72</container>
          <container id="aspace_16fbcf0c0a33817efccb87b91adfa87c" parent="aspace_00fc73fee7c218da90623fb389c329b8" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_43b31e9dd0e56b4393c587638541da8a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_d0277fd8830f2d769496c88f15bb859c" level="file">
        <did>
          <unittitle>TML - Fungal Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_23cbdcdcd6a63a1d0460c3981ce932f7" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_ef6d2253d872089e6bbb5bfe1f6f5fa0" parent="aspace_23cbdcdcd6a63a1d0460c3981ce932f7" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_0374c695f899676ae2f0f4ab46c32079">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_38f15317a1ab04ccab7ddf87c59865ca" level="file">
        <did>
          <unittitle>TML, 44-65 - Fulvestrant (Faslodex) for advanced breast cancer</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="aspace_9ef64a79ea1a7d45d62d20dcaf697ae7" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_038dc7fb86c8fad340ed0a454ba14333" parent="aspace_9ef64a79ea1a7d45d62d20dcaf697ae7" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_ce879f9aa1fe59c4646fb8a958d249d1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_c2dd44962d67176662e4db78dd0a66d1" level="file">
        <did>
          <unittitle>TML, 44-5 - Cefditoren (Spectracef) - A new oral cephalosporin</unittitle>
          <unitdate type="inclusive">2002 January 21</unitdate>
          <container id="aspace_e64be9b915024c210311d58a51694dcf" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_2774470c7dacc183c9b7e42cba8d4415" parent="aspace_e64be9b915024c210311d58a51694dcf" type="folder">5-7</container>
        </did>
        <accessrestrict id="aspace_a137a040fd97e7017313ae9a82d2fe86">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_70993f6f906adca6d28b7cec87c5cbab" level="file">
        <did>
          <unittitle>TML, 44-93 - Drugs past their expiration date</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="aspace_1c9501046382aef122033100cb8ff978" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_305b25b5e0bb8dafd2a62b7d17dd6dcf" parent="aspace_1c9501046382aef122033100cb8ff978" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_e06690c5813977cdcc6c8a5a7653718f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_f9bc602671296cc3d2de922401f1986e" level="file">
        <did>
          <unittitle>TML, 44-83 - Escitalopram (Lexapro) for depression</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="aspace_f400bec2e1bcbc38f62a7d0ab25b6fed" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_4d7f167f86a7b5f0d8679c3f832c0eed" parent="aspace_f400bec2e1bcbc38f62a7d0ab25b6fed" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_fdb13be24c2193fa8c3289e7d5ad654a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_88bf2c423e244a87d79645badbf2e9f3" level="file">
        <did>
          <unittitle>TML, 44-43 - Fondaparinux (Arixtra) - a new anticoagulant</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="aspace_9f7890a122814c7d36756c37ebb29ee0" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_8cc14498998044ad3034f2ff6e905603" parent="aspace_9f7890a122814c7d36756c37ebb29ee0" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_bbbdd53df2b8ebd0612902a21d46a748">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_05b64e3022467a23598c9201bc74dfdf" level="file">
        <did>
          <unittitle>TML - Cefepime</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_de7382903fee4bc4e843f8e418d0ce50" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_b1fd69ec3d57fddc0bdbabeaa81d3b31" parent="aspace_de7382903fee4bc4e843f8e418d0ce50" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_394b3115bcff39760eac5c39dc81bdb6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0b79a2b45ac5a48beb03988b3255f34c" level="file">
        <did>
          <unittitle>TML, 44-126 - Eratapenem - a new parenteral carbapenem</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="aspace_9cb3b360ccb0f4a7b2371d29d0c33950" label="Mixed Materials (A0000000075915)" type="box">73</container>
          <container id="aspace_57f5c113bacfd515b6338827608a4730" parent="aspace_9cb3b360ccb0f4a7b2371d29d0c33950" type="folder">19-21</container>
        </did>
        <accessrestrict id="aspace_556a688586b09ef7523a269879e4d606">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_2ab8dcb85ae9ce0ddd2d1fdc51a02ee6" level="file">
        <did>
          <unittitle>TML - Echinacea</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_5796a66245284674fa80e271cacb9ca4" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="aspace_75877c19d7a5e6dc60349a0bcfd7e66f" parent="aspace_5796a66245284674fa80e271cacb9ca4" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_dc18fb2ef4fb05f2fdaba6355d199ff6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_af85bd11efe07fd729751c8c218f32d2" level="file">
        <did>
          <unittitle>TML, 44-47 - Botulinum Toxin (Botox Cosmetic) for frown lines</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="aspace_94ac1db317fa0846cfd9bd7c32895343" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="aspace_eb0315a23853096482c5fdbc305b5fd2" parent="aspace_94ac1db317fa0846cfd9bd7c32895343" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_e67c688500af00baeca0146003fa4b6f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_45aa8fe42fd0ddc4536be77350df4b57" level="file">
        <did>
          <unittitle>TML - Fungal Infections - Reprints</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_6c52e3d1df74139580f95fb3977b21ef" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="aspace_d6b6b2e71aaf47a6f97c3e0f0ae93069" parent="aspace_6c52e3d1df74139580f95fb3977b21ef" type="folder">7</container>
        </did>
        <accessrestrict id="aspace_1f1099e38699970b363bae0c6975a70b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_2e47b4ee1607009a90bcdea23b07a404" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_86c12c63c33df10d9282fd7d99ae369c" label="Mixed Materials (A0000000075916)" type="box">74</container>
          <container id="aspace_052215f07dfdc270a2f53d6950e1f3fd" parent="aspace_86c12c63c33df10d9282fd7d99ae369c" type="folder">8-19</container>
        </did>
        <accessrestrict id="aspace_831283e78ef78563e6f6b9e3060a60fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_f41b47c09c3e11ca72cf6fe9fcfca8b2" level="file">
        <did>
          <unittitle>TML - Drugs for Asthma - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_03caf30e44a49a5a3392ec5fd0466ecb" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_0c3c5902fa1528faf361dee0a8b9956e" parent="aspace_03caf30e44a49a5a3392ec5fd0466ecb" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_37075cc131616efa32d821ddec70e19a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0785dbde88fe25acb019e68e53796851" level="file">
        <did>
          <unittitle>TML, 44-73 - Neotame - a new artificial sweetner</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="aspace_affbfb772d58a0599bae46df2394ccaa" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_3197485ee5705502bfc4354b4a026458" parent="aspace_affbfb772d58a0599bae46df2394ccaa" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_423a699022dfc41e5a19356b8ede358f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_daec721a5877ed667e3be025c5b3972b" level="file">
        <did>
          <unittitle>TML, 44-95 - Valacyclovir (Valtrex) for herpes labialis</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="aspace_ef1a9a02575686bb62368c7801e30b92" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_db4612dc7bf870e02a99166f04b79048" parent="aspace_ef1a9a02575686bb62368c7801e30b92" type="folder">5-6</container>
        </did>
        <accessrestrict id="aspace_65275a0edfafc2779f6f3b12b167613d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_daaa98dacc14a33f7dd8c3607f43fabe" level="file">
        <did>
          <unittitle>TML - Drugs for prevention and treatment of postmenopausal osteoporosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 November 1</unitdate>
          <container id="aspace_a5773f89a08f4c71b74755d385f35338" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_111ae0c30fe8567aeb5360025cbde144" parent="aspace_a5773f89a08f4c71b74755d385f35338" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_66fca14cfc643877b243d938549ef683">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_6c5c80d095e7afd1c721854326e0f8cc" level="file">
        <did>
          <unittitle>TML, 44-9 - Drugs for Non-HIV viral infections</unittitle>
          <unitdate type="inclusive">2002 February 4</unitdate>
          <container id="aspace_f76fad43ad85c06102532f2d0b6e7a21" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_ce4c893f452a8533632f67901dd7879d" parent="aspace_f76fad43ad85c06102532f2d0b6e7a21" type="folder">11-17</container>
        </did>
        <accessrestrict id="aspace_bdf05fc38d86db9b72f37658b33c4730">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_bcfed60146a9353c15a7810e066eb562" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="aspace_9dfc9b0f64963c1d4bb4de01906774d0" label="Mixed Materials (A0000000075917)" type="box">75</container>
          <container id="aspace_71fa7c6d32f7242183d11feff0141dff" parent="aspace_9dfc9b0f64963c1d4bb4de01906774d0" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_3f36d4c0ac7dd42dca225464d90a4a7b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_26f9f680797154013e700d36b1ee02cc" level="file">
        <did>
          <unittitle>TML, 44-39 - Valdecoxib (Bextra) - a new COX2 inhibitor</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="aspace_a755ff22d6e37e6cae5a0cb52ebef54a" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_33b09ca74089debfd20201b57928deb4" parent="aspace_a755ff22d6e37e6cae5a0cb52ebef54a" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_538e6db36155fc336b5cd7453b267830">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_87edb03339d8ce2c8587c9b08fa0c33c" level="file">
        <did>
          <unittitle>TML, 44-52 - Tazarotene (Tazorac) for acne</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="aspace_1b82739b5f931a9b1678e37e1f739f93" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_453c93088edccb61138e910e73c06691" parent="aspace_1b82739b5f931a9b1678e37e1f739f93" type="folder">3-5</container>
        </did>
        <accessrestrict id="aspace_009827e7a43d5b337cbe6459416c7913">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_4e2f11c3afbd278cc01889db51cc3594" level="file">
        <did>
          <unittitle>TML - Safety of antimicrobials in pregnancy</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_de627a66c7b136dab1652f9f95428793" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_abeda4a04ae09f1cf86dbc6bece93fc9" parent="aspace_de627a66c7b136dab1652f9f95428793" type="folder">6-9</container>
        </did>
        <accessrestrict id="aspace_4077280e1fc84a55fa2f33342e312820">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_d9af5da201c75753edd17152b98006c9" level="file">
        <did>
          <unittitle>TML, 44-63 - Voriconazole</unittitle>
          <unitdate type="inclusive">2002 July 22</unitdate>
          <container id="aspace_f0f893a538eef1497f2d40ca72eedc3f" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_a3bfc14c89ff5c49e418482df82721a5" parent="aspace_f0f893a538eef1497f2d40ca72eedc3f" type="folder">10-14</container>
        </did>
        <accessrestrict id="aspace_7f7313cf1c86daf164b8b5b1d2c47390">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_f449d0ea0cb02a16dc4bb161afd0e8e1" level="file">
        <did>
          <unittitle>TML - Cardiovascular drugs in the ICU - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 December</unitdate>
          <container id="aspace_905d0fd7b5cd5ef23def1b6caa0f8a29" label="Mixed Materials (A0000000075918)" type="box">76</container>
          <container id="aspace_cf4b2145118a9e381d16a8eae02fb9ee" parent="aspace_905d0fd7b5cd5ef23def1b6caa0f8a29" type="folder">15-20</container>
        </did>
        <accessrestrict id="aspace_d78727a12815fb45316cee4c1bb66369">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_4536f53d88709a34f9764f238002f522" level="file">
        <did>
          <unittitle>TML, 44-51 - Triptorelin Pamoate (Trelstar)</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="aspace_b21529007fdbd8f02877616abbf52f19" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_a5490800a1f3a005886748d6d147cc0e" parent="aspace_b21529007fdbd8f02877616abbf52f19" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_3f564956f49faf84f827624973a86572">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_8319ac1e74f3772c55f953d49d1fe802" level="file">
        <did>
          <unittitle>TML - Drugs for Tuberculosis</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_06d75696c6c33c06198dbaee201c68b2" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_5f2b4d74e592628aa43e4940c6f8048b" parent="aspace_06d75696c6c33c06198dbaee201c68b2" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_6e3e6b2b8bab0f3a6559d5327bba741c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_c61123a9a767eb2a2f0665b7e710f056" level="file">
        <did>
          <unittitle>TML, 44-80 - Tepostinil (Remodulin) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="aspace_a2602023fd158bf51299b07106f9da61" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_b8edff164c89c417cad84ba9588f92e2" parent="aspace_a2602023fd158bf51299b07106f9da61" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_96d0a14409c624606417824206c572f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_9c1edb72ecb57f4a5cf544ab8a33f1ca" level="file">
        <did>
          <unittitle>TML, 44-59 - Drugs that may cause psychiatric symptoms</unittitle>
          <unitdate type="inclusive">2002 July 8</unitdate>
          <container id="aspace_f77130b552b6e71606c161800e224db0" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_3c471c480b4dc25c573b61a409592949" parent="aspace_f77130b552b6e71606c161800e224db0" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_049b266831555277c80bf92411b09f0b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_83c1e0a1fb9e3488cec1e298480b45b9" level="file">
        <did>
          <unittitle>TML, 44-79 - Tegaserod Maleate (Zelnom) for IBS with constipation</unittitle>
          <unitdate type="inclusive">2002 September 16</unitdate>
          <container id="aspace_673505a1a6f08588567d11a08f24161c" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_1bc4d948703b863c073805ffd7105242" parent="aspace_673505a1a6f08588567d11a08f24161c" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_6b6e7ca2998642d620f912e4ae273e58">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_702df7b3933e28f25249b7010b1efc23" level="file">
        <did>
          <unittitle>TML - HAT</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_3b1d1f499b07a6c910dd7d2860554003" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_20cd0501a88a032fd833b4b33ce28606" parent="aspace_3b1d1f499b07a6c910dd7d2860554003" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_21f8d786633e1a74c8baaec02b6e69c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_fbd9f3d2b393e963f637e86d90ca6f0c" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_fc7914af610a5f49b4490006b36fbbba" label="Mixed Materials (A0000000075919)" type="box">77</container>
          <container id="aspace_e8401aedeb0d13bbf7b869ee87293dda" parent="aspace_fc7914af610a5f49b4490006b36fbbba" type="folder">21</container>
        </did>
        <accessrestrict id="aspace_8c19ab74e7734be86d15ccfc2ffd8632">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_3238875c71befee0c843bfb578b0af6f" level="file">
        <did>
          <unittitle>TML - Drugs for sexually transmitted infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_85e71bd7b9c4670734604763dec0efa0" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_1e892c9e01ca0826cb6b150f0c6d4ee0" parent="aspace_85e71bd7b9c4670734604763dec0efa0" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_f07baa851539686de763d2f786c2177e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f73f901dbd4ead91b01d80ceed67c30" level="file">
        <did>
          <unittitle>TML, 44-75 - Influenza prevention 2002-2003</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="aspace_26fb315860cedeb034371cf45d0d82d0" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_b8a853c2a2dd730b42bc062b41a1680d" parent="aspace_26fb315860cedeb034371cf45d0d82d0" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_f979eb1f784b0838d5a64de4d9ac9da1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_23ee674858aa228c8597cb11a5363b5d" level="file">
        <did>
          <unittitle>TML, 44-33 - Advice for travelers</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_2e948c53aa97bb876064707c4c5477ad" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_e577f0a9e192ff6eb15ddcb8085891b5" parent="aspace_2e948c53aa97bb876064707c4c5477ad" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_687d9c16855007cc90b89408873e9116">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_c3ff86733b644974c019ea29b403f49f" level="file">
        <did>
          <unittitle>TML, 44-97 - Potassium Iodine for thyroid protection in a nuclear accident or attack</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="aspace_cf95bb21180bef68fddeadad725e0aaf" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_4be43ef578aa75fc7cf256dc10f3fe64" parent="aspace_cf95bb21180bef68fddeadad725e0aaf" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_ae3d1b9904d63ec7a442b7bf1ecd8dc5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_24af9a9128ef19b87942303f71c93a4b" level="file">
        <did>
          <unittitle>TML, 44-91 - Acetaminophen safety</unittitle>
          <unitdate type="inclusive">2002 October 28</unitdate>
          <container id="aspace_6acd0f3df60cb7e2b23ff822a56e20af" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_d2099b91a1b91cb7cc5b34629d08aed0" parent="aspace_6acd0f3df60cb7e2b23ff822a56e20af" type="folder">12-16</container>
        </did>
        <accessrestrict id="aspace_7768a5d75ddf57469eb3bbdfec0f20af">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_b3aae1ba9f482e9eeee3c33251fd33f7" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="aspace_a8f18bfa0cbef386631799ee1ee139bf" label="Mixed Materials (A0000000075920)" type="box">78</container>
          <container id="aspace_43b18f5300cdcb684ae67924dd39e521" parent="aspace_a8f18bfa0cbef386631799ee1ee139bf" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_afa4af3e07bce4f2fa04d79ed2a8e09b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_8104e8da1a3aff8455ce0008f38fee5a" level="file">
        <did>
          <unittitle>TML, 44-57 - New treatments for actinic keratoses</unittitle>
          <unitdate type="inclusive">2002 June 24</unitdate>
          <container id="aspace_b0985ad4a45be4804bc9b341fb861a09" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_ca330299b0d6c7cf941099e72617ae43" parent="aspace_b0985ad4a45be4804bc9b341fb861a09" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_aca0e4a78b7223c626fd6a43994f5d31">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_02479e2c1173076c05f34aa17007ba49" level="file">
        <did>
          <unittitle>TML, 44-21 - Acute reactions of drug abuse</unittitle>
          <unitdate type="inclusive">2002 March 4</unitdate>
          <container id="aspace_8230b6a32be1630320f29a51e5dd5fb4" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_ad33013df8d8b7a8a150f0c290546662" parent="aspace_8230b6a32be1630320f29a51e5dd5fb4" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_c95f7f827b4be73752d104280c14ae0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_d1098818233489d81f3ee9a35c491fda" level="file">
        <did>
          <unittitle>TML, 44-71 - Tests for drug abuse</unittitle>
          <unitdate type="inclusive">2002 August 19</unitdate>
          <container id="aspace_a24a30e72789a1eac75fe26b1b191dbb" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_c00d616b809cfdceaa61efe543f6ad64" parent="aspace_a24a30e72789a1eac75fe26b1b191dbb" type="folder">7-10</container>
        </did>
        <accessrestrict id="aspace_6b5deed194656d7a78e4584eaf23da1c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a2d97df9926c22348169dc85fc2da466" level="file">
        <did>
          <unittitle>TML, 44-82 - Accutane</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="aspace_9ce2506bb0b4bf621c29707690c67ecb" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_1a1276d4fc937a481937c30f9b72d7cb" parent="aspace_9ce2506bb0b4bf621c29707690c67ecb" type="folder">11-12</container>
        </did>
        <accessrestrict id="aspace_811a73112a0f3db0c61460c6f50c3a83">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_77f6dda8f57e4d024c751d9255cb8084" level="file">
        <did>
          <unittitle>TML, 44-50 - Spinal Manipulation</unittitle>
          <unitdate type="inclusive">2002 May 22</unitdate>
          <container id="aspace_47a5aa5f93f74d78c3b357935f844272" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_4636974fcc588aa0f5e39a3a30df65fd" parent="aspace_47a5aa5f93f74d78c3b357935f844272" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_c6a5678b6a97ed4390bd98a720535a47">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_09411c4ec2cd0e10526be529fdbb7c1d" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="aspace_3b8380a511d86a1283a5329f2c726d88" label="Mixed Materials (A0000000075921)" type="box">79</container>
          <container id="aspace_571eb881fb471b7dc38e417ae024ff7c" parent="aspace_3b8380a511d86a1283a5329f2c726d88" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_1fde5116b8525bf37872775d4c998b9e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_2af7784d4333e1386ceb5387b0141573" level="file">
        <did>
          <unittitle>TML, 44-101 - Irbritumomab tiuxetan (Zevalin) for non-hodgkins lymphoma</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="aspace_1f53a580d60df45efb74d62347e88692" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_660bb66bca21c5a5f8359f663459fe17" parent="aspace_1f53a580d60df45efb74d62347e88692" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_b2d240752dac7c5d6b161365b06fbe2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_45b86f5c46903225f479639e02061c91" level="file">
        <did>
          <unittitle>TML, 44-17 - Drotecogin - Activated Protein C (Xigris) for Severe Sepsis</unittitle>
          <unitdate type="inclusive">2002 February 18</unitdate>
          <container id="aspace_8077ad43768d0db710ef7a7f6c94a39f" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_7212a06013920b172384c97b46335b05" parent="aspace_8077ad43768d0db710ef7a7f6c94a39f" type="folder">3-7</container>
        </did>
        <accessrestrict id="aspace_c6644b7dd17dbfbedd1d1af2963340f4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_2df9fa1b1dadedbd80d056c6d1eb7e1b" level="file">
        <did>
          <unittitle>TML, 44-78 - Hormone replacement therapy</unittitle>
          <unitdate type="inclusive">2002 September 2</unitdate>
          <container id="aspace_6171a060d7aa351f48404e3bc594d31e" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_7512d03b87c0c3b8da457e42ecf6d408" parent="aspace_6171a060d7aa351f48404e3bc594d31e" type="folder">8-9</container>
        </did>
        <accessrestrict id="aspace_25fbac45d92806e8263c700a8600b817">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_79ecc959704f5a99033f6383c71d5e2b" level="file">
        <did>
          <unittitle>TML, 44-30 -Bosentan (Tracleer) for pulmonary arterial hypertension</unittitle>
          <unitdate type="inclusive">2002 April 11</unitdate>
          <container id="aspace_dbbcb207b04f89d114fa2cb6b5d7c1c9" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_5d101cdfc183d61f232237c8bc3e8b51" parent="aspace_dbbcb207b04f89d114fa2cb6b5d7c1c9" type="folder">10-12</container>
        </did>
        <accessrestrict id="aspace_c218a513a6535a5ceb72241f53f1083c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_ebeb0b87fb29433a1b670b6a4d5aa5fc" level="file">
        <did>
          <unittitle>TML, 44-45 - Dexmethylphenidate (Focalin) for ADHD</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="aspace_4ba9778758c3e41568d20b02a22c5159" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_fff9cb066e0652f9adbe66f32d61524d" parent="aspace_4ba9778758c3e41568d20b02a22c5159" type="folder">13-14</container>
        </did>
        <accessrestrict id="aspace_daa9fc43588271721e9668e6387b1ecc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_9cf28c7502d38a3253794dc0aff81d12" level="file">
        <did>
          <unittitle>TML, 44-53 - Droperidol Risk - Arrhythmias</unittitle>
          <unitdate type="inclusive">2002 June 10</unitdate>
          <container id="aspace_fe63b016d0103f3b62917ee873549dbc" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_73e4f4e2f5478fff149cc8262b2c2957" parent="aspace_fe63b016d0103f3b62917ee873549dbc" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_9343665bbaab14cdc391de9fbda39aab">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_037a4523e063f09b403c4b86b056b0b9" level="file">
        <did>
          <unittitle>TML, 44-84 - Herbal Products - Problems with dietary supplements</unittitle>
          <unitdate type="inclusive">2002 September 30</unitdate>
          <container id="aspace_0a4dd9c2143b74e1327c0c513ff4f98f" label="Mixed Materials (A0000000075922)" type="box">80</container>
          <container id="aspace_1e908b35ea6240cbfcbf77ad4f6cbb33" parent="aspace_0a4dd9c2143b74e1327c0c513ff4f98f" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_2fdc328774c9f82ce8ebb61aee7387a6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_606c2c7591fb4c21ba3d38fc6c7462b0" level="file">
        <did>
          <unittitle>TML, 44-96 - Rasburicase</unittitle>
          <unitdate type="inclusive">2002 November 11</unitdate>
          <container id="aspace_c3e9cd6a039d12237aa2befe24ae972b" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_18be7d4b7bbe02f1df5db236cc60568c" parent="aspace_c3e9cd6a039d12237aa2befe24ae972b" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_6dd42fdac95221294c398b8dad4d3a7e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_b3d8e525fd2c6ceabdefb1c16c80e100" level="file">
        <did>
          <unittitle>TML, 44-88 - Three beta-interferons for MS</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="aspace_00584446231f0e752d87d7bb123bd085" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_feb8d7ea280d5d4e2f32dc40af5bdd7c" parent="aspace_00584446231f0e752d87d7bb123bd085" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_de5073ebce08ff223cdc3bac4b44096d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_cd35b74adb66fbee3caa77d502914319" level="file">
        <did>
          <unittitle>TML, 44-99 - Indications for an implantable cardioverter defibrillator</unittitle>
          <unitdate type="inclusive">2002 November 25</unitdate>
          <container id="aspace_8baa9b338513c1ab5f198162f1950aef" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_f7ee2b39f08140bce466799baf1d8ab5" parent="aspace_8baa9b338513c1ab5f198162f1950aef" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_44a756d7626a6484624c170f3c9fe601">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_caba3d20cbb6ac2bcf0fffb6486cd172" level="file">
        <did>
          <unittitle>TML - Drugs for Diabetes - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2002 September</unitdate>
          <container id="aspace_b405e6a0d861a356c9aee4fb1237adae" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_ce32752ebf79fe582c3668a882b47613" parent="aspace_b405e6a0d861a356c9aee4fb1237adae" type="folder">10-13</container>
        </did>
        <accessrestrict id="aspace_27fb92f6dcd523eaebbcb18be6a423a5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0cdc8024ee854934a00a2e6cc658127c" level="file">
        <did>
          <unittitle>TML, 44-87 - Once-a-Week risedronate (Actonel)</unittitle>
          <unitdate type="inclusive">2002 October 14</unitdate>
          <container id="aspace_f54a5ffd661ca0251b7295eb67df3d02" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_72425f69e48fe605f7f5220154783f61" parent="aspace_f54a5ffd661ca0251b7295eb67df3d02" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_3c69c2eda4cf5e33f151894a6dae98fa">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_6373e1ea574b03380381b604f8f317ea" level="file">
        <did>
          <unittitle>TML, 44-48 - Topical Primecrolimus (Elidel) for treatment of atopic dermatitis</unittitle>
          <unitdate type="inclusive">2002 May 27</unitdate>
          <container id="aspace_562a9ac363fdc30bcafe00d8ae7dea08" label="Mixed Materials (A0000000075923)" type="box">81</container>
          <container id="aspace_dd0f160dfc4e29c37916906c89508ac2" parent="aspace_562a9ac363fdc30bcafe00d8ae7dea08" type="folder">16-17</container>
        </did>
        <accessrestrict id="aspace_c8982cc8907e5273994dc146b1a74168">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0a43de1bea99678d0bd3f43b5c8e3aab" level="file">
        <did>
          <unittitle>TML, 44-107 - Metaglip and Avandamet for type 2 diabetes</unittitle>
          <unitdate type="inclusive">2002 December 23</unitdate>
          <container id="aspace_2adb675f05e3fc2e76e5c59fab9d809e" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_f4bb683a9e1add92abdef0cb244f1f33" parent="aspace_2adb675f05e3fc2e76e5c59fab9d809e" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_77f5cb2d5690ac4fb8b1401da5ce42c3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ad024dbe91f78abe8bfbef002c6b1ff" level="file">
        <did>
          <unittitle>TML, 44-27 - Desloratadine</unittitle>
          <unitdate type="inclusive">2002 March 18</unitdate>
          <container id="aspace_f660ec3bbbff6c6af5464bce9a56b37b" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_0bc52f4f372ede7184687e5ee738064c" parent="aspace_f660ec3bbbff6c6af5464bce9a56b37b" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_36a5c8671473d8ebde644f9ea2a482bc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_b7991b9a56fe105d30e6587c04553698" level="file">
        <did>
          <unittitle>TML, 44-41 - Pantoprazole (Protonix IV)</unittitle>
          <unitdate type="inclusive">2002 April 29</unitdate>
          <container id="aspace_d70f3279a4b1775a3e951362c0ef2b3e" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_c90f5c9a1fa9840760e209e6a9dd3488" parent="aspace_d70f3279a4b1775a3e951362c0ef2b3e" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_ecf59515bb41f3b93d8d69d9976e28b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_e886d7140f04a51e798f5685595d8a64" level="file">
        <did>
          <unittitle>TML, 44-69 - Olmesartan (Benicar) for hypertension</unittitle>
          <unitdate type="inclusive">2002 August 5</unitdate>
          <container id="aspace_4223ddb0579eb3dda07f87ea5cffb335" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_b9b6dc273c3efd4f17eccc6d40d9c00b" parent="aspace_4223ddb0579eb3dda07f87ea5cffb335" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_74dedc4bdd750d18fabe19b677cbe4fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_a62ab234ffcd38be2c7ecb1b5105a478" level="file">
        <did>
          <unittitle>TML - Drugs for Parasitic Infections</unittitle>
          <unitdate type="inclusive">2002</unitdate>
          <container id="aspace_9a50b4302f7f13c4bbbb3668f10d931a" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_bcb2c7f0f9bcddced4713e959e82c420" parent="aspace_9a50b4302f7f13c4bbbb3668f10d931a" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_a1761f494a6aadd735240b5f6234da0c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_334f7d2fdf7bebf0df4dbded68f76c8d" level="file">
        <did>
          <unittitle>TML, 44-44 - Pegfilgrastin (Neulasta) for prevention of febrile neutropenia</unittitle>
          <unitdate type="inclusive">2002 May 13</unitdate>
          <container id="aspace_ebc4833431839c549216e246ad444256" label="Mixed Materials (A0000000075924)" type="box">82</container>
          <container id="aspace_98b7cb2aff40f733c7e3239a1c153893" parent="aspace_ebc4833431839c549216e246ad444256" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_a69e5af2889f08c295264781d0dc1080">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2028</p>
        </accessrestrict>
      </c>
      <c id="aspace_f777550cceb72905734014265970ba2d" level="file">
        <did>
          <unittitle>TML, 45-25 - Adalimumab (Humira) for rheumatoid arthritis</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="aspace_ff8624e5b2dcb53aa9a425c14525e324" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_b2417523e2b02ae0982b0cb1884e8ff7" parent="aspace_ff8624e5b2dcb53aa9a425c14525e324" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_843488d272c7cd2629b6cfaf3ea233ef">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_755a5cb278c5674c278d62217583d0dc" level="file">
        <did>
          <unittitle>TML, 45-31 - Alefacept (Amevive) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="aspace_e6097d4db13d114d55eb91c07815e08c" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_182abfddb7967ed5f7d6d56c0073626b" parent="aspace_e6097d4db13d114d55eb91c07815e08c" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_a72cbce0a6c64d80126a119167b5dc50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9a2ad2a43a1bd9b6c3ff840aca327639" level="file">
        <did>
          <unittitle>TML, 45-43 - Alprazolam XR for panic disorder</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="aspace_13d6f03fc2e3895e4e98c67bd4d0e44c" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_85e9963ed4302f46281e64470850e711" parent="aspace_13d6f03fc2e3895e4e98c67bd4d0e44c" type="folder">7</container>
        </did>
        <accessrestrict id="aspace_7facc30ebfc92bd3e698021dbdeb21fe">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_32827b05df08c432fb2cbb3d952c316a" level="file">
        <did>
          <unittitle>TML, 45-15 - Aripiprazole (Abilify) for schizophrenia</unittitle>
          <unitdate type="inclusive">2003 February 17</unitdate>
          <container id="aspace_c2206fede8b12c938729165378cb626b" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_5b24a2f9fb7ff06d0b722b751dd3312b" parent="aspace_c2206fede8b12c938729165378cb626b" type="folder">8-10</container>
        </did>
        <accessrestrict id="aspace_e9db4aba5feb72c13178e46e3f2599e5">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_2dcb5260bf184933786c79514811276a" level="file">
        <did>
          <unittitle>TML, 45-5 - Augmentin XR</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="aspace_576ca42c349e280bebe83819a3443c5c" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_0249f15f5b460b5e2500616207de991b" parent="aspace_576ca42c349e280bebe83819a3443c5c" type="folder">11-13</container>
        </did>
        <accessrestrict id="aspace_352c7f8bef5faa523d50be8830568d03">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_6719542efa0dd7e6ff2199fb0fc45784" level="file">
        <did>
          <unittitle>TML, 45-50 - Blue Light (Clearlight) for acne vulgaris</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="aspace_256cc71c26fdab34c9f193fd0b26509e" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_d4790a5d07f1aa3e154800e4177b8434" parent="aspace_256cc71c26fdab34c9f193fd0b26509e" type="folder">14-15</container>
        </did>
        <accessrestrict id="aspace_dd3798d0577bb9e1fc29332ed3c1ed16">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_face99254c656f96b64bf580e5f85bcf" level="file">
        <did>
          <unittitle>TML, 45-57 - Bortezomib for multiple myeloma</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="aspace_42cac729a71a89d38ce16edc643c084d" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_cd46d6575efb3f89a4fb2c218c183894" parent="aspace_42cac729a71a89d38ce16edc643c084d" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_5b737b9395121e3828a6f6fa407666da">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9ec231ed3611900061caae3128c95513" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="aspace_1f4ffaaf5a5d2c91a22dcd02126ff629" label="Mixed Materials (A0000000075925)" type="box">83</container>
          <container id="aspace_012dbc412719c495e3df485fe992c929" parent="aspace_1f4ffaaf5a5d2c91a22dcd02126ff629" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_e0dca88a43ebdabbfbf835cde2da0a4f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c6404194bb02ecf2496bacd146a0cc60" level="file">
        <did>
          <unittitle>TML, 45-102 - Choice of an Antipsychotic</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="aspace_e4aba9fe6a1c48f4657f72e939a0e58e" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_1b60442507a9fbf51e11f13d87ea0274" parent="aspace_e4aba9fe6a1c48f4657f72e939a0e58e" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_ff3d2237bfc8f29c4712b54bf885e9be">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_2ddbc741772355d7dce54b4b63ef6749" level="file">
        <did>
          <unittitle>TML, 45-97 - Efalizumabe (Raptiva) for treatment of psoriasis</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="aspace_10c3f80aed5ffff033472d7050c49a05" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_aa8f4518506bc6eb68eaca6528f035c7" parent="aspace_10c3f80aed5ffff033472d7050c49a05" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_6eb237f5b70a5174ed44b4dc845e1439">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_0f45b082b3a08c7cce74229a00644b02" level="file">
        <did>
          <unittitle>TML, 45-97 (45-333) - Eletriptan (Replax) for migraine</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="aspace_5745ff861ec32e2884e26dde5c7b38ca" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_1e3e64ee290dd6c556785f3788de5390" parent="aspace_5745ff861ec32e2884e26dde5c7b38ca" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_f517a35e209156fcce5cddbc43b68b14">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_94948e6e42424f89ec840de91511a768" level="file">
        <did>
          <unittitle>TML, 45-49 - Enfuvirtide (Fuzeon) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="aspace_3e2c801f90ebc9d32e1273821199678b" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_1f7428426531353a7b3fb47d5804797d" parent="aspace_3e2c801f90ebc9d32e1273821199678b" type="folder">9-11</container>
        </did>
        <accessrestrict id="aspace_a3551a188d335a0b903727fcd2a48fa4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_48f4b3c522fa705a3ae202735e45ac3b" level="file">
        <did>
          <unittitle>TML, 45-89 - Growth hormone for normal short children</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="aspace_321ff144ca148debe2cec21d830c83a9" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_3c896e78e94f7cb52110ee19a2cd6d81" parent="aspace_321ff144ca148debe2cec21d830c83a9" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_3229644ce53e8795f97a65d5d61f18e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_780d425bdbd53ceafd83133223d279a7" level="file">
        <did>
          <unittitle>TML, 45-67 - Omalizumab (Xolair) for Asthma</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="aspace_8e5f03cffcd0cd3256606cb76aff420a" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_18ad015bb5baa6320253373909a50d0e" parent="aspace_8e5f03cffcd0cd3256606cb76aff420a" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_12994eea68e1f09108df54e255ae8cff">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3e27a4c127b0269848618ade1805962f" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="aspace_380f4ab04ceb83dc3bcd9f98059ab10d" label="Mixed Materials (A0000000075926)" type="box">84</container>
          <container id="aspace_8ef22cdc9d8fe22fa3a0c46cedc5aaba" parent="aspace_380f4ab04ceb83dc3bcd9f98059ab10d" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_319e1cb1c4d5a539efc2e6af94af005a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_732aaf61ce82ace45c4354ea0038b752" level="file">
        <did>
          <unittitle>TML, 45-7 - Oxalipatin</unittitle>
          <unitdate type="inclusive">2003 January 20</unitdate>
          <container id="aspace_110a7766538109558f988d31a5fb83ed" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_32336b934bc9daa7e471af9f72cdc019" parent="aspace_110a7766538109558f988d31a5fb83ed" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_c716c8d0ab4facf419cf7e7c4082202e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c4617feb74a721aa21a7112babed977f" level="file">
        <did>
          <unittitle>TML, 45-38 - Oxbutynin trandermal (Oxytrol) for overactive bladder</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="aspace_a95a22731f07f0f8f7baf3d2964dda70" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_248265f82f2db152129cdb7884c8f6ac" parent="aspace_a95a22731f07f0f8f7baf3d2964dda70" type="folder">3-4</container>
        </did>
        <accessrestrict id="aspace_09ded828b852ae6c86297bc23c88adc0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_8486f3e9d9968bc9f1dce0df7483cd4b" level="file">
        <did>
          <unittitle>TML, 45-54 - Rapid tests for HIV infection</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="aspace_e70d24f6a94d64084e3bbcbbf5f62bf7" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_ea4ba8e09ea4eb9538dff7200c2ca1ef" parent="aspace_e70d24f6a94d64084e3bbcbbf5f62bf7" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_9d74192e21e6502b4dff990dec4cbb50">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_e54b07dbb6cb8e75aad0e568c11cae0a" level="file">
        <did>
          <unittitle>TML, 45-77 - Vardenafil (Levitra) for erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="aspace_226878437f09c3fdc9a353007acf70ef" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_9c8e499d4bc246b7b04d98470c81d37c" parent="aspace_226878437f09c3fdc9a353007acf70ef" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_f6350ccd6ef35a9adb3c39e7c7bf3a3c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_fdd62d893c6f422fd7c183e65efa7835" level="file">
        <did>
          <unittitle>TML, 45-11 - Atomoxetine (Strattera)</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="aspace_089acd62755b34cafe71c423fc2f5881" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_0f9c9429829128380d8b18eb35b6faf5" parent="aspace_089acd62755b34cafe71c423fc2f5881" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_36610a7149adbc1f92cfdc7751128db1">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_35402d0a4356ba61f6f491a96f89217a" level="file">
        <did>
          <unittitle>TML, 45-15 - Buprenorphine - an alternative to methadone</unittitle>
          <unitdate type="inclusive">2013 February 17</unitdate>
          <container id="aspace_6de44d899d4322aaaee4437edf370d5e" label="Mixed Materials (A0000000075927)" type="box">85</container>
          <container id="aspace_9350eb9ce011dded179c48ab6c883be9" parent="aspace_6de44d899d4322aaaee4437edf370d5e" type="folder">16-20</container>
        </did>
        <accessrestrict id="aspace_136a1315a2303fa111e5d01cb0517e7d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3fc7a0238f453d851bcf8a694afaf2ab" level="file">
        <did>
          <unittitle>TML, 45-74 - Agalsidase beta (Fabrazyme) for Fabry disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="aspace_ecdd0744c320327717e46a8c267b8043" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_1c9e5df711dd88905f1a85d29637e55c" parent="aspace_ecdd0744c320327717e46a8c267b8043" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_aab1089a7327f8fc78a2fc319190599a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_5569c52b23e7d7eeddf53f7c2b84a996" level="file">
        <did>
          <unittitle>TML, 45-39 - Eplerenone (Inspra)</unittitle>
          <unitdate type="inclusive">2003 May 12</unitdate>
          <container id="aspace_f2964570574d69bf6efad918dcd0608b" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_215158ca227f53ccfa8f0fb1447b5df8" parent="aspace_f2964570574d69bf6efad918dcd0608b" type="folder">4-6</container>
        </did>
        <accessrestrict id="aspace_4fc1e68dd96cabb133f171a2e6a52471">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_19fc064c09e3806caaddbb51b70e4090" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="aspace_a635b59b632d8ab48b58ead0ce6d3657" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_9acb1a45b7a95950e2ac4e1f3012bba1" parent="aspace_a635b59b632d8ab48b58ead0ce6d3657" type="folder">5A-6A</container>
        </did>
        <accessrestrict id="aspace_60b6213d43e89633056c4a067f8c54e8">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_f0a8b264973dfe8db5fe8da9b49f6e58" level="file">
        <did>
          <unittitle>TML, 45-98 - New Glucose-Monitoring Devices</unittitle>
          <unitdate type="inclusive">2003 December 8</unitdate>
          <container id="aspace_7f0f2fa1b0012e56207729ae1b820584" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_90b8ba2c33c4f08b6ad5076132ee9d4b" parent="aspace_7f0f2fa1b0012e56207729ae1b820584" type="folder">7-9</container>
        </did>
        <accessrestrict id="aspace_7a45da012d9d8375ab9c62d057d20b13">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_d1e93fdc68ebf64e073b0d53c908f073" level="file">
        <did>
          <unittitle>TML, 45-101 - Tadalafil (Cialis) for Erectile dysfunction</unittitle>
          <unitdate type="inclusive">2003 December 22</unitdate>
          <container id="aspace_0e4056a1c7ce76d356854363fb00064e" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_f2865eb6e720c3b91f7587f71e49b0c6" parent="aspace_0e4056a1c7ce76d356854363fb00064e" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_a187e298156d35ecb24bf62acbaa2162">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_bf6ed6095bb9e6efdcac9a21b49e00e9" level="file">
        <did>
          <unittitle>TML, 45-95 - Tattoo Removal</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="aspace_35e7bf279d60cc980a1428f1a09110c7" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_dbeb472f600576b2b158ef22412bc021" parent="aspace_35e7bf279d60cc980a1428f1a09110c7" type="folder">12-13</container>
        </did>
        <accessrestrict id="aspace_1cb8774dfbec0195c1be0234b77205c6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_a857cbd537b23d5351b0c89499d70d8e" level="file">
        <did>
          <unittitle>TML, 45-51 - Priloscec, Nexium and stereoisomers</unittitle>
          <unitdate type="inclusive">2003 June 23</unitdate>
          <container id="aspace_72b58ad8c88e8345d6de3e3baee217fa" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_ef61d9927547bea004e0662bdba10ab6" parent="aspace_72b58ad8c88e8345d6de3e3baee217fa" type="folder">14</container>
        </did>
        <accessrestrict id="aspace_4b2308536bb701384ee28edb8995985a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_1ed11b7c73752bdb0689383a30c1baf5" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="aspace_803974d54df9fd471c3e677ba45efec4" label="Mixed Materials (A0000000075928)" type="box">86</container>
          <container id="aspace_cecfc7afd028ea4b384ab739c1f3c7fd" parent="aspace_803974d54df9fd471c3e677ba45efec4" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_4ae7a8a3386cf59e0586622b1db28e61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c48f05a528d95bdfee4855de30cb54e2" level="file">
        <did>
          <unittitle>TML, 45-65 - Immunization, Influenza, Flumist</unittitle>
          <unitdate type="inclusive">2003 August 18</unitdate>
          <container id="aspace_3eb80adc73f81329af325a2ad9e5fd43" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_d0d78e34b16794a0bfbaa9d5e57cb52b" parent="aspace_3eb80adc73f81329af325a2ad9e5fd43" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_d1a19b29c41ed450efa6dd0a35b030ad">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3e6aff84359c7cdd06669d9d72f8c12a" level="file">
        <did>
          <unittitle>TML, 45-21 - Montelukast (Singulair) for allergic rhinitis</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="aspace_757ffaa4d1d928039d6b33164eabe0af" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_897f4b28be2ef12375243c66e4310da1" parent="aspace_757ffaa4d1d928039d6b33164eabe0af" type="folder">2-4</container>
        </did>
        <accessrestrict id="aspace_2b573db89b3a7e7ffb7bbe4571d64e85">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_7d40fbe976113721e79b64dd1d00e27d" level="file">
        <did>
          <unittitle>TML, 45-3 - OTC Loratadine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="aspace_6006f4d18b75c86629e8f7ed82beed07" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_26a4c987c930637f4229c1d945871840" parent="aspace_6006f4d18b75c86629e8f7ed82beed07" type="folder">5</container>
        </did>
        <accessrestrict id="aspace_68d83db5324a44659c1dd3f51c2e2864">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_1823eedc9d0074c8a4265ac61efdfda5" level="file">
        <did>
          <unittitle>TML, 45-41 - Insect repellents</unittitle>
          <unitdate type="inclusive">2003 May 26</unitdate>
          <container id="aspace_49b8de5468f23e39d636f5155a50ea33" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_cfd602a4e8377cbf05877d019db1f997" parent="aspace_49b8de5468f23e39d636f5155a50ea33" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_fd9f974ca565c85df29a51348d8fb4a7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_2f3bcea3a484b983f63233e648e58d71" level="file">
        <did>
          <unittitle>TML, 45-81 - Rosuvastatin - a new lipid-lowering drug</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="aspace_78e1a0c507df270cc0de44a80099a8f0" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_681ceebc906cad5ff41211caab4e615a" parent="aspace_78e1a0c507df270cc0de44a80099a8f0" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_43bf4f6f81d3fbdf04c68bbc454e9040">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_ba56ad48c3bef0d702fff7fdda72fa22" level="file">
        <did>
          <unittitle>TML, 45-35 - Insulin-sensitizing drugs for polycystic ovary syndrome</unittitle>
          <unitdate type="inclusive">2003 April 28</unitdate>
          <container id="aspace_05541b46e12f9caf30111c70c5f469b2" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_3c8ba96e4d6d7a6b0d20cb39ecda570f" parent="aspace_05541b46e12f9caf30111c70c5f469b2" type="folder">13-15</container>
        </did>
        <accessrestrict id="aspace_68c074ca5c7b85d99e37109be8f03f26">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3d9fbb15ae7446c6c645d70bd47fbf3b" level="file">
        <did>
          <unittitle>TML, 45-73 - Memantine for Alzheimer's disease</unittitle>
          <unitdate type="inclusive">2003 September 15</unitdate>
          <container id="aspace_290206b0f8089e955338a4a9b7b3bc82" label="Mixed Materials (A0000000075929)" type="box">87</container>
          <container id="aspace_22cb63873255b8a2200bf55f6f59c01c" parent="aspace_290206b0f8089e955338a4a9b7b3bc82" type="folder">16-18</container>
        </did>
        <accessrestrict id="aspace_349dea74056b705fe12a6e58b6be4a61">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_11bdec471c430a38763f1ea9a86eab38" level="file">
        <did>
          <unittitle>TML, 45-58 - Treatment of heat injury</unittitle>
          <unitdate type="inclusive">2003 July 21</unitdate>
          <container id="aspace_f78ded66f6faa41eac21227694a6a34e" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_bb6e65e4e23b0f6706389cf6d8c5a11c" parent="aspace_f78ded66f6faa41eac21227694a6a34e" type="folder">1-2</container>
        </did>
        <accessrestrict id="aspace_b32e89185eafe8ec72db09448de5ce28">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_806d8942533d66de734e65e88b3304ee" level="file">
        <did>
          <unittitle>TML, 45-90 - Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV infection</unittitle>
          <unitdate type="inclusive">2003 November 10</unitdate>
          <container id="aspace_f72db5f88d7120a829564686e8eec383" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_80ed3529a06411b56f0e84a8e2995f28" parent="aspace_f72db5f88d7120a829564686e8eec383" type="folder">3-6</container>
        </did>
        <accessrestrict id="aspace_d90cbf0a7351c28f0b2d1347edc27949">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_04dee614a81cacb32c43ef5b0a88af03" level="file">
        <did>
          <unittitle>TML, 45-88 - Aldurazyme (Laronidase)</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="aspace_9af1a8ff803a9fc54a144789cb2a0563" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_04c7613cb2b6b4b637fa590a96f809d6" parent="aspace_9af1a8ff803a9fc54a144789cb2a0563" type="folder">7-8</container>
        </did>
        <accessrestrict id="aspace_b53a56596e6cd54c520d93ec764edd68">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9233509af152396c7a0be4f4a4690cec" level="file">
        <did>
          <unittitle>TML, 45-46 - Drug Interactions</unittitle>
          <unitdate type="inclusive">2003 June 9</unitdate>
          <container id="aspace_d7e8e20ebfbeb073284e857c7965116c" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_5fe1c1683cb1c16dac1587d8680d0c22" parent="aspace_d7e8e20ebfbeb073284e857c7965116c" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_7b355cfd23bf5faae7008b6d8dfcd613">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_95a2b9eb73be12648888070a03ead474" level="file">
        <did>
          <unittitle>TML, 45-85 - Lowering Plasma Homocystein</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="aspace_80f3f558459d6beedc76a257e4fa739a" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_eb24a2b959b6c8e8c9de2963575770c5" parent="aspace_80f3f558459d6beedc76a257e4fa739a" type="folder">13-17</container>
        </did>
        <accessrestrict id="aspace_150bc9e4636bdbb6ef444d31120758f6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_dad27947e40b662edd3cc5a90a0be625" level="file">
        <did>
          <unittitle>TML, 45-83 - Lp-Pla2 - A new marker of Vasular Risk</unittitle>
          <unitdate type="inclusive">2003 October 13</unitdate>
          <container id="aspace_112f960008fe7094735a42057136b444" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_9b6f19f6d5e261086265a069400e1f3b" parent="aspace_112f960008fe7094735a42057136b444" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_7bacb749d5cace7b77c6d20686088469">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_e617e6eea5f9996628c705dd200e1ffa" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="aspace_36e1c8300d8976da80ac24e7162c7986" label="Mixed Materials (A0000000075930)" type="box">88</container>
          <container id="aspace_8a5b7309b39c61b49fdaf7fbf40ad7c0" parent="aspace_36e1c8300d8976da80ac24e7162c7986" type="folder">20</container>
        </did>
        <accessrestrict id="aspace_8c291adc86b1ece8d63fe68ecf028b3e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9fd8a0d9db61f711e261afe6ec4c49ea" level="file">
        <did>
          <unittitle>TML, 45-17 - Three new drugs for hyperlipidemia</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="aspace_43744a6bc5d75410160e94c8674f02fa" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_1e40f391123a979fc69c438b9264ecf3" parent="aspace_43744a6bc5d75410160e94c8674f02fa" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_bce92c80f15ffaccbaa401c6170b83ed">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_edaf8bc319227fe95dce9ce1973f3621" level="file">
        <did>
          <unittitle>TML, 45-86 - Iodine-131 - Tositumomab (Bexxar) for treatment of Lymphoma</unittitle>
          <unitdate type="inclusive">2003 October 27</unitdate>
          <container id="aspace_df725e3ba697ab00ee894f0bc152ac0f" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_7f60affc017ab02be1697a8fa10ae54f" parent="aspace_df725e3ba697ab00ee894f0bc152ac0f" type="folder">5-9</container>
        </did>
        <accessrestrict id="aspace_a9e5f083314a82f3692a841eac51a5ca">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_f8dc69e4bf109c9986cc722051633070" level="file">
        <did>
          <unittitle>TML, 45-27 - Pneumococcal Conjugate Vaccine</unittitle>
          <unitdate type="inclusive">2003 March 31</unitdate>
          <container id="aspace_237eda61149ecfd60203baaded4bb3f8" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_4130e4d8a54a7f0ba978389509952457" parent="aspace_237eda61149ecfd60203baaded4bb3f8" type="folder">10-11</container>
        </did>
        <accessrestrict id="aspace_e59f218612780c21cd1831f3c38ec08e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_cc9f06be346fedef1f6102477bee9cb2" level="file">
        <did>
          <unittitle>TML, 45-78 - Influenza Prevention</unittitle>
          <unitdate type="inclusive">2003 September 29</unitdate>
          <container id="aspace_8c09d213d50d374c7a85dea128c4ed4c" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_6eb9511dc49a536e595786245cbbad8e" parent="aspace_8c09d213d50d374c7a85dea128c4ed4c" type="folder">12-14</container>
        </did>
        <accessrestrict id="aspace_cc6daf505d9a0ea7ee4c3ea324aa8478">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_39d9d76dedec7d6057d3eb65d8744ded" level="file">
        <did>
          <unittitle>TML, 45-19 - Peginterferon alfa (Pegasys) for Chronic Hepatitis C</unittitle>
          <unitdate type="inclusive">2003 March 3</unitdate>
          <container id="aspace_b119e84e1a0ec816e4f0aefdc9092d75" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_1a5246fa0e1f9572e65d604b1b3b9167" parent="aspace_b119e84e1a0ec816e4f0aefdc9092d75" type="folder">15-16</container>
        </did>
        <accessrestrict id="aspace_4cfe15ffe7bdd2742771ed54d3c1d07c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_efd0e7eb3789a0bc30a68f63ca9b430c" level="file">
        <did>
          <unittitle>TML, 45-55 - Pegvisomant (Somavert) for Acromegly</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="aspace_0069daa478acd40a2f4ea94c7289ed0c" label="Mixed Materials (A0000000075931)" type="box">89</container>
          <container id="aspace_a459db578c9c0b24a477af0e9293ba2e" parent="aspace_0069daa478acd40a2f4ea94c7289ed0c" type="folder">17-20</container>
        </did>
        <accessrestrict id="aspace_565dbbbdc9cf527d50ca1536a406a58f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_e809ce901af88811ad1fd0cb5bc5882c" level="file">
        <did>
          <unittitle>TML, 45-9 - Teriparatide for Osteoporosis</unittitle>
          <unitdate type="inclusive">2003 February 3</unitdate>
          <container id="aspace_3af08e44a979c5f99305c6ab921d26f0" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_7ce5ce23d257b912d6c10af729bd4bfb" parent="aspace_3af08e44a979c5f99305c6ab921d26f0" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_662bdc9f7dbb54b08b4950ea34c176c4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_acd944256fa6e191f50b1c636b7b7bf4" level="file">
        <did>
          <unittitle>TML, 45-70 - Testim and Striant - two new testosterone products</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="aspace_77ce0003aa80d9e3f662409458ac56ce" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_8fd511f6d0de5097d2af5f003966116d" parent="aspace_77ce0003aa80d9e3f662409458ac56ce" type="folder">5-8</container>
        </did>
        <accessrestrict id="aspace_56655a641344d4055a005097ec27c5cb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_fbdf4b7f30d77eaf33b84599e0a5e6e6" level="file">
        <did>
          <unittitle>TML, 45-1 - Smallpox vaccine</unittitle>
          <unitdate type="inclusive">2003 January 6</unitdate>
          <container id="aspace_77c7a5ad521c9efa34207e6bdc6f4e39" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_3c9cfe6bcfcdde93f35a551b6ac9aebf" parent="aspace_77c7a5ad521c9efa34207e6bdc6f4e39" type="folder">9-12</container>
        </did>
        <accessrestrict id="aspace_df814d1bfcebe53223f1d57c2a6776e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_d9642438ec124cd82d8e135b0198ede7" level="file">
        <did>
          <unittitle>TML, 45-69 - Minimal surgery for treatment of GERD</unittitle>
          <unitdate type="inclusive">2003 September 1</unitdate>
          <container id="aspace_acfb3a5fcc1fd60d04b23f51dd716136" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_fdad75872539c426ff70ec9a79c24293" parent="aspace_acfb3a5fcc1fd60d04b23f51dd716136" type="folder">13-16</container>
        </did>
        <accessrestrict id="aspace_572b2a0e74e3c89c9169b31576cc0b55">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_0e7f3c8cc41ff780e30caa2e1cd3c245" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="aspace_5908b85d8c24174576cf1e3e9f33d99e" label="Mixed Materials (A0000000075932)" type="box">90</container>
          <container id="aspace_25d59ccceacbb6359431797bc126da27" parent="aspace_5908b85d8c24174576cf1e3e9f33d99e" type="folder">17-19</container>
        </did>
        <accessrestrict id="aspace_91472bcb765db5980f76960bca69f7bb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_4cbcc7808efc65afe1e68d84b33f1bea" level="file">
        <did>
          <unittitle>TML, 45-23 - Drug-eluting Stents</unittitle>
          <unitdate type="inclusive">2003 March 17</unitdate>
          <container id="aspace_8a92cb9d7bfb1da7fa0ab9ea25c94ffa" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="aspace_2b2369db0d6973be174c7ef238b0e43f" parent="aspace_8a92cb9d7bfb1da7fa0ab9ea25c94ffa" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_ad37cdcd99a2044624e749e1cd39779d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_f9a9c4fc1896553a888be142b1758016" level="file">
        <did>
          <unittitle>TML, 45-61 - Omeprazole (Prilosec) (OTC)</unittitle>
          <unitdate type="inclusive">2003 August 4</unitdate>
          <container id="aspace_6a0d52d7437ef0e8dc83e7d02fef3f1b" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="aspace_a812a1dce8d5aa4e32e4bc922071b616" parent="aspace_6a0d52d7437ef0e8dc83e7d02fef3f1b" type="folder">2-3</container>
        </did>
        <accessrestrict id="aspace_d9a5d8493c3334bb1cda4ff7afb8a52c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_839fb8691411f959bd1aac5c4ebf7d26" level="file">
        <did>
          <unittitle>TML, 45-29 - Nitazoxanide (Alina) - a new anti-protozoal agent</unittitle>
          <unitdate type="inclusive">2003 April 14</unitdate>
          <container id="aspace_25764c4b71140bc99058a77b8b3bd952" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="aspace_e2d58be1307e5a4a623f09bd9509bd9b" parent="aspace_25764c4b71140bc99058a77b8b3bd952" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_ba825ee552c2bf91acd8b458e0a15d2d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_55365ce4b3ea2d58db64e9416965cb4e" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="aspace_5c174d557be0346b30f8a814f1ae47f4" label="Mixed Materials (A0000000075933)" type="box">91</container>
          <container id="aspace_6bcab6dc83060902f212dd5fa88cc10d" parent="aspace_5c174d557be0346b30f8a814f1ae47f4" type="folder">6-17</container>
        </did>
        <accessrestrict id="aspace_0ed20f41fac45d1a638a3740752cb703">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_668d7e7e07b5750eb2c823e11c095964" level="file">
        <did>
          <unittitle>TML - Drug of Choice for Cancer - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="aspace_c95132bc6ec8502af71a78ccb9b26628" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="aspace_2b5c8302a862fa4fec6ac3aa3647ce61" parent="aspace_c95132bc6ec8502af71a78ccb9b26628" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_c2b71f78c735a86ad9547e6e3d24546c">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c171f13c04b5ef1cf3b3fe5e96a9ef03" level="file">
        <did>
          <unittitle>TML - Weight Loss - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 December</unitdate>
          <container id="aspace_156f59caf624152055a81d6cc662d7bf" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="aspace_a5f309b7849221eed86024c32bf67117" parent="aspace_156f59caf624152055a81d6cc662d7bf" type="folder">5-13</container>
        </did>
        <accessrestrict id="aspace_6dd9eece4a3c89e40bca2442781a600d">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_ee60c4bf66a25475983425024da14c39" level="file">
        <did>
          <unittitle>TML - Heart Failure - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 April</unitdate>
          <container id="aspace_6319d97bf5c5c14764ecdc7620cfdfd1" label="Mixed Materials (A0000000075934)" type="box">92</container>
          <container id="aspace_0c6f01ad0a44142bebcd3f0998919b89" parent="aspace_6319d97bf5c5c14764ecdc7620cfdfd1" type="folder">14-18</container>
        </did>
        <accessrestrict id="aspace_957488be5b6a3b3f5fb3aca8638e23b6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_0be1e684fc9e69b20bc9867cc0b7288f" level="file">
        <did>
          <unittitle>TML - Drugs for rheumatoid arthritis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="aspace_8e9c2827e34e9a1e5258b7157bd878a4" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="aspace_2db6cb08deeb7d83ed23026e2d88f9e5" parent="aspace_8e9c2827e34e9a1e5258b7157bd878a4" type="folder">1-7</container>
        </did>
        <accessrestrict id="aspace_fea0a477360238ce0c79c9e79ad6d39a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_c0978c508033828e366f1d55950a308e" level="file">
        <did>
          <unittitle>TML - Drugs for Psychiatric Disorders</unittitle>
          <unitdate type="inclusive">2003 July</unitdate>
          <container id="aspace_5488e63d2f9692b36988bc7cacce7ae5" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="aspace_a603204429352ec1ece8ae627c681332" parent="aspace_5488e63d2f9692b36988bc7cacce7ae5" type="folder">8-18</container>
        </did>
        <accessrestrict id="aspace_03781a219ff982acf63e0290b3b87f0e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_a9906d72f32382fa1bb39c1ccd388091" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="aspace_52aacab9f1c4c1268ff26a79e68233a9" label="Mixed Materials (A0000000075935)" type="box">93</container>
          <container id="aspace_6340e61aae94518cdb5142a1e2bbb1de" parent="aspace_52aacab9f1c4c1268ff26a79e68233a9" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_a19ba7012ef7e238dc26e208ad0c53df">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_9d1257d4a4ba512b1aa0bb0a4c07fdcd" level="file">
        <did>
          <unittitle>TML - Rheumatoid Arthritis - Treatment Guidelines - Reprints</unittitle>
          <unitdate type="inclusive">2003 January</unitdate>
          <container id="aspace_e7d7bd9c1d192bd813598971cc92fabf" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="aspace_f526c0e23732825ed4c6a08ce8993b09" parent="aspace_e7d7bd9c1d192bd813598971cc92fabf" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_2097ee7f9bd39cd5ea6f974d3df6ff1f">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_380c664090534851fbc806e0558fde2f" level="file">
        <did>
          <unittitle>TML - Assisted Reproduction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 October</unitdate>
          <container id="aspace_83700f0f50fbf2869054dd9e4b96a16b" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="aspace_f9f10c635e82d4eaf4bae0e1a02ba990" parent="aspace_83700f0f50fbf2869054dd9e4b96a16b" type="folder">5-13</container>
        </did>
        <accessrestrict id="aspace_69fb416fcc934ed0c8b1f96140cd08e2">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_dfe820ca0d9eb165533f652cbc41ee32" level="file">
        <did>
          <unittitle>TML - Drugs for Hypertension - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 February</unitdate>
          <container id="aspace_6a562a9bdd5facbb9ab27ec4ae72e5a8" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="aspace_6970acf3c75b6eeb2410a296f407800a" parent="aspace_6a562a9bdd5facbb9ab27ec4ae72e5a8" type="folder">14-17</container>
        </did>
        <accessrestrict id="aspace_5a63fa0917343ef8eb141521fcb9e24e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3ce9ce08c457fba44042e2deea5066f7" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="aspace_d70f232fe30c09d91a78354d8408a318" label="Mixed Materials (A0000000075936)" type="box">94</container>
          <container id="aspace_6dffe3854c5efeaf73a0a949e807d110" parent="aspace_d70f232fe30c09d91a78354d8408a318" type="folder">18</container>
        </did>
        <accessrestrict id="aspace_43bc17de19e0d00f4e7031362b3b3efc">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_d475b54c5095880adce7b8263966fe2d" level="file">
        <did>
          <unittitle>TML - Tobacco Addiction - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 March</unitdate>
          <container id="aspace_9f331ffad521dbb5b75f736349dfb1ce" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="aspace_2de68176c63457e2c91f70053e015644" parent="aspace_9f331ffad521dbb5b75f736349dfb1ce" type="folder">1-8</container>
        </did>
        <accessrestrict id="aspace_d727ecc0d3636f553591f418559bc721">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_a6efb00d5c63c6a2ccedf6563ae43110" level="file">
        <did>
          <unittitle>TML - Drugs for Epilepsy - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 May</unitdate>
          <container id="aspace_6a12bc3da7ebfc1098989332e60be448" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="aspace_3a3aa9d9337e6baaa9f8bfe93688b00e" parent="aspace_6a12bc3da7ebfc1098989332e60be448" type="folder">9-14</container>
        </did>
        <accessrestrict id="aspace_ae7bd45c44b6a19a25f101af3b5a211a">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_5a5ba60bec4d0b97fddcd00799fd7626" level="file">
        <did>
          <unittitle>TML - Drugs for Lipid Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 August</unitdate>
          <container id="aspace_edf884110b955904642cb2d553ce8552" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="aspace_51b13ed202642072a9a3bf8aa723d8b8" parent="aspace_edf884110b955904642cb2d553ce8552" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_334e64660b4fc298f4d1c26e9a76a343">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_3c1aea5febbafdf8b5e437a8e97b9218" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="aspace_01de9dabe067bcfa95be6f3496e97a55" label="Mixed Materials (A0000000075937)" type="box">95</container>
          <container id="aspace_1efdd3a510ad05f2c8f03389a4bf3863" parent="aspace_01de9dabe067bcfa95be6f3496e97a55" type="folder">19</container>
        </did>
        <accessrestrict id="aspace_7cdf942787e0cbed8326189a2020f299">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_ddf6b73987ce0637989f66584610c6ea" level="file">
        <did>
          <unittitle>TML, 49-53 - SSRIs Safe for Children</unittitle>
          <unitdate type="inclusive">2003 July 7</unitdate>
          <container id="aspace_85248b540f9cfbec418d49a166bfc77f" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="aspace_8db2a10b8fcfb7c67f36d5c6564568ff" parent="aspace_85248b540f9cfbec418d49a166bfc77f" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_2b960cecbba771988110df8a9cd33742">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ca468433bcdc6006e7fb9b0ef21814e" level="file">
        <did>
          <unittitle>TML, 45-93 - Which SSRI</unittitle>
          <unitdate type="inclusive">2003 November 24</unitdate>
          <container id="aspace_b58a289458703edeae11f0f99b67d14e" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="aspace_ec0b4fab510ca54e2608c215a4938e6b" parent="aspace_b58a289458703edeae11f0f99b67d14e" type="folder">2-5</container>
        </did>
        <accessrestrict id="aspace_72e10bfbf01df945876de61f8480a08b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_1e5a72f232d4e116685aff32e9ed9f87" level="file">
        <did>
          <unittitle>TML - Drugs for Allergic Disorders - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 November</unitdate>
          <container id="aspace_1b7adb123ababcb411c13cd124b673d7" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="aspace_9bdd7b6cb76aa8573ba5655892155e72" parent="aspace_1b7adb123ababcb411c13cd124b673d7" type="folder">6-9</container>
        </did>
        <accessrestrict id="aspace_ce922dcf8bde445758a34a54106e0ec6">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_7621ca9e85272fb03e367f6102650bf9" level="file">
        <did>
          <unittitle>TML - Drugs for Pneumonia - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2003 September</unitdate>
          <container id="aspace_4ce6998e0e3e247aa44ce9334b399486" label="Mixed Materials (A0000000075938)" type="box">96</container>
          <container id="aspace_e86e113f820ee924826ae326d61747e3" parent="aspace_4ce6998e0e3e247aa44ce9334b399486" type="folder">10-17</container>
        </did>
        <accessrestrict id="aspace_429d1928e15342d8a9639e6b6a92e6d4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2029</p>
        </accessrestrict>
      </c>
      <c id="aspace_68e729c691bb49c8be35f332fbb1e32b" level="file">
        <did>
          <unittitle>TML - Antimicrobial Prophylaxis for Surgery - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="aspace_c10138e3c8ece2354d51d1d4b6e06478" label="Mixed Materials (A0000000075939)" type="box">97</container>
          <container id="aspace_a99a885578b1e64687739a42ff8c1d81" parent="aspace_c10138e3c8ece2354d51d1d4b6e06478" type="folder">1-10</container>
        </did>
        <accessrestrict id="aspace_084a4278da0f4581918db07f8eb825b4">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_07f19737b5f6d3009e9e85a8b0528533" level="file">
        <did>
          <unittitle>TML - Drugs for Cardiac Arrhythmias - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="aspace_13c7b351140f15a233e2a16b5727d2b3" label="Mixed Materials (A0000000075939)" type="box">97</container>
          <container id="aspace_6c1204fa19aed1f5cc74fc0326608c04" parent="aspace_13c7b351140f15a233e2a16b5727d2b3" type="folder">11-18</container>
        </did>
        <accessrestrict id="aspace_8f26a61c71898392ee05f246c39c61b0">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_c099bb967206188345dcdbf9c2975e6d" level="file">
        <did>
          <unittitle>TML - Advice for Travelers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="aspace_fe2c15517dbdfecf50f6b7f3e9dcd613" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="aspace_3019f9ba75350fef4a7481db6102befb" parent="aspace_fe2c15517dbdfecf50f6b7f3e9dcd613" type="folder">1-9</container>
        </did>
        <accessrestrict id="aspace_e0b7814bc924716eb27275e9522cf9ae">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_237497500e700200226282634e319af9" level="file">
        <did>
          <unittitle>TML - Drugs for Migraine - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004</unitdate>
          <container id="aspace_3dd57a922efd0105dab5839adaa7f92b" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="aspace_b57eae784006286c2eee8d97c47ba94e" parent="aspace_3dd57a922efd0105dab5839adaa7f92b" type="folder">10-15</container>
        </did>
        <accessrestrict id="aspace_00d75b64dab2398628516bc88ce53406">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_423b8c383be805c9a485a8fecfe9ddb1" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="aspace_8b370bcbb4a3b9e0a82864b46aa69f41" label="Mixed Materials (A0000000075940)" type="box">98</container>
          <container id="aspace_5d06f05c9bddad1dc8fe7d394b18b9e0" parent="aspace_8b370bcbb4a3b9e0a82864b46aa69f41" type="folder">16</container>
        </did>
        <accessrestrict id="aspace_98f8b37e529ccb193a51c645e7d19af9">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_26700edc7d4dff9bb83e29c005e8dedd" level="file">
        <did>
          <unittitle>TML - Tuberculosis - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 December</unitdate>
          <container id="aspace_df0d81a4cfc1ce47f06a3f3e36f67e83" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="aspace_2279ea1640890c9939e9b0085f04cdb2" parent="aspace_df0d81a4cfc1ce47f06a3f3e36f67e83" type="folder">1-5</container>
        </did>
        <accessrestrict id="aspace_ff906c4305f7b289ec47141f34c41d10">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_bef1ef630d26c3d4f70cc63b2da9dbfa" level="file">
        <did>
          <unittitle>TML - Drugs for Sexually transmitted infections - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 October</unitdate>
          <container id="aspace_fd9669a55e5e828eae2afe3cbd86b071" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="aspace_da6e2901dfebe6422447a043a7f73507" parent="aspace_fd9669a55e5e828eae2afe3cbd86b071" type="folder">6-12</container>
        </did>
        <accessrestrict id="aspace_6db6900a0738aa418a1db1239ba995f3">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_ef8b77a4a9168df66dbaa1d35328f051" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="aspace_95f97750f44d3ebd4f6fab4e6410aca4" label="Mixed Materials (A0000000075941)" type="box">99</container>
          <container id="aspace_d870c31f98bb11e41939030b751ab2c2" parent="aspace_95f97750f44d3ebd4f6fab4e6410aca4" type="folder">13-18</container>
        </did>
        <accessrestrict id="aspace_d4257f7e3e2891eb7db697e7bd0a7fc7">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_4122c98e47eb1d53ed958233e91ca5d6" level="file">
        <did>
          <unittitle>TML - Drugs for Parkinson's disease - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 June</unitdate>
          <container id="aspace_19e9b3c632e74bc0aa9aef987b72b4d0" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_099faa4211cf4ab9a9ea539c47cdbe2f" parent="aspace_19e9b3c632e74bc0aa9aef987b72b4d0" type="folder">1-3</container>
        </did>
        <accessrestrict id="aspace_4ac25a41ad51ce40a2b44624b0c6f458">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_1db0c21858cc9e616d5906c203e6860d" level="file">
        <did>
          <unittitle>TML, 46-22 - Abarelix (Plenaxis) for advanced prostrate cancer</unittitle>
          <unitdate type="inclusive">2004 March 15</unitdate>
          <container id="aspace_d999bd6f95886fa4f43455edac245c60" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_c88d926839358576b70964e0c071b507" parent="aspace_d999bd6f95886fa4f43455edac245c60" type="folder">4-5</container>
        </did>
        <accessrestrict id="aspace_d7dfc37db7d6c404c6134b6250ab6400">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_7f8aea6a2a9125acc397a2b721ccebdb" level="file">
        <did>
          <unittitle>TML, 46-9 - Daptomycin (Cubicin) for skin and soft tissue infections</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="aspace_937c00cf6b4c66c7be4c5616216b4488" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_5ee616653d1ac6d8d570967286e7197c" parent="aspace_937c00cf6b4c66c7be4c5616216b4488" type="folder">6-8</container>
        </did>
        <accessrestrict id="aspace_8b64bb10092754b7b8a4c90c8deb7337">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_08fbdaa8a0871e1576f4bafb794f57f9" level="file">
        <did>
          <unittitle>TML, 46-10 - Emergency Contraception OTC</unittitle>
          <unitdate type="inclusive">2004 February 2</unitdate>
          <container id="aspace_aa1a16e1755ec5468b07b9bef481ef77" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_4421e88af49f4b2224a5eb58d61a0601" parent="aspace_aa1a16e1755ec5468b07b9bef481ef77" type="folder">9-10</container>
        </did>
        <accessrestrict id="aspace_00f05ef1f3a72bb3da4ce317cb793c27">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_9ea3892837eec8429d01fe1dc14e6b41" level="file">
        <did>
          <unittitle>TML, 46-5 - Lasik and its alternatives - an update</unittitle>
          <unitdate type="inclusive">2004 January 19</unitdate>
          <container id="aspace_2788749cfcf902c672ccfc5bd86b56a6" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_b6699dd6a5fd4426c045e0d97bc17ad6" parent="aspace_2788749cfcf902c672ccfc5bd86b56a6" type="folder">11-14</container>
        </did>
        <accessrestrict id="aspace_7815c3c9e1b402b4a02ed5022e168609">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_f1703fc66140060139d86d70ac0c3846" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="aspace_c237d088abb1623b8c140bb0b17aaece" label="Mixed Materials (A0000000075942)" type="box">100</container>
          <container id="aspace_411722bfac43344ce6cce749f5d1f02a" parent="aspace_c237d088abb1623b8c140bb0b17aaece" type="folder">15-18</container>
        </did>
        <accessrestrict id="aspace_dc0cf1e8ca62aefc4f65bdca678ea19e">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_e8f33c13c32daa15598a2e144e9f900f" level="file">
        <did>
          <unittitle>TML, 46-15 - Effexor vs. SSRI</unittitle>
          <unitdate type="inclusive">2004 February 16</unitdate>
          <container id="aspace_016856f03bc5367074be0362bb9a4de8" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="aspace_c5a1a410b9445c49255e327927cbcc89" parent="aspace_016856f03bc5367074be0362bb9a4de8" type="folder">1</container>
        </did>
        <accessrestrict id="aspace_81a1621d7a2a2452c30a530869fc9bea">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_f1258ee39d7e2cce0fa124be57ed0634" level="file">
        <did>
          <unittitle>TML - Choice of Antibacterial Drugs - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 March</unitdate>
          <container id="aspace_b22894d7cf33cb90f3782575397382ae" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="aspace_591894c551f6967affb1affe62931cea" parent="aspace_b22894d7cf33cb90f3782575397382ae" type="folder">2-8</container>
        </did>
        <accessrestrict id="aspace_d14f31516858f5ff1d6ab38316a1acdf">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_dcf6c003359f1d37afb6b89504a47763" level="file">
        <did>
          <unittitle>TML - Drugs for Peptic Ulcers - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 February</unitdate>
          <container id="aspace_0147a35cddf8c8bb65c23a5b0d3670b6" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="aspace_1f39830884900dd61abed11109f963db" parent="aspace_0147a35cddf8c8bb65c23a5b0d3670b6" type="folder">9-17</container>
        </did>
        <accessrestrict id="aspace_ee022307e7bb1d19942f259293477255">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_0ba4f3a6cf74e6af72c13dc1e491dbd6" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="aspace_27522aeffa9a1bb750841bcd299d6a9a" label="Mixed Materials (A0000000075943)" type="box">101</container>
          <container id="aspace_59956875e450b768d1cec41d2cf31b87" parent="aspace_27522aeffa9a1bb750841bcd299d6a9a" type="folder">18-19</container>
        </did>
        <accessrestrict id="aspace_cae76792326d54b966f74999980f0522">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_499346d5020cece037a74d774986c858" level="file">
        <did>
          <unittitle>TML - Drugs for HIV Infection - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 January</unitdate>
          <container id="aspace_34d239187153d5c1e0bc416350f07a84" label="Mixed Materials (A0000000075944)" type="box">102</container>
          <container id="aspace_3f1a5dea0e6d88c4a20eafef4a390cf0" parent="aspace_34d239187153d5c1e0bc416350f07a84" type="folder">1-4</container>
        </did>
        <accessrestrict id="aspace_78b76f282a6087796d952eea7ca3851b">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
      <c id="aspace_e2ff3268992aa759f09a842e60822ffb" level="file">
        <did>
          <unittitle>TML - Drugs for Pain - Treatment Guidelines</unittitle>
          <unitdate type="inclusive">2004 July</unitdate>
          <container id="aspace_74e1bd680e4b313f67ca2f5944e34c1e" label="Mixed Materials (A0000000075944)" type="box">102</container>
          <container id="aspace_8c19731270746d69965444d6757e5062" parent="aspace_74e1bd680e4b313f67ca2f5944e34c1e" type="folder">5-14</container>
        </did>
        <accessrestrict id="aspace_04e11af6b467a1e7c10d7574675c44fb">
          <head>Conditions Governing Access</head>
          <p>Restricted material - Open in 2030</p>
        </accessrestrict>
      </c>
    </dsc>
  </archdesc>
</ead>
